data_1bde_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bde _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 121.772 0.796 . . . . 1.0 110.785 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 pt -79.87 -32.94 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 106.676 -1.601 . . . . 1.0 106.676 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.3 mt -57.16 -28.1 29.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.185 -1.37 . . . . 1.0 109.227 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.403 ' C ' HE21 ' A' ' 66' ' ' GLN . 58.2 mtp180 -70.54 -51.68 26.98 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.574 -1.65 . . . . 1.0 114.746 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -72.79 -30.03 31.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 C-N-CA 118.314 -1.355 . . . . 1.0 111.489 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.503 ' N ' HD13 ' A' ' 63' ' ' ILE . 31.0 tp -69.32 -34.11 74.17 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.001 -0.741 . . . . 1.0 109.001 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.544 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -74.87 -53.86 8.32 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.587 -2.005 . . . . 1.0 105.587 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.403 HE21 ' C ' ' A' ' 62' ' ' ARG . 39.3 mt-30 -50.3 -39.77 46.52 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.431 -1.259 . . . . 1.0 111.61 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.448 ' O ' HG12 ' A' ' 70' ' ' ILE . 69.5 mt -83.54 -20.88 33.07 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.563 -1.199 . . . . 1.0 110.431 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.408 ' O ' ' CD2' ' A' ' 71' ' ' HIS . 15.3 tp -84.58 -7.37 59.28 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 102.883 -3.006 . . . . 1.0 102.883 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 65' ' ' GLN . 17.6 m-30 -87.05 -37.23 17.64 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.434 -0.906 . . . . 1.0 110.169 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 67' ' ' LEU . 1.1 pt -50.41 -37.78 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 118.831 -1.148 . . . . 1.0 113.365 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -55.14 -26.81 41.05 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 118.869 -1.132 . . . . 1.0 109.866 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.417 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 31.1 t80 -84.65 -17.75 37.56 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.988 0.899 . . . . 1.0 111.486 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -98.48 -15.58 19.54 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.462 -1.244 . . . . 1.0 108.635 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.297 -1.691 0 CA-C-N 112.578 -2.101 . . . . 1.0 109.223 179.714 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 119.083 -0.484 . . . . 1.0 110.746 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.409 ' O ' HD11 ' A' ' 63' ' ' ILE . 2.2 pt -86.3 -35.49 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 116.144 -2.222 . . . . 1.0 107.434 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.31 -25.24 35.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.832 1.301 . . . . 1.0 108.513 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -62.45 -56.61 16.56 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.122 -1.399 . . . . 1.0 113.806 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.548 HD11 ' N ' ' A' ' 64' ' ' LEU . 1.6 pp -69.6 -30.68 46.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 C-N-CA 118.684 -1.207 . . . . 1.0 111.363 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.548 ' N ' HD11 ' A' ' 63' ' ' ILE . 45.9 tp -67.86 -35.17 78.08 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.213 -1.032 . . . . 1.0 108.213 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.482 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.83 -47.87 20.13 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 105.676 -1.972 . . . . 1.0 105.676 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.475 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 49.4 mt-30 -51.61 -41.05 60.96 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.967 0.889 . . . . 1.0 111.494 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt -76.3 -36.42 58.37 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.511 -1.276 . . . . 1.0 109.866 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.45 -27.18 67.32 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.308 -2.108 . . . . 1.0 105.308 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 14.6 m-30 -73.53 -48.52 32.5 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 105.728 -1.953 . . . . 1.0 105.728 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 mp -44.43 -43.37 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 124.026 0.829 . . . . 1.0 111.643 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.459 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 5.0 t60 -49.23 -48.46 45.58 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.058 0.932 . . . . 1.0 110.279 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -62.15 -20.15 63.8 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.345 -1.298 . . . . 1.0 112.684 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 24.3 mtt180 -86.72 -43.35 12.64 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 105.742 -1.948 . . . . 1.0 105.742 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.8 mt . . . . . 0 C--N 1.303 -1.418 0 CA-C-N 112.934 -1.939 . . . . 1.0 106.537 179.663 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 119.235 -0.412 . . . . 1.0 111.878 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -87.54 -26.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 116.222 -2.191 . . . . 1.0 108.426 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.92 -32.66 11.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.94 -1.104 . . . . 1.0 110.092 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.402 ' HG2' ' NE2' ' A' ' 66' ' ' GLN . 7.4 ttp180 -56.62 -53.88 52.53 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.697 -0.801 . . . . 1.0 112.407 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.547 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -71.91 -27.86 28.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 C-N-CA 119.224 -0.99 . . . . 1.0 112.634 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.547 ' N ' HD13 ' A' ' 63' ' ' ILE . 51.2 tp -70.82 -29.66 65.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.764 -1.198 . . . . 1.0 107.764 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -54.72 5.0 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 105.847 -1.909 . . . . 1.0 105.847 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.412 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 30.4 mt-30 -51.07 -37.95 48.71 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.177 -0.92 . . . . 1.0 112.198 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.481 ' HA ' HG12 ' A' ' 70' ' ' ILE . 71.1 mt -81.63 -33.37 31.46 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.805 -1.158 . . . . 1.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.48 -18.95 62.98 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 104.856 -2.275 . . . . 1.0 104.856 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 18.5 m-30 -72.9 -36.96 67.41 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 117.608 -1.637 . . . . 1.0 108.835 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.1 mm -48.68 -41.25 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.699 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.469 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -51.17 -36.78 42.8 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -76.78 -20.12 56.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.278 -0.874 . . . . 1.0 111.967 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -91.95 -20.38 21.44 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.418 -1.327 . . . . 1.0 107.418 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.9 mt . . . . . 0 C--N 1.3 -1.548 0 CA-C-N 112.266 -2.243 . . . . 1.0 108.008 179.43 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 112.328 0.492 . . . . 1.0 112.328 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 pt -81.99 -35.85 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 116.828 -1.949 . . . . 1.0 105.816 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.07 -45.74 53.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 105.895 -1.891 . . . . 1.0 105.895 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.554 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 36.5 mmt180 -49.61 -41.44 42.23 Favored 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 118.805 -1.158 . . . . 1.0 113.656 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.492 ' N ' HD11 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -82.54 -27.88 8.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 CA-C-N 114.344 -1.298 . . . . 1.0 109.893 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.86 -32.11 65.21 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.264 -1.374 . . . . 1.0 108.786 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.554 ' NE2' ' HA ' ' A' ' 62' ' ' ARG . 6.3 mt-30 -73.31 -48.82 31.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.04 -1.837 . . . . 1.0 106.04 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -56.3 -52.77 63.32 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.12 -1.4 . . . . 1.0 111.287 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 61.3 mt -67.98 -27.36 66.51 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.695 -1.139 . . . . 1.0 111.185 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -71.4 -15.29 62.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 105.796 -1.927 . . . . 1.0 105.796 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -90.78 -49.24 6.56 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 123.569 1.652 . . . . 1.0 106.967 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.9 mt -57.03 -42.9 80.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 111.766 -2.47 . . . . 1.0 110.922 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -18.98 14.84 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.461 -0.895 . . . . 1.0 110.249 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -86.25 -25.33 25.61 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.579 1.181 . . . . 1.0 110.326 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -86.15 -28.87 23.7 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 113.014 -1.903 . . . . 1.0 108.156 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.9 mt . . . . . 0 C--N 1.297 -1.69 0 N-CA-C 100.439 -3.912 . . . . 1.0 100.439 178.916 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.953 0.406 . . . . 1.0 110.53 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.414 ' O ' HD11 ' A' ' 63' ' ' ILE . 2.4 pt -78.65 -30.03 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 C-N-CA 116.631 -2.028 . . . . 1.0 106.235 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.76 -31.19 52.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 117.883 -1.527 . . . . 1.0 108.771 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.1 mmt-85 -61.9 -57.64 10.97 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.604 1.335 . . . . 1.0 114.604 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.472 HD11 ' N ' ' A' ' 64' ' ' LEU . 1.5 pp -64.88 -31.63 54.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 C-N-CA 118.356 -1.338 . . . . 1.0 111.603 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.472 ' N ' HD11 ' A' ' 63' ' ' ILE . 35.8 tp -70.22 -35.21 73.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.631 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.86 -49.23 16.22 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 115.873 -2.331 . . . . 1.0 106.225 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.446 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 20.6 mt-30 -48.14 -43.72 31.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 113.712 -1.585 . . . . 1.0 111.94 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -81.88 -30.62 31.87 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.994 -1.457 . . . . 1.0 109.583 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.2 tp -70.28 -20.78 63.01 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 104.562 -2.385 . . . . 1.0 104.562 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.446 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 19.0 m-30 -63.25 -29.55 70.86 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.312 -1.355 . . . . 1.0 109.647 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.8 mm -56.97 -38.79 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 113.777 -1.556 . . . . 1.0 111.841 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -58.38 -22.94 55.58 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.377 -0.929 . . . . 1.0 108.74 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.417 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 2.6 t80 -88.4 -17.5 30.36 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.432 0.634 . . . . 1.0 110.735 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -96.31 -13.8 23.06 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--N 1.303 -1.451 0 CA-C-N 112.472 -2.149 . . . . 1.0 109.281 179.293 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 111.731 0.271 . . . . 1.0 111.731 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pt -82.74 -31.28 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 116.767 -1.973 . . . . 1.0 107.53 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.45 -32.27 36.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.364 -1.334 . . . . 1.0 110.231 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -53.57 -59.53 4.48 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.053 0.93 . . . . 1.0 113.266 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -76.97 -27.43 16.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 113.981 -1.463 . . . . 1.0 113.974 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.439 ' N ' HD13 ' A' ' 63' ' ' ILE . 31.1 tp -71.48 -27.87 63.54 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.418 ' O ' ' CD1' ' A' ' 69' ' ' PHE . 2.6 mp0 -90.25 -53.78 4.31 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 117.885 -1.526 . . . . 1.0 107.219 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -57.2 -36.07 70.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.578 -1.192 . . . . 1.0 111.998 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.514 ' HA ' HG12 ' A' ' 70' ' ' ILE . 87.5 mt -83.43 -30.92 26.92 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 117.707 -1.597 . . . . 1.0 112.234 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 tp -67.56 -21.77 65.43 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 104.406 -2.442 . . . . 1.0 104.406 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 65' ' ' GLN . 17.4 m-30 -70.2 -46.65 64.13 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 117.947 -1.501 . . . . 1.0 107.436 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.514 HG12 ' HA ' ' A' ' 67' ' ' LEU . 9.8 mm -49.46 -42.16 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 113.733 -1.576 . . . . 1.0 111.621 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.499 ' C ' ' CD2' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -50.75 -40.3 54.31 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.663 0.744 . . . . 1.0 110.088 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -66.87 -27.91 67.9 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 123.21 1.481 . . . . 1.0 112.422 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.421 ' HE ' ' HA ' ' A' ' 70' ' ' ILE . 18.0 mtm105 -79.13 -44.76 21.36 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 112.383 -2.189 . . . . 1.0 106.281 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.294 -1.839 0 CA-C-N 113.012 -1.904 . . . . 1.0 107.391 179.776 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.9 pt -73.77 -29.33 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 C-N-CA 116.288 -2.165 . . . . 1.0 106.075 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.0 mt -65.42 -24.09 34.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 117.703 -1.599 . . . . 1.0 108.919 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -70.23 -29.61 66.47 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.63 2.085 . . . . 1.0 116.63 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.4 pp -101.99 -21.78 5.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 C-N-CA 117.47 -1.692 . . . . 1.0 108.642 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.439 ' N ' HD13 ' A' ' 63' ' ' ILE . 55.8 tp -77.05 -49.78 14.58 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 123.909 0.756 . . . . 1.0 112.545 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.29 -36.27 74.24 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.052 -1.459 . . . . 1.0 107.961 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 2.7 mp0 -66.54 -51.83 52.34 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 113.083 -1.871 . . . . 1.0 108.999 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 70' ' ' ILE . 3.5 pp -67.98 -29.13 68.09 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 117.668 -1.613 . . . . 1.0 110.419 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -70.29 -19.91 63.06 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.189 -2.152 . . . . 1.0 105.189 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.476 ' CE1' ' HD2' ' A' ' 73' ' ' ARG . 2.2 t80 -81.66 -50.41 9.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.452 -1.684 . . . . 1.0 106.452 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 67' ' ' LEU . 39.3 mt -54.3 -41.83 54.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 112.476 -2.147 . . . . 1.0 109.142 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.8 OUTLIER -48.34 -44.72 34.56 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.068 0.937 . . . . 1.0 110.358 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.424 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 53.9 t80 -63.66 -23.43 67.37 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.258 -1.337 . . . . 1.0 113.058 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.476 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 14.9 mtp180 -85.52 -45.65 11.59 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 112.993 -1.912 . . . . 1.0 106.324 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.0 mt . . . . . 0 C--N 1.296 -1.728 0 CA-C-N 112.659 -2.064 . . . . 1.0 107.672 179.686 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.818 0.342 . . . . 1.0 110.148 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt -80.6 -33.26 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 C-N-CA 116.984 -1.886 . . . . 1.0 105.917 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.3 mt -52.06 -29.72 12.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 114.471 -1.241 . . . . 1.0 108.719 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -66.48 -52.49 45.59 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.483 1.66 . . . . 1.0 115.483 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.494 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.7 pp -78.07 -28.24 15.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.233 -1.387 . . . . 1.0 111.983 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.494 ' N ' HD13 ' A' ' 63' ' ' ILE . 46.5 tp -68.05 -37.02 80.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.528 -1.286 . . . . 1.0 107.528 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.535 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.09 -51.47 12.17 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 117.527 -1.669 . . . . 1.0 106.661 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -49.93 -45.0 50.73 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.598 1.189 . . . . 1.0 111.99 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.0 mt -77.14 -31.87 55.94 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.63 -1.168 . . . . 1.0 111.8 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -67.51 -24.06 65.53 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 102.572 -3.122 . . . . 1.0 102.572 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -75.3 -51.88 12.17 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.003 -1.851 . . . . 1.0 106.003 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.58 -46.34 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 124.253 0.971 . . . . 1.0 111.485 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.485 ' C ' ' CD2' ' A' ' 71' ' ' HIS . 2.7 t60 -46.19 -47.49 17.74 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.815 0.817 . . . . 1.0 112.064 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 58.1 t80 -64.77 -21.22 66.72 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.901 -1.5 . . . . 1.0 113.272 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -88.61 -44.62 10.49 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 104.975 -2.232 . . . . 1.0 104.975 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.8 mt . . . . . 0 C--N 1.296 -1.748 0 N-CA-C 105.109 -2.182 . . . . 1.0 105.109 179.611 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 119.391 -0.338 . . . . 1.0 111.859 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt -90.11 -25.84 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 C-N-CA 116.038 -2.265 . . . . 1.0 109.563 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.44 -30.16 6.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.387 -1.279 . . . . 1.0 109.24 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -55.76 -61.4 2.39 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.453 -1.299 . . . . 1.0 112.589 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.54 HD13 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -59.45 -30.52 44.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 114.836 -1.074 . . . . 1.0 113.454 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.54 ' N ' HD13 ' A' ' 63' ' ' ILE . 59.2 tp -72.67 -33.1 66.3 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.33 -0.989 . . . . 1.0 108.33 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -47.01 19.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 104.972 -2.232 . . . . 1.0 104.972 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.452 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 25.2 mt-30 -49.96 -50.23 47.45 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.734 1.254 . . . . 1.0 112.076 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.93 -29.56 60.99 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.177 -1.374 . . . . 1.0 111.727 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.2 tp -71.13 -22.43 62.07 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 103.469 -2.789 . . . . 1.0 103.469 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 20.7 m-30 -69.2 -49.67 54.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.099 -1.815 . . . . 1.0 106.099 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.3 -44.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-N 114.228 -1.351 . . . . 1.0 111.38 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.459 ' C ' ' CD2' ' A' ' 71' ' ' HIS . 1.4 t60 -50.27 -46.43 55.09 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.116 0.96 . . . . 1.0 111.963 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.439 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 85.2 t80 -61.42 -31.65 71.59 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 123.566 1.65 . . . . 1.0 112.589 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.5 mtt85 -76.43 -46.05 28.78 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 111.361 -2.654 . . . . 1.0 106.112 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 C--N 1.298 -1.651 0 CA-C-N 113.745 -1.571 . . . . 1.0 109.724 179.63 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 120.867 0.365 . . . . 1.0 110.29 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 pt -78.79 -32.89 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 105.62 -1.993 . . . . 1.0 105.62 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -56.89 -25.02 21.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.607 -1.179 . . . . 1.0 109.701 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -66.62 -52.43 45.23 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 114.187 1.18 . . . . 1.0 114.187 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.511 HD13 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -81.35 -27.35 10.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 118.715 -1.194 . . . . 1.0 110.658 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.511 ' N ' HD13 ' A' ' 63' ' ' ILE . 43.1 tp -70.69 -30.03 66.49 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.611 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -84.15 -51.8 6.77 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 116.701 -2.0 . . . . 1.0 106.368 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.514 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 34.3 mt-30 -54.56 -45.19 73.43 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.1 -1.44 . . . . 1.0 113.406 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.2 mt -69.96 -32.66 71.01 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.593 -0.891 . . . . 1.0 108.593 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.466 ' O ' ' CD2' ' A' ' 71' ' ' HIS . 20.9 tp -66.99 -16.91 64.66 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 103.613 -2.736 . . . . 1.0 103.613 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.514 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 12.3 m-30 -88.44 -44.96 10.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 105.343 -2.095 . . . . 1.0 105.343 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.5 mm -58.93 -36.84 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 119.147 -1.021 . . . . 1.0 112.829 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -57.28 -21.34 33.85 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.201 -1.4 . . . . 1.0 108.562 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -86.49 -17.45 34.15 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.111 0.957 . . . . 1.0 110.163 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -95.26 -16.41 22.48 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.228 -1.351 . . . . 1.0 107.358 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt . . . . . 0 C--N 1.298 -1.653 0 CA-C-N 112.378 -2.192 . . . . 1.0 106.431 179.116 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -86.83 -34.22 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 116.75 -1.98 . . . . 1.0 106.357 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.9 -24.52 36.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.253 -1.379 . . . . 1.0 110.963 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -69.35 -45.79 68.57 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 117.516 -1.674 . . . . 1.0 115.031 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.513 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -80.77 -29.67 11.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.101 -1.04 . . . . 1.0 111.876 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.513 ' N ' HD13 ' A' ' 63' ' ' ILE . 42.6 tp -71.23 -27.14 63.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.44 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -84.24 -53.76 5.27 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.204 -1.776 . . . . 1.0 106.204 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -53.06 -36.51 60.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.47 -1.292 . . . . 1.0 112.738 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.476 ' HA ' HG12 ' A' ' 70' ' ' ILE . 80.0 mt -80.75 -32.8 35.45 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.158 -1.017 . . . . 1.0 111.806 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -67.91 -21.79 65.11 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 104.252 -2.499 . . . . 1.0 104.252 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.413 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 17.6 m-30 -73.39 -48.22 35.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 117.506 -1.678 . . . . 1.0 107.91 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 67' ' ' LEU . 7.1 mm -50.55 -41.04 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 114.517 -1.22 . . . . 1.0 111.497 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -48.59 -37.27 17.59 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.172 -0.611 . . . . 1.0 110.525 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.61 -21.33 48.66 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.645 -1.161 . . . . 1.0 111.425 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 22.5 mtp85 -86.56 -22.7 26.15 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 123.448 1.594 . . . . 1.0 107.275 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.9 mt . . . . . 0 C--N 1.3 -1.582 0 CA-C-N 111.606 -2.543 . . . . 1.0 106.839 179.639 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 121.237 0.541 . . . . 1.0 109.873 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 pt -75.96 -31.43 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 116.793 -1.963 . . . . 1.0 105.809 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mt -60.15 -23.43 27.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 118.215 -1.394 . . . . 1.0 109.019 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -76.0 -52.04 11.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 116.596 -2.042 . . . . 1.0 111.222 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 64' ' ' LEU . 2.3 pp -70.83 -29.17 36.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 118.756 -1.178 . . . . 1.0 111.503 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.515 ' N ' HD13 ' A' ' 63' ' ' ILE . 30.9 tp -67.68 -31.36 71.28 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.547 -1.279 . . . . 1.0 107.547 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.579 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -81.87 -54.14 5.59 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 117.923 -1.511 . . . . 1.0 107.541 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.409 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 24.9 mt-30 -51.72 -38.06 53.61 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.325 -1.307 . . . . 1.0 112.658 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.508 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 64.3 mt -81.62 -37.04 28.2 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.863 -1.062 . . . . 1.0 108.559 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.3 tp -67.09 -14.29 62.76 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.409 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 18.2 m-30 -73.6 -36.61 65.53 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 117.305 -1.758 . . . . 1.0 107.121 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.51 ' N ' HH21 ' A' ' 73' ' ' ARG . 57.2 mt -45.35 -46.15 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 112.853 -1.976 . . . . 1.0 110.749 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.454 ' C ' ' CD2' ' A' ' 71' ' ' HIS . 1.7 t60 -47.3 -43.85 22.9 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.988 0.899 . . . . 1.0 111.172 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.97 -28.65 69.06 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.808 -1.542 . . . . 1.0 112.21 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.51 HH21 ' N ' ' A' ' 70' ' ' ILE . 12.1 mtm180 -79.99 -38.52 31.99 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 113.293 -1.776 . . . . 1.0 107.76 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 mt . . . . . 0 C--N 1.302 -1.471 0 CA-C-N 113.28 -1.782 . . . . 1.0 109.276 179.889 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 119.527 -0.273 . . . . 1.0 111.625 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -83.98 -31.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 116.754 -1.978 . . . . 1.0 107.562 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.92 -28.68 24.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 117.13 -1.828 . . . . 1.0 109.884 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -59.29 -56.74 18.27 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 117.93 -1.508 . . . . 1.0 112.913 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.46 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -73.44 -28.21 24.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.46 ' N ' HD13 ' A' ' 63' ' ' ILE . 28.2 tp -70.02 -32.39 70.52 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.46 -53.81 5.43 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 117.911 -1.516 . . . . 1.0 107.652 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.461 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 23.9 mt-30 -51.28 -37.67 48.64 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.739 -1.118 . . . . 1.0 112.039 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 70' ' ' ILE . 76.6 mt -84.75 -34.91 22.76 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 117.798 -1.561 . . . . 1.0 110.124 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp -65.67 -22.44 66.64 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 104.398 -2.445 . . . . 1.0 104.398 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.461 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 18.5 m-30 -60.21 -32.82 71.47 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 117.337 -1.745 . . . . 1.0 108.109 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 67' ' ' LEU . 1.6 mp -46.98 -42.12 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 C-N-CA 118.359 -1.337 . . . . 1.0 111.083 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.481 ' C ' ' CD2' ' A' ' 71' ' ' HIS . 0.3 OUTLIER -52.5 -39.2 60.98 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.568 0.699 . . . . 1.0 110.924 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -75.14 -26.15 58.93 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.438 -1.255 . . . . 1.0 111.266 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 43.3 mtm180 -82.98 -24.65 32.83 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.734 -1.58 . . . . 1.0 106.734 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--N 1.303 -1.445 0 CA-C-N 113.94 -1.482 . . . . 1.0 111.09 179.576 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 111.721 0.267 . . . . 1.0 111.721 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.9 pt -82.09 -38.47 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 105.47 -2.048 . . . . 1.0 105.47 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mt -52.7 -45.84 49.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 106.383 -1.71 . . . . 1.0 106.383 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.603 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 15.0 ttm180 -46.09 -36.42 5.78 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.41 -1.268 . . . . 1.0 110.465 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.475 ' N ' HD12 ' A' ' 63' ' ' ILE . 2.0 mm -91.41 -26.14 5.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.113 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.408 HD13 ' C ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -69.76 -30.95 68.65 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.875 -1.53 . . . . 1.0 108.304 -179.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.603 ' NE2' ' HA ' ' A' ' 62' ' ' ARG . 1.9 pt20 -85.25 -47.85 9.67 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.109 -1.812 . . . . 1.0 106.109 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.424 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 29.6 mt-30 -54.1 -36.36 63.12 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 117.83 -1.548 . . . . 1.0 109.385 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.504 ' HA ' HG12 ' A' ' 70' ' ' ILE . 97.8 mt -81.43 -36.98 28.8 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.66 -1.216 . . . . 1.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.9 tp -66.35 -17.51 64.81 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 105.278 -2.119 . . . . 1.0 105.278 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.401 ' CZ ' ' HG3' ' A' ' 65' ' ' GLN . 19.4 m-30 -76.22 -32.68 59.07 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 117.869 -1.532 . . . . 1.0 109.065 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.504 HG12 ' HA ' ' A' ' 67' ' ' LEU . 19.4 mm -52.86 -41.48 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.51 -1.223 . . . . 1.0 114.174 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -24.18 48.64 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 117.972 -1.491 . . . . 1.0 109.007 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -83.65 -20.76 33.03 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.337 -0.945 . . . . 1.0 110.44 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -89.45 -18.61 26.42 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.443 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--N 1.302 -1.48 0 CA-C-N 112.881 -1.963 . . . . 1.0 111.153 179.5 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pt -76.6 -33.01 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 104.74 -2.318 . . . . 1.0 104.74 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.415 ' O ' ' HG3' ' A' ' 65' ' ' GLN . 1.6 mt -58.48 -37.74 66.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 118.373 -1.331 . . . . 1.0 107.563 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -56.04 -24.0 36.82 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.077 -1.449 . . . . 1.0 113.49 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.2 mm -95.15 -7.61 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 119.634 -0.827 . . . . 1.0 109.23 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.435 HD13 ' C ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.28 -45.39 5.62 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.933 -0.707 . . . . 1.0 109.552 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 61' ' ' ILE . 4.0 pp0? -68.79 -27.64 66.06 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 117.709 -1.596 . . . . 1.0 107.687 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.432 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -65.4 -61.43 2.11 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.256 -1.338 . . . . 1.0 108.501 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.2 mt -61.94 -32.12 72.51 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.474 -1.239 . . . . 1.0 111.391 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.484 ' O ' ' CD2' ' A' ' 71' ' ' HIS . 36.1 tp -70.38 -14.38 62.54 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.492 ' CD2' HD11 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -91.04 -45.87 8.46 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 105.234 -2.135 . . . . 1.0 105.234 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.492 HD11 ' CD2' ' A' ' 69' ' ' PHE . 9.9 mm -57.8 -37.21 58.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 118.239 -1.384 . . . . 1.0 111.411 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.484 ' CD2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -55.94 -20.39 15.97 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 118.478 -1.289 . . . . 1.0 109.585 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -85.18 -24.27 27.99 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.982 0.896 . . . . 1.0 109.694 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HD3' ' CE1' ' A' ' 69' ' ' PHE . 17.3 mtm105 -90.23 -17.44 27.49 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.597 -1.26 . . . . 1.0 107.597 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.3 mt . . . . . 0 C--N 1.299 -1.612 0 CA-C-N 111.838 -2.437 . . . . 1.0 110.426 179.179 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 119.64 -0.219 . . . . 1.0 110.553 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.408 ' O ' HD13 ' A' ' 63' ' ' ILE . 1.5 pt -84.46 -36.95 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 116.165 -2.214 . . . . 1.0 107.474 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.98 -29.65 47.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 117.6 -1.64 . . . . 1.0 110.211 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -63.81 -54.19 38.97 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.207 -1.397 . . . . 1.0 114.239 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.534 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -73.59 -29.13 26.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 118.771 -1.172 . . . . 1.0 112.829 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.534 ' N ' HD13 ' A' ' 63' ' ' ILE . 39.9 tp -69.32 -30.23 68.24 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.423 ' NE2' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -82.26 -52.41 6.97 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.166 -1.79 . . . . 1.0 106.166 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.476 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 50.8 mt-30 -50.22 -38.33 39.85 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.389 -0.823 . . . . 1.0 113.076 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.5 mt -84.15 -33.21 24.29 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.985 -1.007 . . . . 1.0 110.392 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.49 -15.0 61.8 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.035 -2.209 . . . . 1.0 105.035 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.476 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 17.4 m-30 -66.86 -37.21 84.01 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 116.823 -1.951 . . . . 1.0 107.716 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 32.9 mt -48.31 -47.68 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 114.211 -1.359 . . . . 1.0 111.858 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.488 ' C ' ' CD2' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -51.78 -34.44 39.79 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.061 0.457 . . . . 1.0 111.087 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.75 -13.42 56.35 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.141 -0.936 . . . . 1.0 111.671 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 49.1 mtm180 -101.02 -20.42 15.4 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.453 -1.249 . . . . 1.0 109.13 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--N 1.303 -1.435 0 CA-C-N 113.401 -1.727 . . . . 1.0 109.018 179.293 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 118.799 -0.619 . . . . 1.0 111.612 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 pt -94.57 -35.05 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 117.263 -1.775 . . . . 1.0 110.21 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.51 -23.21 22.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 113.743 -1.571 . . . . 1.0 108.272 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -73.61 -52.36 13.67 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 115.38 -2.528 . . . . 1.0 112.15 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 64' ' ' LEU . 2.3 pp -70.66 -29.31 37.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 113.776 1.028 . . . . 1.0 113.776 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.531 ' N ' HD13 ' A' ' 63' ' ' ILE . 26.4 tp -68.87 -37.63 79.19 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.937 -1.505 . . . . 1.0 106.937 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -74.74 -48.15 27.3 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 117.24 -1.784 . . . . 1.0 106.617 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.444 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -52.04 -44.17 64.11 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.76 -1.109 . . . . 1.0 112.038 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 70' ' ' ILE . 3.6 pp -75.52 -37.65 59.95 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.67 -1.15 . . . . 1.0 109.279 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.5 mt -67.11 -16.21 64.19 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.928 -1.879 . . . . 1.0 105.928 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 20.9 m-30 -73.55 -35.72 65.53 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.507 -1.677 . . . . 1.0 106.686 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.0 mm -53.25 -43.71 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.373 -1.285 . . . . 1.0 112.296 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.474 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -54.41 -28.61 44.95 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 120.066 1.303 . . . . 1.0 110.924 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.474 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 39.9 t80 -75.32 -29.68 60.08 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.756 1.265 . . . . 1.0 111.381 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -82.44 -38.64 23.71 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 113.46 -1.7 . . . . 1.0 108.149 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--N 1.3 -1.556 0 CA-C-N 113.141 -1.845 . . . . 1.0 106.794 179.495 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 112.023 0.379 . . . . 1.0 112.023 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 pt -81.31 -35.03 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 106.533 -1.654 . . . . 1.0 106.533 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.7 mt -52.14 -43.47 38.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 112.842 -1.981 . . . . 1.0 105.82 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.648 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 81.6 mtm180 -51.86 -31.75 29.19 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 118.586 -1.246 . . . . 1.0 112.418 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 63' ' ' ILE . 1.4 mm -88.66 -17.62 8.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 114.455 -1.248 . . . . 1.0 110.791 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.44 -35.29 25.09 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.392 -1.323 . . . . 1.0 109.434 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.648 ' NE2' ' HA ' ' A' ' 62' ' ' ARG . 4.0 pt20 -76.01 -46.49 29.18 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 116.343 -2.143 . . . . 1.0 106.868 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.466 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 35.9 mt-30 -49.71 -45.98 49.69 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.315 1.055 . . . . 1.0 112.514 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 70' ' ' ILE . 89.1 mt -72.35 -40.13 67.58 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.957 -1.474 . . . . 1.0 110.033 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.7 mt -65.39 -15.3 62.45 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.822 -1.551 . . . . 1.0 107.019 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.466 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 21.0 m-30 -78.66 -39.19 37.54 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 106.92 -1.511 . . . . 1.0 106.92 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.3 mm -49.97 -40.47 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 114.607 -1.179 . . . . 1.0 111.235 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.474 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 1.4 t60 -50.25 -41.3 50.05 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.485 0.66 . . . . 1.0 109.705 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -66.6 -31.2 71.75 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 123.24 1.495 . . . . 1.0 111.81 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -73.62 -42.29 61.67 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 112.781 -2.009 . . . . 1.0 106.624 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.259 1.1 mp . . . . . 0 C--N 1.296 -1.736 0 CA-C-N 113.82 -1.536 . . . . 1.0 107.245 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 119.462 -0.304 . . . . 1.0 110.597 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt -83.16 -28.93 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 C-N-CA 116.07 -2.252 . . . . 1.0 108.327 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.53 -31.39 42.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 114.028 -1.442 . . . . 1.0 109.298 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -50.03 -62.16 1.73 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.619 -1.173 . . . . 1.0 113.032 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.507 HD13 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -75.8 -27.85 18.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 113.173 -1.83 . . . . 1.0 113.589 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.507 ' N ' HD13 ' A' ' 63' ' ' ILE . 29.6 tp -70.31 -34.97 73.35 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.443 -1.318 . . . . 1.0 107.443 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -82.75 -53.38 5.94 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 116.551 -2.06 . . . . 1.0 108.062 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -52.16 -37.04 53.34 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.82 -1.082 . . . . 1.0 112.796 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.467 ' HA ' HG12 ' A' ' 70' ' ' ILE . 83.5 mt -82.28 -38.63 24.11 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.487 -1.285 . . . . 1.0 110.943 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.9 tt -62.86 -23.75 67.47 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.445 -2.058 . . . . 1.0 105.445 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -66.3 -35.26 79.92 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 117.635 -1.626 . . . . 1.0 109.363 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 67' ' ' LEU . 12.6 mm -54.29 -38.19 39.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 113.453 -1.703 . . . . 1.0 113.103 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.431 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -60.15 -27.36 67.03 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 120.913 1.688 . . . . 1.0 109.188 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.431 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 58.4 t80 -73.86 -22.72 59.64 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.609 1.195 . . . . 1.0 110.422 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -85.97 -55.84 3.76 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 105.424 -2.065 . . . . 1.0 105.424 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--N 1.294 -1.839 0 CA-C-N 113.503 -1.68 . . . . 1.0 111.368 179.813 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 111.648 0.24 . . . . 1.0 111.648 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.403 ' O ' HD11 ' A' ' 63' ' ' ILE . 1.7 pt -82.31 -29.83 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 117.061 -1.856 . . . . 1.0 106.83 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mt -61.71 -30.73 48.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.038 -1.437 . . . . 1.0 108.373 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -64.27 -55.83 18.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.43 -1.308 . . . . 1.0 114.228 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.514 HD11 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -69.7 -28.32 36.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 118.624 -1.23 . . . . 1.0 112.411 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.514 ' N ' HD11 ' A' ' 63' ' ' ILE . 29.0 tp -71.89 -33.28 68.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.513 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -79.41 -43.98 22.32 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 116.872 -1.931 . . . . 1.0 107.278 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.48 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 1.5 pt20 -54.42 -37.06 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.291 -0.963 . . . . 1.0 111.62 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.8 mt -82.77 -38.89 22.57 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.077 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.6 tp -66.21 -15.49 63.22 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.48 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 19.3 m-30 -69.76 -28.32 65.67 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 116.571 -2.052 . . . . 1.0 108.602 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.3 mt -53.44 -42.25 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 114.575 -1.193 . . . . 1.0 110.662 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.445 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -53.41 -32.37 49.32 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.606 0.717 . . . . 1.0 110.051 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -83.13 -18.19 40.38 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.576 -1.193 . . . . 1.0 111.151 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 53.5 mtm180 -96.35 -16.98 20.98 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.875 -1.157 . . . . 1.0 107.875 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 mt . . . . . 0 C--N 1.3 -1.545 0 CA-C-N 113.524 -1.671 . . . . 1.0 107.928 179.183 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 50' A ACE . . . . . 0.423 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . . . . . . 0 C--O 1.213 -0.837 . . . . . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 57.47 -17.99 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.643 0 N-CA-C 117.442 2.386 . . . . 1.0 117.442 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 50' A ACE . . . -65.93 115.65 7.74 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 108.473 -1.851 . . . . 1.0 108.473 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -28.0 -46.36 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.035 1.865 . . . . 1.0 116.035 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.8 p -70.84 -58.32 3.73 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.307 1.051 . . . . 1.0 111.453 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -63.06 -56.76 14.17 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.172 -1.376 . . . . 1.0 111.69 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.55 95.97 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 124.892 1.37 . . . . 1.0 109.854 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.76 -42.63 98.51 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 118.105 -1.998 . . . . 1.0 110.727 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.482 ' HA ' ' CG1' ' A' ' 60' ' ' ILE . 92.4 t -77.43 -32.0 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.584 -0.846 . . . . 1.0 111.832 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -71.93 -21.64 61.58 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.776 -0.824 . . . . 1.0 108.776 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.92 -38.87 22.23 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.756 -1.565 . . . . 1.0 110.785 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.482 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 3.6 pt -79.87 -32.94 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 106.676 -1.601 . . . . 1.0 106.676 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 1.3 mt -57.16 -28.1 29.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.185 -1.37 . . . . 1.0 109.227 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.403 ' C ' HE21 ' A' ' 66' ' ' GLN . 58.2 mtp180 -70.54 -51.68 26.98 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.574 -1.65 . . . . 1.0 114.746 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -72.79 -30.03 31.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 C-N-CA 118.314 -1.355 . . . . 1.0 111.489 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.503 ' N ' HD13 ' A' ' 63' ' ' ILE . 31.0 tp -69.32 -34.11 74.17 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.001 -0.741 . . . . 1.0 109.001 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.544 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -74.87 -53.86 8.32 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.587 -2.005 . . . . 1.0 105.587 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.403 HE21 ' C ' ' A' ' 62' ' ' ARG . 39.3 mt-30 -50.3 -39.77 46.52 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.431 -1.259 . . . . 1.0 111.61 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.448 ' O ' HG12 ' A' ' 70' ' ' ILE . 69.5 mt -83.54 -20.88 33.07 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.563 -1.199 . . . . 1.0 110.431 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.408 ' O ' ' CD2' ' A' ' 71' ' ' HIS . 15.3 tp -84.58 -7.37 59.28 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 102.883 -3.006 . . . . 1.0 102.883 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 65' ' ' GLN . 17.6 m-30 -87.05 -37.23 17.64 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.434 -0.906 . . . . 1.0 110.169 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 67' ' ' LEU . 1.1 pt -50.41 -37.78 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 118.831 -1.148 . . . . 1.0 113.365 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -55.14 -26.81 41.05 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 118.869 -1.132 . . . . 1.0 109.866 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.417 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 31.1 t80 -84.65 -17.75 37.56 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.988 0.899 . . . . 1.0 111.486 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -98.48 -15.58 19.54 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.462 -1.244 . . . . 1.0 108.635 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.4 mt -95.77 -54.4 7.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 112.578 -2.101 . . . . 1.0 109.223 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 77' ' ' ARG . . . -64.49 -65.51 2.95 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.354 -1.403 . . . . 1.0 110.642 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 39.3 m -59.84 9.81 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 114.35 1.241 . . . . 1.0 114.35 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.471 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -128.06 -42.62 1.54 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -82.03 -32.76 30.31 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.184 -0.916 . . . . 1.0 113.307 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.8 t -127.46 33.67 4.81 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.664 1.357 . . . . 1.0 114.664 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.72 39.3 0.13 Allowed 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 119.85 -0.74 . . . . 1.0 111.6 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.2 mm -81.29 59.05 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.033 -1.042 . . . . 1.0 110.008 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.74 38.21 0.87 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.157 -1.977 . . . . 1.0 108.157 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.634 0 O-C-N 119.215 -2.344 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.825 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 62.44 -25.11 0.05 Allowed 'General case' 0 N--CA 1.512 2.636 0 N-CA-C 116.634 2.087 . . . . 1.0 116.634 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.69 139.05 34.37 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 109.562 -1.415 . . . . 1.0 109.562 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -27.53 -54.48 0.09 Allowed 'General case' 0 N--CA 1.511 2.624 0 N-CA-C 115.023 1.49 . . . . 1.0 115.023 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 p -70.73 -41.81 71.38 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.535 -0.757 . . . . 1.0 111.299 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -64.83 -56.78 11.39 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.512 -0.875 . . . . 1.0 109.699 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.18 87.59 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.119 -1.032 . . . . 1.0 108.472 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.8 -39.54 77.51 Favored Glycine 0 N--CA 1.494 2.526 0 CA-C-N 114.165 -1.379 . . . . 1.0 112.348 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 60' ' ' ILE . 99.4 t -86.75 -39.39 13.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 120.135 -0.626 . . . . 1.0 110.909 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.36 -28.4 69.73 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.17 -30.39 54.87 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 114.227 -1.351 . . . . 1.0 110.746 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.2 pt -86.3 -35.49 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 116.144 -2.222 . . . . 1.0 107.434 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 1.0 OUTLIER -61.31 -25.24 35.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.832 1.301 . . . . 1.0 108.513 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -62.45 -56.61 16.56 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.122 -1.399 . . . . 1.0 113.806 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.548 HD11 ' N ' ' A' ' 64' ' ' LEU . 1.6 pp -69.6 -30.68 46.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 C-N-CA 118.684 -1.207 . . . . 1.0 111.363 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.548 ' N ' HD11 ' A' ' 63' ' ' ILE . 45.9 tp -67.86 -35.17 78.08 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.213 -1.032 . . . . 1.0 108.213 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.482 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.83 -47.87 20.13 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 105.676 -1.972 . . . . 1.0 105.676 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.475 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 49.4 mt-30 -51.61 -41.05 60.96 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.967 0.889 . . . . 1.0 111.494 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt -76.3 -36.42 58.37 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.511 -1.276 . . . . 1.0 109.866 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.45 -27.18 67.32 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.308 -2.108 . . . . 1.0 105.308 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 14.6 m-30 -73.53 -48.52 32.5 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 105.728 -1.953 . . . . 1.0 105.728 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 mp -44.43 -43.37 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 124.026 0.829 . . . . 1.0 111.643 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.459 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 5.0 t60 -49.23 -48.46 45.58 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.058 0.932 . . . . 1.0 110.279 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -62.15 -20.15 63.8 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.345 -1.298 . . . . 1.0 112.684 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 24.3 mtt180 -86.72 -43.35 12.64 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 105.742 -1.948 . . . . 1.0 105.742 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.8 mt -58.24 -35.24 52.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 112.934 -1.939 . . . . 1.0 106.537 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.08 -58.15 4.11 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 107.11 -2.396 . . . . 1.0 107.11 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 50.4 t -47.01 -65.17 0.61 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 115.371 -0.414 . . . . 1.0 111.851 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -49.96 -29.25 8.09 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.372 -0.831 . . . . 1.0 111.635 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -104.38 -2.25 25.71 Favored 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 112.955 0.724 . . . . 1.0 112.955 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.8 t -118.4 13.51 13.58 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 123.49 0.494 . . . . 1.0 112.067 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.6 tpt85 -118.79 77.83 1.22 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 120.474 -0.49 . . . . 1.0 111.925 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.2 mt -118.21 33.28 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 CA-C-O 122.866 1.317 . . . . 1.0 108.95 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.49 -54.72 1.21 Allowed Glycine 0 N--CA 1.5 2.929 0 CA-C-N 113.955 -1.475 . . . . 1.0 111.895 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.697 0 O-C-N 118.049 -3.03 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.679 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -80.81 72.87 7.81 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.739 0.78 . . . . 1.0 110.584 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.63 170.56 37.39 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 108.5 -1.84 . . . . 1.0 108.5 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -90.28 -124.4 0.07 Allowed 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.291 -1.744 . . . . 1.0 106.291 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.3 m -31.56 -42.39 0.05 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.848 2.166 . . . . 1.0 116.848 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.414 ' CG ' ' N ' ' A' ' 55' ' ' ALA . 9.3 t-105 -65.72 -67.35 0.45 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.178 -1.409 . . . . 1.0 110.39 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 54' ' ' TRP . . . -51.94 -47.33 64.79 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.736 -1.574 . . . . 1.0 108.261 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -49.38 -42.06 33.17 Favored Glycine 0 N--CA 1.491 2.362 0 CA-C-N 112.934 -1.939 . . . . 1.0 109.819 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 60' ' ' ILE . 60.3 t -79.95 -38.49 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 C-N-CA 119.034 -1.067 . . . . 1.0 112.305 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -31.18 70.8 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.792 -1.558 . . . . 1.0 106.792 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.9 -33.18 63.9 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 113.363 -1.744 . . . . 1.0 111.878 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.497 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.7 pt -87.54 -26.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 116.222 -2.191 . . . . 1.0 108.426 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -81.92 -32.66 11.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.94 -1.104 . . . . 1.0 110.092 179.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.402 ' HG2' ' NE2' ' A' ' 66' ' ' GLN . 7.4 ttp180 -56.62 -53.88 52.53 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.697 -0.801 . . . . 1.0 112.407 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.547 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -71.91 -27.86 28.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 C-N-CA 119.224 -0.99 . . . . 1.0 112.634 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.547 ' N ' HD13 ' A' ' 63' ' ' ILE . 51.2 tp -70.82 -29.66 65.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.764 -1.198 . . . . 1.0 107.764 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -54.72 5.0 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 105.847 -1.909 . . . . 1.0 105.847 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.412 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 30.4 mt-30 -51.07 -37.95 48.71 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.177 -0.92 . . . . 1.0 112.198 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.481 ' HA ' HG12 ' A' ' 70' ' ' ILE . 71.1 mt -81.63 -33.37 31.46 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.805 -1.158 . . . . 1.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.48 -18.95 62.98 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 104.856 -2.275 . . . . 1.0 104.856 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 18.5 m-30 -72.9 -36.96 67.41 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 117.608 -1.637 . . . . 1.0 108.835 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.1 mm -48.68 -41.25 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.699 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.469 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -51.17 -36.78 42.8 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -76.78 -20.12 56.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.278 -0.874 . . . . 1.0 111.967 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -91.95 -20.38 21.44 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.418 -1.327 . . . . 1.0 107.418 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.9 mt -86.46 -58.92 3.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 112.266 -2.243 . . . . 1.0 108.008 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -45.94 -74.22 0.24 Allowed Glycine 0 N--CA 1.501 2.994 0 N-CA-C 117.199 1.64 . . . . 1.0 117.199 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 26.7 p -66.56 4.84 0.69 Allowed 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 116.18 1.919 . . . . 1.0 116.18 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -118.52 -40.97 2.85 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 122.784 1.278 . . . . 1.0 109.604 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -78.94 -24.1 44.2 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 112.545 -2.116 . . . . 1.0 108.25 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.6 t -122.29 -134.27 0.29 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 116.376 -0.374 . . . . 1.0 110.092 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 55.08 41.71 31.49 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 123.346 1.546 . . . . 1.0 107.778 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.6 mt -70.52 75.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 113.326 -1.761 . . . . 1.0 108.503 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.56 -32.42 61.21 Favored Glycine 0 N--CA 1.497 2.745 0 CA-C-N 115.283 -0.871 . . . . 1.0 112.22 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.563 0 O-C-N 118.167 -2.96 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.658 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.488 ' C ' ' H ' ' A' ' 52' ' ' ASP . 83.4 m-85 66.91 -56.08 0.43 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 114.505 1.298 . . . . 1.0 114.505 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.25 11.73 1.41 Allowed Glycine 0 N--CA 1.505 3.247 0 C-N-CA 121.362 -0.447 . . . . 1.0 112.868 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -29.29 -60.25 0.14 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 113.609 0.966 . . . . 1.0 113.609 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.8 m -57.01 -38.27 72.88 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.624 0.972 . . . . 1.0 113.624 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 14.2 m95 -85.72 -52.1 6.0 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.541 -1.263 . . . . 1.0 112.257 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.38 -45.4 94.51 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.053 -1.43 . . . . 1.0 111.151 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.89 -43.36 99.31 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.676 -1.369 . . . . 1.0 109.676 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.508 ' HA ' HG12 ' A' ' 60' ' ' ILE . 96.3 t -75.87 -33.71 26.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 118.739 -1.184 . . . . 1.0 112.843 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.05 -30.63 67.94 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 105.047 -2.205 . . . . 1.0 105.047 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.37 -34.85 70.82 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.429 -1.26 . . . . 1.0 112.328 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.508 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.1 pt -81.99 -35.85 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 116.828 -1.949 . . . . 1.0 105.816 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -53.07 -45.74 53.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 105.895 -1.891 . . . . 1.0 105.895 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.554 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 36.5 mmt180 -49.61 -41.44 42.23 Favored 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 118.805 -1.158 . . . . 1.0 113.656 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.492 ' N ' HD11 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -82.54 -27.88 8.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 CA-C-N 114.344 -1.298 . . . . 1.0 109.893 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.86 -32.11 65.21 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.264 -1.374 . . . . 1.0 108.786 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.554 ' NE2' ' HA ' ' A' ' 62' ' ' ARG . 6.3 mt-30 -73.31 -48.82 31.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.04 -1.837 . . . . 1.0 106.04 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -56.3 -52.77 63.32 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.12 -1.4 . . . . 1.0 111.287 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 61.3 mt -67.98 -27.36 66.51 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.695 -1.139 . . . . 1.0 111.185 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -71.4 -15.29 62.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 105.796 -1.927 . . . . 1.0 105.796 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -90.78 -49.24 6.56 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 123.569 1.652 . . . . 1.0 106.967 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.9 mt -57.03 -42.9 80.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 111.766 -2.47 . . . . 1.0 110.922 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -18.98 14.84 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.461 -0.895 . . . . 1.0 110.249 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -86.25 -25.33 25.61 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.579 1.181 . . . . 1.0 110.326 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -86.15 -28.87 23.7 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 113.014 -1.903 . . . . 1.0 108.156 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.9 mt -81.28 -57.35 4.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 100.439 -3.912 . . . . 1.0 100.439 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -43.41 -70.31 0.55 Allowed Glycine 0 N--CA 1.494 2.514 0 CA-C-N 113.279 -1.782 . . . . 1.0 114.221 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.7 m -50.41 -48.32 56.2 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 122.155 0.979 . . . . 1.0 112.502 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' A' ' 77' ' ' ARG . 3.0 mpt_? -65.62 -28.73 69.33 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.296 -1.32 . . . . 1.0 112.509 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -55.39 -23.07 22.56 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.638 0.732 . . . . 1.0 111.075 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.0 t -134.27 28.2 3.75 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.065 -1.425 . . . . 1.0 107.94 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.8 ptt85 32.83 44.28 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 122.469 1.128 . . . . 1.0 113.301 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.62 83.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-N 113.922 -1.49 . . . . 1.0 107.216 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.9 26.35 24.63 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 106.249 -2.741 . . . . 1.0 106.249 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.577 0 O-C-N 119.221 -2.34 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.847 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.9 t80 53.18 23.41 3.08 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 122.132 0.968 . . . . 1.0 110.86 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.48 52.54 2.3 Favored Glycine 0 N--CA 1.499 2.836 0 CA-C-O 119.248 -0.751 . . . . 1.0 112.58 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -41.21 -60.88 1.13 Allowed 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 117.714 0.757 . . . . 1.0 112.166 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.2 m -57.49 -30.15 64.86 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.483 -0.781 . . . . 1.0 112.214 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -63.51 -52.93 59.12 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.914 -1.143 . . . . 1.0 107.914 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.6 -43.51 72.23 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 112.466 -2.152 . . . . 1.0 109.163 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.15 -38.77 95.64 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 118.486 -1.816 . . . . 1.0 111.482 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.48 ' HA ' HG12 ' A' ' 60' ' ' ILE . 96.1 t -80.01 -31.23 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 116.445 2.017 . . . . 1.0 116.445 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.96 -27.48 66.63 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.88 -42.51 57.74 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 112.54 -2.118 . . . . 1.0 110.53 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.4 pt -78.65 -30.03 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 C-N-CA 116.631 -2.028 . . . . 1.0 106.235 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.403 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 1.9 mm -63.76 -31.19 52.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 117.883 -1.527 . . . . 1.0 108.771 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.1 mmt-85 -61.9 -57.64 10.97 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.604 1.335 . . . . 1.0 114.604 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.472 HD11 ' N ' ' A' ' 64' ' ' LEU . 1.5 pp -64.88 -31.63 54.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 C-N-CA 118.356 -1.338 . . . . 1.0 111.603 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.472 ' N ' HD11 ' A' ' 63' ' ' ILE . 35.8 tp -70.22 -35.21 73.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.631 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.86 -49.23 16.22 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 115.873 -2.331 . . . . 1.0 106.225 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.446 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 20.6 mt-30 -48.14 -43.72 31.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 113.712 -1.585 . . . . 1.0 111.94 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -81.88 -30.62 31.87 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.994 -1.457 . . . . 1.0 109.583 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.2 tp -70.28 -20.78 63.01 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 104.562 -2.385 . . . . 1.0 104.562 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.446 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 19.0 m-30 -63.25 -29.55 70.86 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.312 -1.355 . . . . 1.0 109.647 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.8 mm -56.97 -38.79 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 113.777 -1.556 . . . . 1.0 111.841 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -58.38 -22.94 55.58 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.377 -0.929 . . . . 1.0 108.74 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.417 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 2.6 t80 -88.4 -17.5 30.36 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.432 0.634 . . . . 1.0 110.735 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -96.31 -13.8 23.06 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mt -100.93 -59.44 3.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 112.472 -2.149 . . . . 1.0 109.281 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.55 -68.42 1.67 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 115.717 -0.674 . . . . 1.0 112.334 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -53.14 -34.18 55.7 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.213 -0.995 . . . . 1.0 111.409 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.6 ttm-85 -76.71 -29.31 56.19 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.318 -0.953 . . . . 1.0 112.469 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.406 ' O ' ' CB ' ' A' ' 79' ' ' SER . 38.4 t-80 -38.14 -45.93 0.99 Allowed 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 112.878 0.696 . . . . 1.0 112.878 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 78' ' ' HIS . 33.0 t 134.26 123.76 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 105.669 -1.975 . . . . 1.0 105.669 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -177.57 69.01 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 106.646 -1.613 . . . . 1.0 106.646 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 22.0 pt -123.65 147.9 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.22 -63.11 1.02 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 110.341 -1.104 . . . . 1.0 110.341 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.687 0 O-C-N 118.086 -3.008 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.732 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 43.69 31.74 0.49 Allowed 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 114.816 1.414 . . . . 1.0 114.816 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.47 14.7 43.14 Favored Glycine 0 N--CA 1.505 3.284 0 C-N-CA 120.679 -0.772 . . . . 1.0 112.956 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -39.82 -47.92 2.19 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 113.022 0.749 . . . . 1.0 113.022 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 m -61.14 -35.93 78.4 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.484 -0.487 . . . . 1.0 112.196 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -83.42 -54.78 4.72 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 118.346 -1.342 . . . . 1.0 109.769 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.42 -51.08 70.99 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.158 0.98 . . . . 1.0 110.035 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.89 -39.04 76.88 Favored Glycine 0 N--CA 1.49 2.253 0 CA-C-N 113.657 -1.611 . . . . 1.0 112.004 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.486 ' HA ' HG12 ' A' ' 60' ' ' ILE . 89.3 t -85.06 -36.28 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 118.848 -1.141 . . . . 1.0 111.758 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.64 -31.6 72.9 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 105.409 -2.071 . . . . 1.0 105.409 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.97 -37.06 72.76 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 113.705 -1.589 . . . . 1.0 111.731 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.486 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.3 pt -82.74 -31.28 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 116.767 -1.973 . . . . 1.0 107.53 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.452 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -73.45 -32.27 36.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.364 -1.334 . . . . 1.0 110.231 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -53.57 -59.53 4.48 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.053 0.93 . . . . 1.0 113.266 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -76.97 -27.43 16.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 113.981 -1.463 . . . . 1.0 113.974 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.439 ' N ' HD13 ' A' ' 63' ' ' ILE . 31.1 tp -71.48 -27.87 63.54 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.418 ' O ' ' CD1' ' A' ' 69' ' ' PHE . 2.6 mp0 -90.25 -53.78 4.31 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 117.885 -1.526 . . . . 1.0 107.219 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -57.2 -36.07 70.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.578 -1.192 . . . . 1.0 111.998 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.514 ' HA ' HG12 ' A' ' 70' ' ' ILE . 87.5 mt -83.43 -30.92 26.92 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 117.707 -1.597 . . . . 1.0 112.234 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 tp -67.56 -21.77 65.43 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 104.406 -2.442 . . . . 1.0 104.406 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 65' ' ' GLN . 17.4 m-30 -70.2 -46.65 64.13 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 117.947 -1.501 . . . . 1.0 107.436 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.514 HG12 ' HA ' ' A' ' 67' ' ' LEU . 9.8 mm -49.46 -42.16 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 113.733 -1.576 . . . . 1.0 111.621 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.499 ' C ' ' CD2' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -50.75 -40.3 54.31 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.663 0.744 . . . . 1.0 110.088 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -66.87 -27.91 67.9 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 123.21 1.481 . . . . 1.0 112.422 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.421 ' HE ' ' HA ' ' A' ' 70' ' ' ILE . 18.0 mtm105 -79.13 -44.76 21.36 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 112.383 -2.189 . . . . 1.0 106.281 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.4 mt -57.3 -53.25 46.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 113.012 -1.904 . . . . 1.0 107.391 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.55 -56.32 23.85 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 120.575 -0.821 . . . . 1.0 111.725 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 53.3 t -59.92 -35.69 75.43 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.001 1.112 . . . . 1.0 114.001 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -84.08 -29.09 27.09 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 112.983 0.734 . . . . 1.0 112.983 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -35.66 -44.66 0.33 Allowed 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 114.893 1.442 . . . . 1.0 114.893 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.2 m 51.8 42.57 30.06 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 114.971 1.471 . . . . 1.0 114.971 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 53.89 64.23 1.91 Allowed 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 118.204 2.668 . . . . 1.0 118.204 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.3 mt -86.31 135.47 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 106.884 -1.525 . . . . 1.0 106.884 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.56 -176.36 44.67 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 105.574 -3.01 . . . . 1.0 105.574 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.792 0 O-C-N 119.123 -2.398 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.804 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -107.61 -27.51 10.3 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 112.805 0.668 . . . . 1.0 112.805 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.05 115.08 3.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.024 -1.231 . . . . 1.0 110.024 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -135.54 -120.58 0.16 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.061 -1.829 . . . . 1.0 106.061 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -47.15 -41.84 18.49 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 113.969 1.1 . . . . 1.0 113.969 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.459 ' CD2' ' N ' ' A' ' 55' ' ' ALA . 39.9 p-90 -71.06 -43.28 68.12 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.169 -1.012 . . . . 1.0 111.7 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.459 ' N ' ' CD2' ' A' ' 54' ' ' TRP . . . -65.36 -40.87 94.1 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.58 -1.637 . . . . 1.0 106.58 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.23 -47.32 91.66 Favored Glycine 0 N--CA 1.489 2.218 0 CA-C-N 113.587 -1.642 . . . . 1.0 110.757 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.511 ' HA ' HG12 ' A' ' 60' ' ' ILE . 3.6 p -72.18 -34.12 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 117.307 -1.757 . . . . 1.0 110.089 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -68.86 -27.0 65.42 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.349 -0.982 . . . . 1.0 108.349 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.59 -44.17 19.4 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 112.92 -1.945 . . . . 1.0 109.816 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.511 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.9 pt -73.77 -29.33 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 C-N-CA 116.288 -2.165 . . . . 1.0 106.075 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 4.0 mt -65.42 -24.09 34.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 117.703 -1.599 . . . . 1.0 108.919 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -70.23 -29.61 66.47 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.63 2.085 . . . . 1.0 116.63 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.4 pp -101.99 -21.78 5.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 C-N-CA 117.47 -1.692 . . . . 1.0 108.642 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.439 ' N ' HD13 ' A' ' 63' ' ' ILE . 55.8 tp -77.05 -49.78 14.58 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 123.909 0.756 . . . . 1.0 112.545 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.29 -36.27 74.24 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.052 -1.459 . . . . 1.0 107.961 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 2.7 mp0 -66.54 -51.83 52.34 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 113.083 -1.871 . . . . 1.0 108.999 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 70' ' ' ILE . 3.5 pp -67.98 -29.13 68.09 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 117.668 -1.613 . . . . 1.0 110.419 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -70.29 -19.91 63.06 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.189 -2.152 . . . . 1.0 105.189 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.476 ' CE1' ' HD2' ' A' ' 73' ' ' ARG . 2.2 t80 -81.66 -50.41 9.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.452 -1.684 . . . . 1.0 106.452 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 67' ' ' LEU . 39.3 mt -54.3 -41.83 54.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 112.476 -2.147 . . . . 1.0 109.142 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.8 OUTLIER -48.34 -44.72 34.56 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.068 0.937 . . . . 1.0 110.358 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.424 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 53.9 t80 -63.66 -23.43 67.37 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.258 -1.337 . . . . 1.0 113.058 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.476 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 14.9 mtp180 -85.52 -45.65 11.59 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 112.993 -1.912 . . . . 1.0 106.324 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.0 mt -55.67 -48.29 77.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 112.659 -2.064 . . . . 1.0 107.672 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.59 -63.19 5.54 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 120.577 -0.821 . . . . 1.0 112.072 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 73' ' ' ARG . 26.5 p -55.64 -41.2 73.21 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.987 -0.685 . . . . 1.0 111.438 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -71.08 -26.83 63.23 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.188 -1.405 . . . . 1.0 109.284 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' A' ' 79' ' ' SER . 29.1 t-80 -73.67 -62.96 1.31 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.444 -1.302 . . . . 1.0 108.177 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 78' ' ' HIS . 11.0 t 168.91 92.32 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 113.58 0.955 . . . . 1.0 113.58 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.525 ' HA ' ' NE ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -116.94 27.86 8.88 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.539 1.161 . . . . 1.0 111.392 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.99 77.45 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 106.203 -1.777 . . . . 1.0 106.203 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.35 -64.19 2.11 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 107.404 -2.279 . . . . 1.0 107.404 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.632 0 O-C-N 118.026 -3.043 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.826 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.2 t80 73.55 -43.61 0.56 Allowed 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 113.027 0.751 . . . . 1.0 113.027 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -177.83 86.56 0.07 OUTLIER Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.552 -1.019 . . . . 1.0 110.552 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -125.79 -114.84 0.28 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.752 -0.779 . . . . 1.0 109.172 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 m -33.49 -35.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 115.731 1.752 . . . . 1.0 115.731 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -65.28 -54.03 35.19 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.933 -1.136 . . . . 1.0 107.933 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.2 -49.13 68.33 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 113.085 -1.87 . . . . 1.0 108.757 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -50.91 -44.64 49.96 Favored Glycine 0 N--CA 1.5 2.96 0 CA-C-N 115.18 -0.918 . . . . 1.0 111.698 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.505 ' HA ' HG12 ' A' ' 60' ' ' ILE . 91.0 t -80.91 -32.75 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 119.42 -0.912 . . . . 1.0 111.138 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -71.59 -21.65 61.83 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.935 -1.506 . . . . 1.0 106.935 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.34 -36.75 29.3 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.954 -1.021 . . . . 1.0 110.148 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.505 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.9 pt -80.6 -33.26 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 C-N-CA 116.984 -1.886 . . . . 1.0 105.917 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.3 mt -52.06 -29.72 12.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 114.471 -1.241 . . . . 1.0 108.719 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -66.48 -52.49 45.59 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.483 1.66 . . . . 1.0 115.483 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.494 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.7 pp -78.07 -28.24 15.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.233 -1.387 . . . . 1.0 111.983 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.494 ' N ' HD13 ' A' ' 63' ' ' ILE . 46.5 tp -68.05 -37.02 80.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.528 -1.286 . . . . 1.0 107.528 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.535 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.09 -51.47 12.17 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 117.527 -1.669 . . . . 1.0 106.661 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -49.93 -45.0 50.73 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.598 1.189 . . . . 1.0 111.99 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.0 mt -77.14 -31.87 55.94 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.63 -1.168 . . . . 1.0 111.8 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -67.51 -24.06 65.53 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 102.572 -3.122 . . . . 1.0 102.572 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -75.3 -51.88 12.17 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.003 -1.851 . . . . 1.0 106.003 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.58 -46.34 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 124.253 0.971 . . . . 1.0 111.485 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.485 ' C ' ' CD2' ' A' ' 71' ' ' HIS . 2.7 t60 -46.19 -47.49 17.74 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.815 0.817 . . . . 1.0 112.064 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 58.1 t80 -64.77 -21.22 66.72 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.901 -1.5 . . . . 1.0 113.272 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -88.61 -44.62 10.49 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 104.975 -2.232 . . . . 1.0 104.975 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.513 ' O ' ' ND1' ' A' ' 78' ' ' HIS . 16.8 mt -60.83 -35.68 66.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 105.109 -2.182 . . . . 1.0 105.109 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.74 -73.81 0.83 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.763 -1.735 . . . . 1.0 108.763 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 78.1 m -49.22 -36.12 19.14 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 115.992 1.849 . . . . 1.0 115.992 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -87.46 -15.58 37.26 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.457 0.91 . . . . 1.0 113.457 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -50.21 -52.13 38.41 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 113.496 0.924 . . . . 1.0 113.496 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.9 t 170.01 155.07 0.05 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.814 -1.55 . . . . 1.0 106.814 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.04 30.55 3.03 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 111.642 -2.526 . . . . 1.0 105.861 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.4 pt 42.36 -123.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 114.732 1.382 . . . . 1.0 114.732 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.75 -161.29 35.07 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 105.551 -3.02 . . . . 1.0 105.551 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.784 0 O-C-N 119.214 -2.345 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.875 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 58.82 20.24 7.77 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-O 121.781 0.8 . . . . 1.0 109.724 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.04 140.72 13.31 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 106.353 -2.699 . . . . 1.0 106.353 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -132.97 -102.07 0.26 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.249 -1.389 . . . . 1.0 107.249 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.9 p -60.49 -48.71 80.57 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 119.603 1.092 . . . . 1.0 112.879 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.93 -63.56 1.03 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 114.081 -1.418 . . . . 1.0 109.17 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.49 95.24 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.027 -1.442 . . . . 1.0 109.007 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.29 -37.71 48.18 Favored Glycine 0 N--CA 1.491 2.365 0 CA-C-N 114.403 -1.271 . . . . 1.0 110.559 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.47 ' HA ' HG12 ' A' ' 60' ' ' ILE . 78.1 t -91.94 -39.68 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.312 -0.955 . . . . 1.0 111.838 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -59.5 -29.54 67.93 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 118.084 -1.446 . . . . 1.0 107.801 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.3 -30.32 48.32 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.128 -1.396 . . . . 1.0 111.859 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.8 pt -90.11 -25.84 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 C-N-CA 116.038 -2.265 . . . . 1.0 109.563 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.44 -30.16 6.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.387 -1.279 . . . . 1.0 109.24 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -55.76 -61.4 2.39 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.453 -1.299 . . . . 1.0 112.589 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.54 HD13 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -59.45 -30.52 44.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 114.836 -1.074 . . . . 1.0 113.454 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.54 ' N ' HD13 ' A' ' 63' ' ' ILE . 59.2 tp -72.67 -33.1 66.3 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.33 -0.989 . . . . 1.0 108.33 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -47.01 19.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 104.972 -2.232 . . . . 1.0 104.972 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.452 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 25.2 mt-30 -49.96 -50.23 47.45 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.734 1.254 . . . . 1.0 112.076 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.93 -29.56 60.99 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.177 -1.374 . . . . 1.0 111.727 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.2 tp -71.13 -22.43 62.07 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 103.469 -2.789 . . . . 1.0 103.469 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 20.7 m-30 -69.2 -49.67 54.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.099 -1.815 . . . . 1.0 106.099 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.3 -44.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-N 114.228 -1.351 . . . . 1.0 111.38 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.459 ' C ' ' CD2' ' A' ' 71' ' ' HIS . 1.4 t60 -50.27 -46.43 55.09 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.116 0.96 . . . . 1.0 111.963 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.439 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 85.2 t80 -61.42 -31.65 71.59 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 123.566 1.65 . . . . 1.0 112.589 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.5 mtt85 -76.43 -46.05 28.78 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 111.361 -2.654 . . . . 1.0 106.112 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mt -55.73 -52.59 46.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 113.745 -1.571 . . . . 1.0 109.724 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.69 -58.06 16.54 Favored Glycine 0 N--CA 1.5 2.924 0 C-N-CA 120.346 -0.931 . . . . 1.0 112.558 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 48.6 t -55.47 -51.11 68.05 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 118.929 -1.108 . . . . 1.0 110.005 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -60.95 -27.77 68.48 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.909 -1.496 . . . . 1.0 110.912 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.422 ' O ' ' CB ' ' A' ' 79' ' ' SER . 51.6 t-80 -69.95 -25.9 63.87 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 123.84 0.712 . . . . 1.0 109.549 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 78' ' ' HIS . 5.4 t 83.0 74.37 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.481 1.134 . . . . 1.0 108.122 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -110.31 76.75 1.0 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.641 -0.708 . . . . 1.0 110.949 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.9 pt -139.17 167.54 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.319 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.28 80.8 0.08 OUTLIER Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.281 -1.127 . . . . 1.0 110.281 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.651 0 O-C-N 118.203 -2.939 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.747 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -73.64 49.71 0.31 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.339 0.496 . . . . 1.0 112.339 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.51 78.33 0.86 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 106.036 -2.826 . . . . 1.0 106.036 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -88.83 -73.56 0.5 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.873 1.434 . . . . 1.0 114.873 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.8 m -50.64 -60.43 3.04 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 117.685 2.476 . . . . 1.0 117.685 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -65.1 -60.56 2.89 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.153 -1.019 . . . . 1.0 113.386 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.56 89.04 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.635 -0.826 . . . . 1.0 109.475 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.91 -41.13 99.62 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 118.509 -1.805 . . . . 1.0 110.937 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.502 ' HA ' HG12 ' A' ' 60' ' ' ILE . 72.0 t -80.28 -33.72 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 119.385 -0.926 . . . . 1.0 111.296 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -71.62 -22.46 61.7 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.395 -1.335 . . . . 1.0 107.395 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.28 -37.75 23.07 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.818 -1.083 . . . . 1.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.502 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.5 pt -78.79 -32.89 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 105.62 -1.993 . . . . 1.0 105.62 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 1.5 mt -56.89 -25.02 21.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.607 -1.179 . . . . 1.0 109.701 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -66.62 -52.43 45.23 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 114.187 1.18 . . . . 1.0 114.187 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.511 HD13 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -81.35 -27.35 10.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 118.715 -1.194 . . . . 1.0 110.658 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.511 ' N ' HD13 ' A' ' 63' ' ' ILE . 43.1 tp -70.69 -30.03 66.49 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.611 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -84.15 -51.8 6.77 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 116.701 -2.0 . . . . 1.0 106.368 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.514 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 34.3 mt-30 -54.56 -45.19 73.43 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.1 -1.44 . . . . 1.0 113.406 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.2 mt -69.96 -32.66 71.01 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.593 -0.891 . . . . 1.0 108.593 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.466 ' O ' ' CD2' ' A' ' 71' ' ' HIS . 20.9 tp -66.99 -16.91 64.66 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 103.613 -2.736 . . . . 1.0 103.613 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.514 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 12.3 m-30 -88.44 -44.96 10.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 105.343 -2.095 . . . . 1.0 105.343 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.5 mm -58.93 -36.84 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 119.147 -1.021 . . . . 1.0 112.829 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -57.28 -21.34 33.85 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.201 -1.4 . . . . 1.0 108.562 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -86.49 -17.45 34.15 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.111 0.957 . . . . 1.0 110.163 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -95.26 -16.41 22.48 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.228 -1.351 . . . . 1.0 107.358 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt -94.39 -64.84 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 112.378 -2.192 . . . . 1.0 106.431 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -53.18 -71.68 0.65 Allowed Glycine 0 N--CA 1.495 2.569 0 C-N-CA 120.755 -0.736 . . . . 1.0 114.402 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 37.0 t -54.7 -13.06 0.89 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.312 -0.944 . . . . 1.0 113.187 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -103.33 -29.5 11.2 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.607 -0.437 . . . . 1.0 110.912 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -30.07 70.16 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.858 -1.164 . . . . 1.0 107.858 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 t 78.51 105.22 0.07 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 126.136 2.148 . . . . 1.0 111.664 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -55.65 -13.75 1.81 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 114.419 1.266 . . . . 1.0 114.419 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.6 mm -81.96 56.98 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 122.127 0.965 . . . . 1.0 108.761 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.43 60.06 2.4 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.136 -1.186 . . . . 1.0 110.136 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.658 0 O-C-N 118.714 -2.639 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.743 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 64.15 -69.89 0.08 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 124.577 1.173 . . . . 1.0 113.356 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.1 84.53 0.71 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.637 -1.385 . . . . 1.0 109.637 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -27.04 -58.04 0.09 Allowed 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 115.85 1.796 . . . . 1.0 115.85 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.2 t -61.0 -41.95 97.5 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 119.862 -0.735 . . . . 1.0 110.889 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -61.1 -49.32 77.77 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.31 -40.47 77.93 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.695 -1.593 . . . . 1.0 107.705 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.94 -43.45 98.88 Favored Glycine 0 N--CA 1.497 2.756 0 C-N-CA 118.881 -1.628 . . . . 1.0 110.168 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 60' ' ' ILE . 92.5 t -70.51 -34.41 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 119.705 -0.798 . . . . 1.0 111.053 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.61 -13.6 62.46 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.172 -1.048 . . . . 1.0 108.172 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.82 -29.62 15.88 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.518 -1.219 . . . . 1.0 109.86 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.484 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.7 pt -86.83 -34.22 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 116.75 -1.98 . . . . 1.0 106.357 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 1.2 mp -62.9 -24.52 36.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.253 -1.379 . . . . 1.0 110.963 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -69.35 -45.79 68.57 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 117.516 -1.674 . . . . 1.0 115.031 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.513 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -80.77 -29.67 11.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.101 -1.04 . . . . 1.0 111.876 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.513 ' N ' HD13 ' A' ' 63' ' ' ILE . 42.6 tp -71.23 -27.14 63.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.44 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -84.24 -53.76 5.27 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.204 -1.776 . . . . 1.0 106.204 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -53.06 -36.51 60.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.47 -1.292 . . . . 1.0 112.738 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.476 ' HA ' HG12 ' A' ' 70' ' ' ILE . 80.0 mt -80.75 -32.8 35.45 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.158 -1.017 . . . . 1.0 111.806 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -67.91 -21.79 65.11 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 104.252 -2.499 . . . . 1.0 104.252 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.413 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 17.6 m-30 -73.39 -48.22 35.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 117.506 -1.678 . . . . 1.0 107.91 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 67' ' ' LEU . 7.1 mm -50.55 -41.04 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 114.517 -1.22 . . . . 1.0 111.497 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -48.59 -37.27 17.59 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.172 -0.611 . . . . 1.0 110.525 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.61 -21.33 48.66 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.645 -1.161 . . . . 1.0 111.425 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 22.5 mtp85 -86.56 -22.7 26.15 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 123.448 1.594 . . . . 1.0 107.275 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.9 mt -84.59 -70.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 111.606 -2.543 . . . . 1.0 106.839 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -33.89 -77.52 0.04 OUTLIER Glycine 0 N--CA 1.502 3.045 0 N-CA-C 116.149 1.22 . . . . 1.0 116.149 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 66.4 m -55.64 -30.21 60.58 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.098 1.518 . . . . 1.0 115.098 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -81.34 -25.89 36.02 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.123 -1.065 . . . . 1.0 108.123 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -85.47 -68.55 0.72 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 114.605 -1.18 . . . . 1.0 113.59 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.7 m -162.59 117.62 1.82 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.991 -1.114 . . . . 1.0 107.991 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -159.81 -66.45 0.07 Allowed 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 118.757 -1.177 . . . . 1.0 112.879 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.0 mt -143.56 165.34 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 107.645 -1.242 . . . . 1.0 107.645 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.94 157.27 29.48 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 105.142 -3.183 . . . . 1.0 105.142 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.786 0 O-C-N 118.864 -2.551 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.876 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 41.2 39.25 0.89 Allowed 'General case' 0 N--CA 1.51 2.537 0 CA-C-O 122.401 1.096 . . . . 1.0 112.033 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.58 73.99 0.01 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 116.295 1.278 . . . . 1.0 116.295 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -47.32 -34.15 6.5 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 112.324 0.49 . . . . 1.0 112.324 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.2 m -58.68 -33.74 70.47 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.722 -1.191 . . . . 1.0 109.459 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -90.39 -55.11 3.72 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.49 -0.777 . . . . 1.0 108.945 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.55 -46.93 83.31 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 124.322 1.014 . . . . 1.0 113.501 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.74 -41.53 97.58 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.778 -1.329 . . . . 1.0 109.778 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 60' ' ' ILE . 97.8 t -73.44 -33.44 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 118.301 -1.36 . . . . 1.0 110.154 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -72.47 -21.06 61.28 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.61 -40.56 16.1 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 113.95 -1.477 . . . . 1.0 109.873 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.0 pt -75.96 -31.43 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 116.793 -1.963 . . . . 1.0 105.809 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 1.8 mt -60.15 -23.43 27.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 118.215 -1.394 . . . . 1.0 109.019 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -76.0 -52.04 11.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 116.596 -2.042 . . . . 1.0 111.222 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 64' ' ' LEU . 2.3 pp -70.83 -29.17 36.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 118.756 -1.178 . . . . 1.0 111.503 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.515 ' N ' HD13 ' A' ' 63' ' ' ILE . 30.9 tp -67.68 -31.36 71.28 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.547 -1.279 . . . . 1.0 107.547 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.579 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -81.87 -54.14 5.59 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 117.923 -1.511 . . . . 1.0 107.541 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.409 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 24.9 mt-30 -51.72 -38.06 53.61 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.325 -1.307 . . . . 1.0 112.658 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.508 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 64.3 mt -81.62 -37.04 28.2 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.863 -1.062 . . . . 1.0 108.559 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.3 tp -67.09 -14.29 62.76 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.409 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 18.2 m-30 -73.6 -36.61 65.53 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 117.305 -1.758 . . . . 1.0 107.121 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.51 ' N ' HH21 ' A' ' 73' ' ' ARG . 57.2 mt -45.35 -46.15 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 112.853 -1.976 . . . . 1.0 110.749 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.454 ' C ' ' CD2' ' A' ' 71' ' ' HIS . 1.7 t60 -47.3 -43.85 22.9 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.988 0.899 . . . . 1.0 111.172 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.97 -28.65 69.06 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.808 -1.542 . . . . 1.0 112.21 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.51 HH21 ' N ' ' A' ' 70' ' ' ILE . 12.1 mtm180 -79.99 -38.52 31.99 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 113.293 -1.776 . . . . 1.0 107.76 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.478 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 3.6 mt -65.31 -46.81 89.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 113.28 -1.782 . . . . 1.0 109.276 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.32 -56.91 22.53 Favored Glycine 0 N--CA 1.501 3.01 0 N-CA-C 108.281 -1.928 . . . . 1.0 108.281 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 74.2 m -53.18 -44.34 67.81 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.459 -0.871 . . . . 1.0 112.397 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 74' ' ' ILE . 9.6 ptm180 -70.99 -13.06 61.87 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 118.924 -1.11 . . . . 1.0 112.972 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -81.28 -47.37 13.44 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.887 -1.125 . . . . 1.0 113.16 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.435 ' HG ' ' N ' ' A' ' 83' ' ' NH2 . 24.4 t 164.76 -46.15 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.801 0 CA-C-O 121.346 0.593 . . . . 1.0 110.95 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 48.48 58.27 5.39 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 113.971 -1.468 . . . . 1.0 110.398 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.1 mt 72.03 15.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-N 114.017 -1.447 . . . . 1.0 110.276 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.13 -11.64 62.81 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.351 -1.1 . . . . 1.0 110.351 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . 0.435 ' N ' ' HG ' ' A' ' 79' ' ' SER . . . . . . . . 0 C--N 1.299 -1.598 0 O-C-N 118.681 -2.658 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.686 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -80.76 52.49 1.72 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.686 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.24 79.76 0.03 OUTLIER Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.01 -1.566 . . . . 1.0 113.004 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -125.55 -119.4 0.27 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 105.022 -2.214 . . . . 1.0 105.022 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t -50.77 -32.94 21.33 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 119.305 0.957 . . . . 1.0 111.626 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -67.63 -36.59 81.1 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.706 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.18 -36.68 82.28 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.268 -1.012 . . . . 1.0 108.268 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.76 -42.69 16.4 Favored Glycine 0 N--CA 1.498 2.788 0 C-N-CA 118.089 -2.005 . . . . 1.0 112.482 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.461 ' HA ' HG12 ' A' ' 60' ' ' ILE . 85.4 t -78.21 -35.5 19.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 115.993 1.849 . . . . 1.0 115.993 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -64.38 -31.79 73.14 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.145 -1.798 . . . . 1.0 106.145 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.87 -38.55 76.43 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 111.903 -2.408 . . . . 1.0 111.625 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.9 pt -83.98 -31.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 116.754 -1.978 . . . . 1.0 107.562 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -73.92 -28.68 24.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 117.13 -1.828 . . . . 1.0 109.884 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -59.29 -56.74 18.27 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 117.93 -1.508 . . . . 1.0 112.913 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.46 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -73.44 -28.21 24.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.46 ' N ' HD13 ' A' ' 63' ' ' ILE . 28.2 tp -70.02 -32.39 70.52 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.46 -53.81 5.43 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 117.911 -1.516 . . . . 1.0 107.652 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.461 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 23.9 mt-30 -51.28 -37.67 48.64 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.739 -1.118 . . . . 1.0 112.039 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 70' ' ' ILE . 76.6 mt -84.75 -34.91 22.76 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 117.798 -1.561 . . . . 1.0 110.124 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp -65.67 -22.44 66.64 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 104.398 -2.445 . . . . 1.0 104.398 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.461 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 18.5 m-30 -60.21 -32.82 71.47 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 117.337 -1.745 . . . . 1.0 108.109 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 67' ' ' LEU . 1.6 mp -46.98 -42.12 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 C-N-CA 118.359 -1.337 . . . . 1.0 111.083 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.481 ' C ' ' CD2' ' A' ' 71' ' ' HIS . 0.3 OUTLIER -52.5 -39.2 60.98 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.568 0.699 . . . . 1.0 110.924 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -75.14 -26.15 58.93 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.438 -1.255 . . . . 1.0 111.266 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 43.3 mtm180 -82.98 -24.65 32.83 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.734 -1.58 . . . . 1.0 106.734 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mt -80.72 -58.55 3.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 113.94 -1.482 . . . . 1.0 111.09 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -47.09 -35.25 8.44 Favored Glycine 0 N--CA 1.506 3.314 0 CA-C-O 121.414 0.452 . . . . 1.0 112.338 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.7 m -77.99 -66.8 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.559 -1.32 . . . . 1.0 110.26 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -51.91 -48.08 64.32 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.269 1.211 . . . . 1.0 114.269 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -49.41 -63.3 1.15 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 125.218 1.574 . . . . 1.0 112.208 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.409 ' HG ' ' CG2' ' A' ' 81' ' ' ILE . 64.9 p -171.67 40.77 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.982 -1.087 . . . . 1.0 110.583 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? 31.5 68.62 0.12 Allowed 'General case' 0 N--CA 1.509 2.515 0 O-C-N 124.95 1.406 . . . . 1.0 110.452 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.409 ' CG2' ' HG ' ' A' ' 79' ' ' SER . 2.1 pp -95.85 -164.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 114.712 1.375 . . . . 1.0 114.712 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.37 -81.24 0.68 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.859 -1.696 . . . . 1.0 108.859 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.657 0 O-C-N 119.078 -2.425 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.758 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.421 ' C ' ' H ' ' A' ' 52' ' ' ASP . 71.9 m-85 -78.61 -35.46 45.62 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 112.891 0.7 . . . . 1.0 112.891 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.13 -19.55 0.02 OUTLIER Glycine 0 N--CA 1.511 3.658 0 N-CA-C 117.725 1.85 . . . . 1.0 117.725 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 50' ' ' TYR . 5.9 p-10 -36.21 -45.38 0.45 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.434 1.642 . . . . 1.0 115.434 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.3 m -62.81 -26.43 68.73 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 113.523 0.935 . . . . 1.0 113.523 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 -76.91 -68.67 0.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 106.739 -1.578 . . . . 1.0 106.739 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.2 -55.26 10.88 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 112.128 -2.306 . . . . 1.0 111.096 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.18 -30.45 31.7 Favored Glycine 0 N--CA 1.496 2.642 0 CA-C-N 113.869 -1.514 . . . . 1.0 112.632 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 60' ' ' ILE . 97.9 t -96.1 -28.29 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 118.815 -1.154 . . . . 1.0 112.44 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -71.69 -29.89 65.08 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 105.127 -2.175 . . . . 1.0 105.127 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.98 79.09 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 113.397 -1.729 . . . . 1.0 111.721 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.9 pt -82.09 -38.47 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 105.47 -2.048 . . . . 1.0 105.47 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mt -52.7 -45.84 49.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 106.383 -1.71 . . . . 1.0 106.383 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.603 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 15.0 ttm180 -46.09 -36.42 5.78 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.41 -1.268 . . . . 1.0 110.465 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.475 ' N ' HD12 ' A' ' 63' ' ' ILE . 2.0 mm -91.41 -26.14 5.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.113 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.408 HD13 ' C ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -69.76 -30.95 68.65 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.875 -1.53 . . . . 1.0 108.304 -179.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.603 ' NE2' ' HA ' ' A' ' 62' ' ' ARG . 1.9 pt20 -85.25 -47.85 9.67 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.109 -1.812 . . . . 1.0 106.109 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.424 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 29.6 mt-30 -54.1 -36.36 63.12 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 117.83 -1.548 . . . . 1.0 109.385 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.504 ' HA ' HG12 ' A' ' 70' ' ' ILE . 97.8 mt -81.43 -36.98 28.8 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.66 -1.216 . . . . 1.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.9 tp -66.35 -17.51 64.81 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 105.278 -2.119 . . . . 1.0 105.278 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.401 ' CZ ' ' HG3' ' A' ' 65' ' ' GLN . 19.4 m-30 -76.22 -32.68 59.07 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 117.869 -1.532 . . . . 1.0 109.065 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.504 HG12 ' HA ' ' A' ' 67' ' ' LEU . 19.4 mm -52.86 -41.48 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.51 -1.223 . . . . 1.0 114.174 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -24.18 48.64 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 117.972 -1.491 . . . . 1.0 109.007 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -83.65 -20.76 33.03 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.337 -0.945 . . . . 1.0 110.44 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -89.45 -18.61 26.42 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.443 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.4 mp -95.2 -61.93 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 112.881 -1.963 . . . . 1.0 111.153 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.84 -67.48 2.18 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 120.0 -1.095 . . . . 1.0 112.218 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 78.8 m -56.61 -13.87 2.75 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.37 0.878 . . . . 1.0 113.37 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.6 ttm-85 -102.97 -15.95 15.97 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.233 -0.987 . . . . 1.0 110.415 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -53.21 -73.02 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.446 1.276 . . . . 1.0 114.446 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.2 t 153.35 -165.47 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.273 1 N-CA-C 99.366 -4.309 . . . . 1.0 99.366 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.85 58.09 2.27 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.366 -0.833 . . . . 1.0 110.053 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.7 mm 44.27 49.57 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 CA-C-O 122.315 1.055 . . . . 1.0 111.79 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.8 -97.36 0.43 Allowed Glycine 0 N--CA 1.498 2.804 0 C-N-CA 120.093 -1.051 . . . . 1.0 110.704 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.636 0 O-C-N 118.396 -2.826 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.682 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -78.06 53.45 1.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.064 0.935 . . . . 1.0 111.497 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.36 72.07 0.39 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 107.246 -2.342 . . . . 1.0 107.246 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -102.05 -123.4 0.18 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.7 t -42.16 -35.81 1.03 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.832 1.79 . . . . 1.0 115.832 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.413 ' HA ' HG11 ' A' ' 57' ' ' VAL . 27.1 p-90 -75.79 -38.96 57.74 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 117.436 -1.706 . . . . 1.0 108.19 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.35 -39.25 92.12 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.492 -1.283 . . . . 1.0 108.618 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.6 -44.71 39.21 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.731 -1.223 . . . . 1.0 111.616 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.461 ' HA ' ' CG1' ' A' ' 60' ' ' ILE . 2.1 p -70.71 -32.47 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 118.356 -1.338 . . . . 1.0 109.783 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.35 -21.49 61.3 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.982 -1.087 . . . . 1.0 108.842 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.15 -40.22 18.46 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.736 -1.575 . . . . 1.0 109.732 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.461 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 2.3 pt -76.6 -33.01 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 104.74 -2.318 . . . . 1.0 104.74 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.415 ' O ' ' HG3' ' A' ' 65' ' ' GLN . 1.6 mt -58.48 -37.74 66.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 118.373 -1.331 . . . . 1.0 107.563 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -56.04 -24.0 36.82 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.077 -1.449 . . . . 1.0 113.49 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.2 mm -95.15 -7.61 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 119.634 -0.827 . . . . 1.0 109.23 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.435 HD13 ' C ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.28 -45.39 5.62 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.933 -0.707 . . . . 1.0 109.552 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 61' ' ' ILE . 4.0 pp0? -68.79 -27.64 66.06 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 117.709 -1.596 . . . . 1.0 107.687 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.432 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -65.4 -61.43 2.11 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.256 -1.338 . . . . 1.0 108.501 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.2 mt -61.94 -32.12 72.51 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.474 -1.239 . . . . 1.0 111.391 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.484 ' O ' ' CD2' ' A' ' 71' ' ' HIS . 36.1 tp -70.38 -14.38 62.54 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.492 ' CD2' HD11 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -91.04 -45.87 8.46 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 105.234 -2.135 . . . . 1.0 105.234 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.492 HD11 ' CD2' ' A' ' 69' ' ' PHE . 9.9 mm -57.8 -37.21 58.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 118.239 -1.384 . . . . 1.0 111.411 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.484 ' CD2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -55.94 -20.39 15.97 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 118.478 -1.289 . . . . 1.0 109.585 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -85.18 -24.27 27.99 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.982 0.896 . . . . 1.0 109.694 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HD3' ' CE1' ' A' ' 69' ' ' PHE . 17.3 mtm105 -90.23 -17.44 27.49 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.597 -1.26 . . . . 1.0 107.597 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.3 mt -91.28 -59.25 3.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 111.838 -2.437 . . . . 1.0 110.426 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.72 -57.4 11.18 Favored Glycine 0 N--CA 1.506 3.329 0 N-CA-C 116.267 1.267 . . . . 1.0 116.267 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 63.7 m -56.97 -33.68 67.3 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.826 -0.687 . . . . 1.0 110.016 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.486 ' HA ' ' NE ' ' A' ' 77' ' ' ARG . 1.1 tpm_? -83.67 -37.88 22.21 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.129 -1.028 . . . . 1.0 109.07 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.544 ' ND1' ' OG ' ' A' ' 79' ' ' SER . 29.4 t-80 -57.67 -43.53 85.07 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 123.651 0.594 . . . . 1.0 109.907 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.544 ' OG ' ' ND1' ' A' ' 78' ' ' HIS . 6.3 p 161.43 -1.02 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 117.079 2.252 . . . . 1.0 117.079 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -50.92 -35.77 34.98 Favored 'General case' 0 N--CA 1.507 2.412 0 C-N-CA 118.169 -1.412 . . . . 1.0 111.648 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 37.0 pt -114.65 41.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.275 -1.75 . . . . 1.0 106.275 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.63 -61.71 4.45 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.477 -2.249 . . . . 1.0 107.477 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.684 0 O-C-N 119.394 -2.239 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.828 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -128.19 72.1 1.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.99 27.56 0.04 OUTLIER Glycine 0 N--CA 1.506 3.353 0 C-N-CA 120.005 -1.093 . . . . 1.0 113.399 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -42.26 -57.55 2.51 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 112.881 0.697 . . . . 1.0 112.881 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -55.44 -31.13 61.67 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.114 0.783 . . . . 1.0 113.114 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -65.58 -58.73 5.06 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.927 -1.508 . . . . 1.0 106.927 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.72 -48.74 58.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 111.866 -2.424 . . . . 1.0 108.787 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.85 -36.99 67.93 Favored Glycine 0 N--CA 1.494 2.538 0 CA-C-N 114.081 -1.418 . . . . 1.0 111.176 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.456 ' HA ' HG12 ' A' ' 60' ' ' ILE . 59.9 t -79.97 -33.02 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 114.699 1.37 . . . . 1.0 114.699 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -65.55 -29.38 69.99 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 116.656 -2.018 . . . . 1.0 107.231 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.05 -36.45 79.9 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 112.069 -2.332 . . . . 1.0 110.553 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.456 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.5 pt -84.46 -36.95 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 116.165 -2.214 . . . . 1.0 107.474 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.98 -29.65 47.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 117.6 -1.64 . . . . 1.0 110.211 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -63.81 -54.19 38.97 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.207 -1.397 . . . . 1.0 114.239 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.534 HD13 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -73.59 -29.13 26.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 118.771 -1.172 . . . . 1.0 112.829 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.534 ' N ' HD13 ' A' ' 63' ' ' ILE . 39.9 tp -69.32 -30.23 68.24 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.423 ' NE2' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -82.26 -52.41 6.97 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.166 -1.79 . . . . 1.0 106.166 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.476 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 50.8 mt-30 -50.22 -38.33 39.85 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.389 -0.823 . . . . 1.0 113.076 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.5 mt -84.15 -33.21 24.29 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.985 -1.007 . . . . 1.0 110.392 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.49 -15.0 61.8 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.035 -2.209 . . . . 1.0 105.035 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.476 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 17.4 m-30 -66.86 -37.21 84.01 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 116.823 -1.951 . . . . 1.0 107.716 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 32.9 mt -48.31 -47.68 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 114.211 -1.359 . . . . 1.0 111.858 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.488 ' C ' ' CD2' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -51.78 -34.44 39.79 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.061 0.457 . . . . 1.0 111.087 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.75 -13.42 56.35 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.141 -0.936 . . . . 1.0 111.671 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 49.1 mtm180 -101.02 -20.42 15.4 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.453 -1.249 . . . . 1.0 109.13 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 mt -95.69 -45.98 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 113.401 -1.727 . . . . 1.0 109.018 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -43.19 -62.97 2.21 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 121.329 -0.463 . . . . 1.0 112.686 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 24.7 p -56.44 -25.88 51.92 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 112.975 0.732 . . . . 1.0 112.975 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.1 mtp-105 -90.77 -13.71 33.44 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.56 -0.745 . . . . 1.0 111.528 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.444 ' ND1' ' C ' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -72.29 -17.34 61.88 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.926 -1.11 . . . . 1.0 111.191 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 t 174.63 119.63 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 123.287 0.367 . . . . 1.0 110.836 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -161.62 95.94 1.02 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.853 -0.739 . . . . 1.0 109.04 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 81' ' ' ILE . 2.6 mp -97.14 152.85 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 104.371 -2.455 . . . . 1.0 104.371 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 176.92 173.09 42.17 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 104.939 -3.264 . . . . 1.0 104.939 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.837 0 O-C-N 118.93 -2.512 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.722 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 35.8 t80 71.73 -54.05 0.68 Allowed 'General case' 0 N--CA 1.508 2.449 0 O-C-N 124.265 0.978 . . . . 1.0 111.904 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.65 123.91 7.14 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 106.234 -2.746 . . . . 1.0 106.234 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -108.66 -100.29 0.38 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 117.363 0.582 . . . . 1.0 110.198 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.6 t -45.95 -32.33 2.66 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 113.686 0.995 . . . . 1.0 113.686 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -58.64 -50.81 72.47 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.542 -0.863 . . . . 1.0 110.873 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.16 -42.78 68.67 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.89 -32.47 62.28 Favored Glycine 0 N--CA 1.494 2.554 0 CA-C-N 113.425 -1.716 . . . . 1.0 112.861 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.464 ' HA ' HG12 ' A' ' 60' ' ' ILE . 87.9 t -98.53 -42.63 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 113.087 0.773 . . . . 1.0 113.087 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.79 -28.08 67.11 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.453 -1.299 . . . . 1.0 108.34 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.31 -25.95 51.74 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.93 -1.486 . . . . 1.0 111.612 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.8 pt -94.57 -35.05 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 117.263 -1.775 . . . . 1.0 110.21 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.51 -23.21 22.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 113.743 -1.571 . . . . 1.0 108.272 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -73.61 -52.36 13.67 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 115.38 -2.528 . . . . 1.0 112.15 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 64' ' ' LEU . 2.3 pp -70.66 -29.31 37.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 113.776 1.028 . . . . 1.0 113.776 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.531 ' N ' HD13 ' A' ' 63' ' ' ILE . 26.4 tp -68.87 -37.63 79.19 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.937 -1.505 . . . . 1.0 106.937 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -74.74 -48.15 27.3 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 117.24 -1.784 . . . . 1.0 106.617 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.444 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -52.04 -44.17 64.11 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.76 -1.109 . . . . 1.0 112.038 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 70' ' ' ILE . 3.6 pp -75.52 -37.65 59.95 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.67 -1.15 . . . . 1.0 109.279 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.5 mt -67.11 -16.21 64.19 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.928 -1.879 . . . . 1.0 105.928 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 20.9 m-30 -73.55 -35.72 65.53 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.507 -1.677 . . . . 1.0 106.686 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.0 mm -53.25 -43.71 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.373 -1.285 . . . . 1.0 112.296 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.474 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -54.41 -28.61 44.95 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 120.066 1.303 . . . . 1.0 110.924 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.474 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 39.9 t80 -75.32 -29.68 60.08 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.756 1.265 . . . . 1.0 111.381 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -82.44 -38.64 23.71 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 113.46 -1.7 . . . . 1.0 108.149 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.58 -50.24 72.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 113.141 -1.845 . . . . 1.0 106.794 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -50.83 -51.69 33.06 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.468 -1.349 . . . . 1.0 109.744 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 53.2 t -46.83 -59.29 3.16 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.815 0.817 . . . . 1.0 111.181 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -53.95 -37.74 64.22 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.691 -1.14 . . . . 1.0 112.658 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -84.74 -11.23 56.24 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 118.79 -1.164 . . . . 1.0 109.595 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.9 t -89.56 -25.2 21.48 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 114.333 1.234 . . . . 1.0 114.333 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.0 ttm105 -115.88 57.67 0.75 Allowed 'General case' 0 N--CA 1.507 2.414 0 CA-C-N 119.356 0.98 . . . . 1.0 110.574 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.6 pt -140.72 173.46 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 120.077 -0.649 . . . . 1.0 111.62 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.25 -165.77 32.5 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 104.289 -3.525 . . . . 1.0 104.289 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.733 0 O-C-N 118.865 -2.55 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.875 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 49.72 34.02 6.88 Favored 'General case' 0 N--CA 1.507 2.418 0 CA-C-O 122.255 1.026 . . . . 1.0 109.281 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -127.75 133.12 7.71 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 105.461 -3.056 . . . . 1.0 105.461 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -114.55 -73.46 0.65 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.528 -1.286 . . . . 1.0 107.528 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.6 p -56.82 -42.6 79.89 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.709 -1.132 . . . . 1.0 110.793 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -62.95 -61.11 2.62 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 123.068 1.413 . . . . 1.0 109.971 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.09 -42.44 38.87 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 111.976 -2.375 . . . . 1.0 108.816 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.15 -38.55 72.78 Favored Glycine 0 N--CA 1.488 2.144 0 CA-C-N 113.958 -1.474 . . . . 1.0 112.251 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.539 ' HA ' HG12 ' A' ' 60' ' ' ILE . 1.8 p -73.5 -35.29 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 117.339 -1.744 . . . . 1.0 113.11 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -68.08 -28.79 67.66 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 117.287 -1.765 . . . . 1.0 107.538 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.72 -37.34 73.5 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 112.744 -2.026 . . . . 1.0 112.023 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 57' ' ' VAL . 4.8 pt -81.31 -35.03 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 106.533 -1.654 . . . . 1.0 106.533 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.7 mt -52.14 -43.47 38.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 112.842 -1.981 . . . . 1.0 105.82 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.648 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 81.6 mtm180 -51.86 -31.75 29.19 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 118.586 -1.246 . . . . 1.0 112.418 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 63' ' ' ILE . 1.4 mm -88.66 -17.62 8.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 114.455 -1.248 . . . . 1.0 110.791 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.44 -35.29 25.09 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.392 -1.323 . . . . 1.0 109.434 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.648 ' NE2' ' HA ' ' A' ' 62' ' ' ARG . 4.0 pt20 -76.01 -46.49 29.18 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 116.343 -2.143 . . . . 1.0 106.868 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.466 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 35.9 mt-30 -49.71 -45.98 49.69 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.315 1.055 . . . . 1.0 112.514 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 70' ' ' ILE . 89.1 mt -72.35 -40.13 67.58 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.957 -1.474 . . . . 1.0 110.033 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.7 mt -65.39 -15.3 62.45 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.822 -1.551 . . . . 1.0 107.019 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.466 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 21.0 m-30 -78.66 -39.19 37.54 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 106.92 -1.511 . . . . 1.0 106.92 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.3 mm -49.97 -40.47 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 114.607 -1.179 . . . . 1.0 111.235 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.474 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 1.4 t60 -50.25 -41.3 50.05 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.485 0.66 . . . . 1.0 109.705 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -66.6 -31.2 71.75 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 123.24 1.495 . . . . 1.0 111.81 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -73.62 -42.29 61.67 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 112.781 -2.009 . . . . 1.0 106.624 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.259 1.1 mp -60.85 -55.97 21.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 113.82 -1.536 . . . . 1.0 107.245 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.26 -51.81 48.44 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 109.608 -1.397 . . . . 1.0 109.608 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 52.1 t -50.43 -53.95 25.64 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 114.801 -0.699 . . . . 1.0 110.33 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -30.7 61.05 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.641 -0.709 . . . . 1.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -76.1 -9.54 58.71 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 118.872 -1.131 . . . . 1.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.1 t 54.6 14.25 0.81 Allowed 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 115.44 1.644 . . . . 1.0 115.44 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.4 mtp-105 -64.99 -22.45 67.0 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 119.663 -0.815 . . . . 1.0 112.097 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.9 tt -62.16 74.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 123.01 1.386 . . . . 1.0 111.415 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 162.99 -24.19 0.2 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.021 -1.631 . . . . 1.0 109.021 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.508 0 O-C-N 118.731 -2.629 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.764 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -77.44 57.55 1.55 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 122.272 1.034 . . . . 1.0 109.525 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.18 -114.7 5.7 Favored Glycine 0 N--CA 1.493 2.488 0 CA-C-N 115.272 -0.876 . . . . 1.0 112.355 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.4 t0 69.35 -62.78 0.4 Allowed 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 124.827 1.251 . . . . 1.0 110.32 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.0 p -69.69 -59.99 2.6 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-N 114.714 -1.13 . . . . 1.0 111.477 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.475 ' CG ' ' N ' ' A' ' 55' ' ' ALA . 6.7 t-105 -44.01 -71.91 0.07 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.215 -1.812 . . . . 1.0 110.045 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.475 ' N ' ' CG ' ' A' ' 54' ' ' TRP . . . -52.54 -40.11 62.14 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 112.315 -2.221 . . . . 1.0 107.939 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.62 -36.35 70.96 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 114.316 -1.311 . . . . 1.0 110.002 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.492 ' HA ' HG12 ' A' ' 60' ' ' ILE . 95.5 t -78.61 -39.39 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.788 -0.765 . . . . 1.0 110.544 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -29.38 70.25 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 118.325 -1.35 . . . . 1.0 107.684 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.5 -37.09 63.23 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.208 -2.269 . . . . 1.0 110.597 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.492 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.2 pt -83.16 -28.93 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 C-N-CA 116.07 -2.252 . . . . 1.0 108.327 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -71.53 -31.39 42.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 114.028 -1.442 . . . . 1.0 109.298 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -50.03 -62.16 1.73 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.619 -1.173 . . . . 1.0 113.032 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.507 HD13 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -75.8 -27.85 18.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 113.173 -1.83 . . . . 1.0 113.589 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.507 ' N ' HD13 ' A' ' 63' ' ' ILE . 29.6 tp -70.31 -34.97 73.35 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.443 -1.318 . . . . 1.0 107.443 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -82.75 -53.38 5.94 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 116.551 -2.06 . . . . 1.0 108.062 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -52.16 -37.04 53.34 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.82 -1.082 . . . . 1.0 112.796 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.467 ' HA ' HG12 ' A' ' 70' ' ' ILE . 83.5 mt -82.28 -38.63 24.11 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.487 -1.285 . . . . 1.0 110.943 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.9 tt -62.86 -23.75 67.47 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.445 -2.058 . . . . 1.0 105.445 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -66.3 -35.26 79.92 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 117.635 -1.626 . . . . 1.0 109.363 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 67' ' ' LEU . 12.6 mm -54.29 -38.19 39.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 113.453 -1.703 . . . . 1.0 113.103 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.431 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -60.15 -27.36 67.03 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 120.913 1.688 . . . . 1.0 109.188 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.431 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 58.4 t80 -73.86 -22.72 59.64 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.609 1.195 . . . . 1.0 110.422 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -85.97 -55.84 3.76 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 105.424 -2.065 . . . . 1.0 105.424 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.84 -35.64 34.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 113.503 -1.68 . . . . 1.0 111.368 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.63 -65.66 2.1 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 106.752 -2.539 . . . . 1.0 106.752 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 44.2 t -49.0 -60.3 2.89 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.97 1.47 . . . . 1.0 114.97 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -10.35 9.63 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 113.347 0.869 . . . . 1.0 113.347 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -63.73 -57.78 8.9 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.651 -1.22 . . . . 1.0 109.75 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.7 t 176.82 63.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.898 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 42.7 25.4 0.05 OUTLIER 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 115.331 1.604 . . . . 1.0 115.331 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.4 mt 56.99 32.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.881 0.848 . . . . 1.0 108.899 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.27 65.69 0.54 Allowed Glycine 0 N--CA 1.498 2.78 0 CA-C-N 115.52 -0.764 . . . . 1.0 112.076 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.65 0 O-C-N 118.5 -2.765 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.839 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 67.8 -44.52 0.48 Allowed 'General case' 0 N--CA 1.51 2.572 0 N-CA-C 116.366 1.987 . . . . 1.0 116.366 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.36 48.74 2.88 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 110.301 -1.12 . . . . 1.0 110.301 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -118.26 -120.51 0.3 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.261 -1.385 . . . . 1.0 107.261 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.4 m -45.87 -33.19 3.04 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 113.953 1.094 . . . . 1.0 113.953 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -52.64 61.94 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 107.763 -1.199 . . . . 1.0 107.763 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.78 -47.01 88.24 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.339 -1.755 . . . . 1.0 108.73 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.62 -41.95 93.92 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 119.103 -1.522 . . . . 1.0 111.917 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 60' ' ' ILE . 94.2 t -79.82 -29.06 12.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 114.433 1.272 . . . . 1.0 114.433 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -65.96 -33.34 75.6 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.575 -2.009 . . . . 1.0 105.575 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.05 93.59 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 111.883 -2.417 . . . . 1.0 111.648 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.7 pt -82.31 -29.83 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 117.061 -1.856 . . . . 1.0 106.83 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mt -61.71 -30.73 48.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.038 -1.437 . . . . 1.0 108.373 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -64.27 -55.83 18.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.43 -1.308 . . . . 1.0 114.228 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.514 HD11 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -69.7 -28.32 36.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 118.624 -1.23 . . . . 1.0 112.411 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.514 ' N ' HD11 ' A' ' 63' ' ' ILE . 29.0 tp -71.89 -33.28 68.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.513 HE21 ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -79.41 -43.98 22.32 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 116.872 -1.931 . . . . 1.0 107.278 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.48 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 1.5 pt20 -54.42 -37.06 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.291 -0.963 . . . . 1.0 111.62 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.8 mt -82.77 -38.89 22.57 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.077 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.6 tp -66.21 -15.49 63.22 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.48 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 19.3 m-30 -69.76 -28.32 65.67 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 116.571 -2.052 . . . . 1.0 108.602 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.3 mt -53.44 -42.25 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 114.575 -1.193 . . . . 1.0 110.662 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.445 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -53.41 -32.37 49.32 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.606 0.717 . . . . 1.0 110.051 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -83.13 -18.19 40.38 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.576 -1.193 . . . . 1.0 111.151 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 53.5 mtm180 -96.35 -16.98 20.98 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.875 -1.157 . . . . 1.0 107.875 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 mt -93.26 -56.18 5.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 113.524 -1.671 . . . . 1.0 107.928 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.88 -63.67 4.99 Favored Glycine 0 N--CA 1.499 2.836 0 C-N-CA 119.888 -1.148 . . . . 1.0 112.304 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 80.8 m -50.99 -44.97 60.95 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.464 -0.494 . . . . 1.0 110.096 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -63.14 -35.42 80.22 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.564 -0.744 . . . . 1.0 109.426 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.443 ' ND1' ' C ' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -82.81 -15.42 51.71 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 118.431 -1.308 . . . . 1.0 107.48 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 81' ' ' ILE . 14.3 p -159.09 101.05 1.58 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 122.106 0.955 . . . . 1.0 113.217 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.465 ' H ' ' CD ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -64.28 7.68 0.13 Allowed 'General case' 0 N--CA 1.507 2.399 0 CA-C-N 115.015 -0.993 . . . . 1.0 113.355 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.411 ' H ' ' C ' ' A' ' 79' ' ' SER . 25.5 mt 47.55 49.45 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-O 122.739 1.257 . . . . 1.0 110.793 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.07 61.33 1.38 Allowed Glycine 0 N--CA 1.497 2.705 0 CA-C-N 114.388 -1.278 . . . . 1.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.676 0 O-C-N 118.374 -2.839 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 121.772 0.796 . . . . 1.0 110.785 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 pt -79.87 -32.94 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 106.676 -1.601 . . . . 1.0 106.676 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.455 HG23 ' NE2' ' A' ' 65' ' ' GLN . 1.3 mt -57.16 -28.1 29.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.185 -1.37 . . . . 1.0 109.227 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -70.54 -51.68 26.98 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.574 -1.65 . . . . 1.0 114.746 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -72.79 -30.03 31.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 C-N-CA 118.314 -1.355 . . . . 1.0 111.489 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 63' ' ' ILE . 31.0 tp -69.32 -34.11 74.17 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.001 -0.741 . . . . 1.0 109.001 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -74.87 -53.86 8.32 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.587 -2.005 . . . . 1.0 105.587 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -50.3 -39.77 46.52 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.431 -1.259 . . . . 1.0 111.61 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.544 ' HA ' HD13 ' A' ' 70' ' ' ILE . 69.5 mt -83.54 -20.88 33.07 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.563 -1.199 . . . . 1.0 110.431 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.3 tp -84.58 -7.37 59.28 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 102.883 -3.006 . . . . 1.0 102.883 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 65' ' ' GLN . 17.6 m-30 -87.05 -37.23 17.64 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.434 -0.906 . . . . 1.0 110.169 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.544 HD13 ' HA ' ' A' ' 67' ' ' LEU . 1.1 pt -50.41 -37.78 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 118.831 -1.148 . . . . 1.0 113.365 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -55.14 -26.81 41.05 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 118.869 -1.132 . . . . 1.0 109.866 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -84.65 -17.75 37.56 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.988 0.899 . . . . 1.0 111.486 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -98.48 -15.58 19.54 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.462 -1.244 . . . . 1.0 108.635 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.297 -1.691 0 CA-C-N 112.578 -2.101 . . . . 1.0 109.223 179.714 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 119.083 -0.484 . . . . 1.0 110.746 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.426 ' O ' HD12 ' A' ' 63' ' ' ILE . 2.2 pt -86.3 -35.49 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 116.144 -2.222 . . . . 1.0 107.434 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.503 HG23 ' NE2' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -61.31 -25.24 35.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.832 1.301 . . . . 1.0 108.513 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -62.45 -56.61 16.56 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.122 -1.399 . . . . 1.0 113.806 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.577 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.6 pp -69.6 -30.68 46.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 C-N-CA 118.684 -1.207 . . . . 1.0 111.363 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.9 tp -67.86 -35.17 78.08 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.213 -1.032 . . . . 1.0 108.213 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.503 ' NE2' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -76.83 -47.87 20.13 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 105.676 -1.972 . . . . 1.0 105.676 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 42.2 mt-30 -51.61 -41.05 60.96 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.967 0.889 . . . . 1.0 111.494 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt -76.3 -36.42 58.37 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.511 -1.276 . . . . 1.0 109.866 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.45 -27.18 67.32 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.308 -2.108 . . . . 1.0 105.308 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.479 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 14.6 m-30 -73.53 -48.52 32.5 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 105.728 -1.953 . . . . 1.0 105.728 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 mp -44.43 -43.37 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 124.026 0.829 . . . . 1.0 111.643 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -49.23 -48.46 45.58 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.058 0.932 . . . . 1.0 110.279 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -62.15 -20.15 63.8 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.345 -1.298 . . . . 1.0 112.684 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 24.3 mtt180 -86.72 -43.35 12.64 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 105.742 -1.948 . . . . 1.0 105.742 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.8 mt . . . . . 0 C--N 1.303 -1.418 0 CA-C-N 112.934 -1.939 . . . . 1.0 106.537 179.663 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 119.235 -0.412 . . . . 1.0 111.878 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -87.54 -26.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 116.222 -2.191 . . . . 1.0 108.426 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.92 -32.66 11.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.94 -1.104 . . . . 1.0 110.092 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -56.62 -53.88 52.53 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.697 -0.801 . . . . 1.0 112.407 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.631 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -71.91 -27.86 28.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 C-N-CA 119.224 -0.99 . . . . 1.0 112.634 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.631 ' N ' HD12 ' A' ' 63' ' ' ILE . 51.2 tp -70.82 -29.66 65.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.764 -1.198 . . . . 1.0 107.764 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -54.72 5.0 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 105.847 -1.909 . . . . 1.0 105.847 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.411 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 87.2 mt-30 -51.07 -37.95 48.71 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.177 -0.92 . . . . 1.0 112.198 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 70' ' ' ILE . 71.1 mt -81.63 -33.37 31.46 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.805 -1.158 . . . . 1.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.48 -18.95 62.98 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 104.856 -2.275 . . . . 1.0 104.856 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.431 ' HB2' ' NH1' ' A' ' 73' ' ' ARG . 18.5 m-30 -72.9 -36.96 67.41 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 117.608 -1.637 . . . . 1.0 108.835 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.568 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.1 mm -48.68 -41.25 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.699 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -36.78 42.8 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -76.78 -20.12 56.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.278 -0.874 . . . . 1.0 111.967 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.431 ' NH1' ' HB2' ' A' ' 69' ' ' PHE . 39.2 mtt180 -91.95 -20.38 21.44 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.418 -1.327 . . . . 1.0 107.418 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.9 mt . . . . . 0 C--N 1.3 -1.548 0 CA-C-N 112.266 -2.243 . . . . 1.0 108.008 179.43 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 112.328 0.492 . . . . 1.0 112.328 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 pt -81.99 -35.85 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 116.828 -1.949 . . . . 1.0 105.816 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.07 -45.74 53.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 105.895 -1.891 . . . . 1.0 105.895 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.456 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 36.5 mmt180 -49.61 -41.44 42.23 Favored 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 118.805 -1.158 . . . . 1.0 113.656 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.556 ' N ' HD13 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -82.54 -27.88 8.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 CA-C-N 114.344 -1.298 . . . . 1.0 109.893 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -72.86 -32.11 65.21 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.264 -1.374 . . . . 1.0 108.786 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 62' ' ' ARG . 35.8 mt-30 -73.31 -48.82 31.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.04 -1.837 . . . . 1.0 106.04 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -56.3 -52.77 63.32 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.12 -1.4 . . . . 1.0 111.287 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 61.3 mt -67.98 -27.36 66.51 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.695 -1.139 . . . . 1.0 111.185 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -71.4 -15.29 62.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 105.796 -1.927 . . . . 1.0 105.796 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -90.78 -49.24 6.56 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 123.569 1.652 . . . . 1.0 106.967 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.9 mt -57.03 -42.9 80.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 111.766 -2.47 . . . . 1.0 110.922 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -18.98 14.84 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.461 -0.895 . . . . 1.0 110.249 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -86.25 -25.33 25.61 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.579 1.181 . . . . 1.0 110.326 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -86.15 -28.87 23.7 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 113.014 -1.903 . . . . 1.0 108.156 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.9 mt . . . . . 0 C--N 1.297 -1.69 0 N-CA-C 100.439 -3.912 . . . . 1.0 100.439 178.916 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.953 0.406 . . . . 1.0 110.53 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.452 ' O ' HD12 ' A' ' 63' ' ' ILE . 2.4 pt -78.65 -30.03 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 C-N-CA 116.631 -2.028 . . . . 1.0 106.235 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.768 HD12 HE22 ' A' ' 65' ' ' GLN . 1.9 mm -63.76 -31.19 52.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 117.883 -1.527 . . . . 1.0 108.771 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.1 mmt-85 -61.9 -57.64 10.97 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.604 1.335 . . . . 1.0 114.604 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.5 pp -64.88 -31.63 54.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 C-N-CA 118.356 -1.338 . . . . 1.0 111.603 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 63' ' ' ILE . 35.8 tp -70.22 -35.21 73.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.768 HE22 HD12 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -76.86 -49.23 16.22 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 115.873 -2.331 . . . . 1.0 106.225 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.449 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 67.3 mt-30 -48.14 -43.72 31.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 113.712 -1.585 . . . . 1.0 111.94 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -81.88 -30.62 31.87 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.994 -1.457 . . . . 1.0 109.583 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.2 tp -70.28 -20.78 63.01 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 104.562 -2.385 . . . . 1.0 104.562 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 19.0 m-30 -63.25 -29.55 70.86 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.312 -1.355 . . . . 1.0 109.647 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.8 mm -56.97 -38.79 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 113.777 -1.556 . . . . 1.0 111.841 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -22.94 55.58 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.377 -0.929 . . . . 1.0 108.74 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -88.4 -17.5 30.36 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.432 0.634 . . . . 1.0 110.735 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -96.31 -13.8 23.06 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--N 1.303 -1.451 0 CA-C-N 112.472 -2.149 . . . . 1.0 109.281 179.293 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 111.731 0.271 . . . . 1.0 111.731 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pt -82.74 -31.28 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 116.767 -1.973 . . . . 1.0 107.53 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.45 -32.27 36.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.364 -1.334 . . . . 1.0 110.231 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -53.57 -59.53 4.48 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.053 0.93 . . . . 1.0 113.266 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -76.97 -27.43 16.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 113.981 -1.463 . . . . 1.0 113.974 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 63' ' ' ILE . 31.1 tp -71.48 -27.87 63.54 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.418 ' O ' ' CD1' ' A' ' 69' ' ' PHE . 2.6 mp0 -90.25 -53.78 4.31 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 117.885 -1.526 . . . . 1.0 107.219 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -57.2 -36.07 70.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.578 -1.192 . . . . 1.0 111.998 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.616 ' HA ' HG12 ' A' ' 70' ' ' ILE . 87.5 mt -83.43 -30.92 26.92 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 117.707 -1.597 . . . . 1.0 112.234 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 tp -67.56 -21.77 65.43 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 104.406 -2.442 . . . . 1.0 104.406 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 65' ' ' GLN . 17.4 m-30 -70.2 -46.65 64.13 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 117.947 -1.501 . . . . 1.0 107.436 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.616 HG12 ' HA ' ' A' ' 67' ' ' LEU . 9.8 mm -49.46 -42.16 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 113.733 -1.576 . . . . 1.0 111.621 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -50.75 -40.3 54.31 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.663 0.744 . . . . 1.0 110.088 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -66.87 -27.91 67.9 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 123.21 1.481 . . . . 1.0 112.422 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HE ' ' HA ' ' A' ' 70' ' ' ILE . 18.0 mtm105 -79.13 -44.76 21.36 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 112.383 -2.189 . . . . 1.0 106.281 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.294 -1.839 0 CA-C-N 113.012 -1.904 . . . . 1.0 107.391 179.776 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.9 pt -73.77 -29.33 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 C-N-CA 116.288 -2.165 . . . . 1.0 106.075 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.0 mt -65.42 -24.09 34.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 117.703 -1.599 . . . . 1.0 108.919 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -70.23 -29.61 66.47 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.63 2.085 . . . . 1.0 116.63 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.4 pp -101.99 -21.78 5.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 C-N-CA 117.47 -1.692 . . . . 1.0 108.642 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 63' ' ' ILE . 55.8 tp -77.05 -49.78 14.58 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 123.909 0.756 . . . . 1.0 112.545 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -70.29 -36.27 74.24 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.052 -1.459 . . . . 1.0 107.961 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 9.7 mp0 -66.54 -51.83 52.34 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 113.083 -1.871 . . . . 1.0 108.999 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.474 ' HA ' HD12 ' A' ' 70' ' ' ILE . 3.5 pp -67.98 -29.13 68.09 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 117.668 -1.613 . . . . 1.0 110.419 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -70.29 -19.91 63.06 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.189 -2.152 . . . . 1.0 105.189 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.521 ' CE1' ' HD2' ' A' ' 73' ' ' ARG . 2.2 t80 -81.66 -50.41 9.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.452 -1.684 . . . . 1.0 106.452 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 67' ' ' LEU . 39.3 mt -54.3 -41.83 54.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 112.476 -2.147 . . . . 1.0 109.142 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -44.72 34.56 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.068 0.937 . . . . 1.0 110.358 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -63.66 -23.43 67.37 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.258 -1.337 . . . . 1.0 113.058 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.521 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 14.9 mtp180 -85.52 -45.65 11.59 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 112.993 -1.912 . . . . 1.0 106.324 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.0 mt . . . . . 0 C--N 1.296 -1.728 0 CA-C-N 112.659 -2.064 . . . . 1.0 107.672 179.686 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.818 0.342 . . . . 1.0 110.148 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.405 ' O ' HD12 ' A' ' 63' ' ' ILE . 2.9 pt -80.6 -33.26 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 C-N-CA 116.984 -1.886 . . . . 1.0 105.917 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.433 HG23 ' NE2' ' A' ' 65' ' ' GLN . 1.3 mt -52.06 -29.72 12.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 114.471 -1.241 . . . . 1.0 108.719 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -66.48 -52.49 45.59 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.483 1.66 . . . . 1.0 115.483 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.7 pp -78.07 -28.24 15.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.233 -1.387 . . . . 1.0 111.983 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 63' ' ' ILE . 46.5 tp -68.05 -37.02 80.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.528 -1.286 . . . . 1.0 107.528 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.433 ' NE2' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -76.09 -51.47 12.17 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 117.527 -1.669 . . . . 1.0 106.661 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -49.93 -45.0 50.73 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.598 1.189 . . . . 1.0 111.99 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.0 mt -77.14 -31.87 55.94 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.63 -1.168 . . . . 1.0 111.8 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -67.51 -24.06 65.53 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 102.572 -3.122 . . . . 1.0 102.572 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -75.3 -51.88 12.17 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.003 -1.851 . . . . 1.0 106.003 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.58 -46.34 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 124.253 0.971 . . . . 1.0 111.485 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -46.19 -47.49 17.74 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.815 0.817 . . . . 1.0 112.064 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -64.77 -21.22 66.72 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.901 -1.5 . . . . 1.0 113.272 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -88.61 -44.62 10.49 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 104.975 -2.232 . . . . 1.0 104.975 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.8 mt . . . . . 0 C--N 1.296 -1.748 0 N-CA-C 105.109 -2.182 . . . . 1.0 105.109 179.611 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 119.391 -0.338 . . . . 1.0 111.859 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt -90.11 -25.84 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 C-N-CA 116.038 -2.265 . . . . 1.0 109.563 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.739 HG12 HE22 ' A' ' 65' ' ' GLN . 0.1 OUTLIER -85.44 -30.16 6.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.387 -1.279 . . . . 1.0 109.24 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -55.76 -61.4 2.39 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.453 -1.299 . . . . 1.0 112.589 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -59.45 -30.52 44.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 114.836 -1.074 . . . . 1.0 113.454 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 63' ' ' ILE . 59.2 tp -72.67 -33.1 66.3 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.33 -0.989 . . . . 1.0 108.33 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.739 HE22 HG12 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -78.17 -47.01 19.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 104.972 -2.232 . . . . 1.0 104.972 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 25.2 mt-30 -49.96 -50.23 47.45 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.734 1.254 . . . . 1.0 112.076 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.93 -29.56 60.99 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.177 -1.374 . . . . 1.0 111.727 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.2 tp -71.13 -22.43 62.07 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 103.469 -2.789 . . . . 1.0 103.469 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 66' ' ' GLN . 20.7 m-30 -69.2 -49.67 54.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.099 -1.815 . . . . 1.0 106.099 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.3 -44.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-N 114.228 -1.351 . . . . 1.0 111.38 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -50.27 -46.43 55.09 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.116 0.96 . . . . 1.0 111.963 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -61.42 -31.65 71.59 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 123.566 1.65 . . . . 1.0 112.589 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.5 mtt85 -76.43 -46.05 28.78 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 111.361 -2.654 . . . . 1.0 106.112 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 C--N 1.298 -1.651 0 CA-C-N 113.745 -1.571 . . . . 1.0 109.724 179.63 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 120.867 0.365 . . . . 1.0 110.29 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 pt -78.79 -32.89 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 105.62 -1.993 . . . . 1.0 105.62 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.563 HG12 HE22 ' A' ' 65' ' ' GLN . 1.5 mt -56.89 -25.02 21.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.607 -1.179 . . . . 1.0 109.701 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -66.62 -52.43 45.23 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 114.187 1.18 . . . . 1.0 114.187 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -81.35 -27.35 10.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 118.715 -1.194 . . . . 1.0 110.658 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 63' ' ' ILE . 43.1 tp -70.69 -30.03 66.49 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.563 HE22 HG12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -84.15 -51.8 6.77 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 116.701 -2.0 . . . . 1.0 106.368 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.517 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 67.0 mt-30 -54.56 -45.19 73.43 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.1 -1.44 . . . . 1.0 113.406 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.2 mt -69.96 -32.66 71.01 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.593 -0.891 . . . . 1.0 108.593 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.9 tp -66.99 -16.91 64.66 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 103.613 -2.736 . . . . 1.0 103.613 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 12.3 m-30 -88.44 -44.96 10.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 105.343 -2.095 . . . . 1.0 105.343 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 66' ' ' GLN . 5.5 mm -58.93 -36.84 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 119.147 -1.021 . . . . 1.0 112.829 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -21.34 33.85 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.201 -1.4 . . . . 1.0 108.562 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -86.49 -17.45 34.15 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.111 0.957 . . . . 1.0 110.163 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -95.26 -16.41 22.48 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.228 -1.351 . . . . 1.0 107.358 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt . . . . . 0 C--N 1.298 -1.653 0 CA-C-N 112.378 -2.192 . . . . 1.0 106.431 179.116 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -86.83 -34.22 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 116.75 -1.98 . . . . 1.0 106.357 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.596 HG13 HE22 ' A' ' 65' ' ' GLN . 1.2 mp -62.9 -24.52 36.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.253 -1.379 . . . . 1.0 110.963 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -69.35 -45.79 68.57 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 117.516 -1.674 . . . . 1.0 115.031 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -80.77 -29.67 11.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.101 -1.04 . . . . 1.0 111.876 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 63' ' ' ILE . 42.6 tp -71.23 -27.14 63.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.596 HE22 HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -84.24 -53.76 5.27 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.204 -1.776 . . . . 1.0 106.204 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -53.06 -36.51 60.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.47 -1.292 . . . . 1.0 112.738 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.54 ' HA ' HG12 ' A' ' 70' ' ' ILE . 80.0 mt -80.75 -32.8 35.45 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.158 -1.017 . . . . 1.0 111.806 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -67.91 -21.79 65.11 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 104.252 -2.499 . . . . 1.0 104.252 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.462 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 17.6 m-30 -73.39 -48.22 35.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 117.506 -1.678 . . . . 1.0 107.91 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.54 HG12 ' HA ' ' A' ' 67' ' ' LEU . 7.1 mm -50.55 -41.04 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 114.517 -1.22 . . . . 1.0 111.497 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -48.59 -37.27 17.59 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.172 -0.611 . . . . 1.0 110.525 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.61 -21.33 48.66 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.645 -1.161 . . . . 1.0 111.425 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 22.5 mtp85 -86.56 -22.7 26.15 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 123.448 1.594 . . . . 1.0 107.275 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.9 mt . . . . . 0 C--N 1.3 -1.582 0 CA-C-N 111.606 -2.543 . . . . 1.0 106.839 179.639 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 121.237 0.541 . . . . 1.0 109.873 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 pt -75.96 -31.43 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 116.793 -1.963 . . . . 1.0 105.809 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mt -60.15 -23.43 27.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 118.215 -1.394 . . . . 1.0 109.019 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -76.0 -52.04 11.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 116.596 -2.042 . . . . 1.0 111.222 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.565 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.3 pp -70.83 -29.17 36.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 118.756 -1.178 . . . . 1.0 111.503 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 63' ' ' ILE . 30.9 tp -67.68 -31.36 71.28 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.547 -1.279 . . . . 1.0 107.547 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.87 -54.14 5.59 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 117.923 -1.511 . . . . 1.0 107.541 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.413 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 88.6 mt-30 -51.72 -38.06 53.61 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.325 -1.307 . . . . 1.0 112.658 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.571 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 64.3 mt -81.62 -37.04 28.2 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.863 -1.062 . . . . 1.0 108.559 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.3 tp -67.09 -14.29 62.76 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.439 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 18.2 m-30 -73.6 -36.61 65.53 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 117.305 -1.758 . . . . 1.0 107.121 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 67' ' ' LEU . 57.2 mt -45.35 -46.15 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 112.853 -1.976 . . . . 1.0 110.749 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -47.3 -43.85 22.9 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.988 0.899 . . . . 1.0 111.172 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.97 -28.65 69.06 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.808 -1.542 . . . . 1.0 112.21 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.534 HH21 ' N ' ' A' ' 70' ' ' ILE . 12.1 mtm180 -79.99 -38.52 31.99 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 113.293 -1.776 . . . . 1.0 107.76 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 mt . . . . . 0 C--N 1.302 -1.471 0 CA-C-N 113.28 -1.782 . . . . 1.0 109.276 179.889 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 119.527 -0.273 . . . . 1.0 111.625 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -83.98 -31.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 116.754 -1.978 . . . . 1.0 107.562 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.92 -28.68 24.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 117.13 -1.828 . . . . 1.0 109.884 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -59.29 -56.74 18.27 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 117.93 -1.508 . . . . 1.0 112.913 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -73.44 -28.21 24.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 63' ' ' ILE . 28.2 tp -70.02 -32.39 70.52 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.46 -53.81 5.43 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 117.911 -1.516 . . . . 1.0 107.652 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.464 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 23.9 mt-30 -51.28 -37.67 48.64 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.739 -1.118 . . . . 1.0 112.039 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.535 ' HA ' HD13 ' A' ' 70' ' ' ILE . 76.6 mt -84.75 -34.91 22.76 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 117.798 -1.561 . . . . 1.0 110.124 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp -65.67 -22.44 66.64 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 104.398 -2.445 . . . . 1.0 104.398 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 18.5 m-30 -60.21 -32.82 71.47 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 117.337 -1.745 . . . . 1.0 108.109 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 67' ' ' LEU . 1.6 mp -46.98 -42.12 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 C-N-CA 118.359 -1.337 . . . . 1.0 111.083 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.5 -39.2 60.98 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.568 0.699 . . . . 1.0 110.924 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -75.14 -26.15 58.93 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.438 -1.255 . . . . 1.0 111.266 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 43.3 mtm180 -82.98 -24.65 32.83 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.734 -1.58 . . . . 1.0 106.734 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--N 1.303 -1.445 0 CA-C-N 113.94 -1.482 . . . . 1.0 111.09 179.576 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 111.721 0.267 . . . . 1.0 111.721 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 61' ' ' ILE . 3.9 pt -82.09 -38.47 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 105.47 -2.048 . . . . 1.0 105.47 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.44 ' N ' HG13 ' A' ' 60' ' ' ILE . 2.6 mt -52.7 -45.84 49.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 106.383 -1.71 . . . . 1.0 106.383 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.471 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 15.0 ttm180 -46.09 -36.42 5.78 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.41 -1.268 . . . . 1.0 110.465 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.522 ' N ' HD13 ' A' ' 63' ' ' ILE . 2.0 mm -91.41 -26.14 5.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.113 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -69.76 -30.95 68.65 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.875 -1.53 . . . . 1.0 108.304 -179.452 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.508 ' HG2' ' N ' ' A' ' 66' ' ' GLN . 4.4 pt20 -85.25 -47.85 9.67 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.109 -1.812 . . . . 1.0 106.109 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.508 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 48.1 mt-30 -54.1 -36.36 63.12 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 117.83 -1.548 . . . . 1.0 109.385 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.588 ' HA ' HG12 ' A' ' 70' ' ' ILE . 97.8 mt -81.43 -36.98 28.8 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.66 -1.216 . . . . 1.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.9 tp -66.35 -17.51 64.81 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 105.278 -2.119 . . . . 1.0 105.278 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 65' ' ' GLN . 19.4 m-30 -76.22 -32.68 59.07 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 117.869 -1.532 . . . . 1.0 109.065 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' A' ' 67' ' ' LEU . 19.4 mm -52.86 -41.48 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.51 -1.223 . . . . 1.0 114.174 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -56.79 -24.18 48.64 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 117.972 -1.491 . . . . 1.0 109.007 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -83.65 -20.76 33.03 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.337 -0.945 . . . . 1.0 110.44 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -89.45 -18.61 26.42 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.443 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--N 1.302 -1.48 0 CA-C-N 112.881 -1.963 . . . . 1.0 111.153 179.5 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pt -76.6 -33.01 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 104.74 -2.318 . . . . 1.0 104.74 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 65' ' ' GLN . 1.6 mt -58.48 -37.74 66.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 118.373 -1.331 . . . . 1.0 107.563 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -56.04 -24.0 36.82 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.077 -1.449 . . . . 1.0 113.49 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.2 mm -95.15 -7.61 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 119.634 -0.827 . . . . 1.0 109.23 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.522 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.28 -45.39 5.62 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.933 -0.707 . . . . 1.0 109.552 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -68.79 -27.64 66.06 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 117.709 -1.596 . . . . 1.0 107.687 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -65.4 -61.43 2.11 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.256 -1.338 . . . . 1.0 108.501 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.2 mt -61.94 -32.12 72.51 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.474 -1.239 . . . . 1.0 111.391 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.1 tp -70.38 -14.38 62.54 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.513 ' CD2' HD13 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -91.04 -45.87 8.46 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 105.234 -2.135 . . . . 1.0 105.234 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.513 HD13 ' CD2' ' A' ' 69' ' ' PHE . 9.9 mm -57.8 -37.21 58.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 118.239 -1.384 . . . . 1.0 111.411 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -20.39 15.97 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 118.478 -1.289 . . . . 1.0 109.585 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -85.18 -24.27 27.99 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.982 0.896 . . . . 1.0 109.694 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.457 ' HD3' ' CE1' ' A' ' 69' ' ' PHE . 17.3 mtm105 -90.23 -17.44 27.49 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.597 -1.26 . . . . 1.0 107.597 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.3 mt . . . . . 0 C--N 1.299 -1.612 0 CA-C-N 111.838 -2.437 . . . . 1.0 110.426 179.179 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 119.64 -0.219 . . . . 1.0 110.553 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -84.46 -36.95 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 116.165 -2.214 . . . . 1.0 107.474 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.98 -29.65 47.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 117.6 -1.64 . . . . 1.0 110.211 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -63.81 -54.19 38.97 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.207 -1.397 . . . . 1.0 114.239 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.578 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -73.59 -29.13 26.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 118.771 -1.172 . . . . 1.0 112.829 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 63' ' ' ILE . 39.9 tp -69.32 -30.23 68.24 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.417 ' NE2' ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -82.26 -52.41 6.97 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.166 -1.79 . . . . 1.0 106.166 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.475 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 39.3 mt-30 -50.22 -38.33 39.85 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.389 -0.823 . . . . 1.0 113.076 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 68.5 mt -84.15 -33.21 24.29 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.985 -1.007 . . . . 1.0 110.392 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.49 -15.0 61.8 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.035 -2.209 . . . . 1.0 105.035 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 17.4 m-30 -66.86 -37.21 84.01 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 116.823 -1.951 . . . . 1.0 107.716 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 67' ' ' LEU . 32.9 mt -48.31 -47.68 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 114.211 -1.359 . . . . 1.0 111.858 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -34.44 39.79 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.061 0.457 . . . . 1.0 111.087 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.75 -13.42 56.35 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.141 -0.936 . . . . 1.0 111.671 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 49.1 mtm180 -101.02 -20.42 15.4 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.453 -1.249 . . . . 1.0 109.13 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--N 1.303 -1.435 0 CA-C-N 113.401 -1.727 . . . . 1.0 109.018 179.293 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 118.799 -0.619 . . . . 1.0 111.612 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 pt -94.57 -35.05 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 117.263 -1.775 . . . . 1.0 110.21 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.51 -23.21 22.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 113.743 -1.571 . . . . 1.0 108.272 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -73.61 -52.36 13.67 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 115.38 -2.528 . . . . 1.0 112.15 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.586 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.3 pp -70.66 -29.31 37.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 113.776 1.028 . . . . 1.0 113.776 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 63' ' ' ILE . 26.4 tp -68.87 -37.63 79.19 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.937 -1.505 . . . . 1.0 106.937 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -74.74 -48.15 27.3 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 117.24 -1.784 . . . . 1.0 106.617 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -52.04 -44.17 64.11 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.76 -1.109 . . . . 1.0 112.038 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HA ' HG12 ' A' ' 70' ' ' ILE . 3.6 pp -75.52 -37.65 59.95 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.67 -1.15 . . . . 1.0 109.279 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 67' ' ' LEU . 39.5 mt -67.11 -16.21 64.19 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.928 -1.879 . . . . 1.0 105.928 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.463 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 20.9 m-30 -73.55 -35.72 65.53 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.507 -1.677 . . . . 1.0 106.686 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.0 mm -53.25 -43.71 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.373 -1.285 . . . . 1.0 112.296 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.41 -28.61 44.95 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 120.066 1.303 . . . . 1.0 110.924 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -75.32 -29.68 60.08 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.756 1.265 . . . . 1.0 111.381 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -82.44 -38.64 23.71 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 113.46 -1.7 . . . . 1.0 108.149 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--N 1.3 -1.556 0 CA-C-N 113.141 -1.845 . . . . 1.0 106.794 179.495 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 112.023 0.379 . . . . 1.0 112.023 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 61' ' ' ILE . 4.8 pt -81.31 -35.03 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 106.533 -1.654 . . . . 1.0 106.533 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.427 ' HA ' HD23 ' A' ' 64' ' ' LEU . 1.7 mt -52.14 -43.47 38.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 112.842 -1.981 . . . . 1.0 105.82 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.578 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 81.6 mtm180 -51.86 -31.75 29.19 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 118.586 -1.246 . . . . 1.0 112.418 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.597 ' N ' HD13 ' A' ' 63' ' ' ILE . 1.4 mm -88.66 -17.62 8.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 114.455 -1.248 . . . . 1.0 110.791 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.469 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -83.44 -35.29 25.09 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.392 -1.323 . . . . 1.0 109.434 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.578 ' OE1' ' HA ' ' A' ' 62' ' ' ARG . 7.8 pt20 -76.01 -46.49 29.18 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 116.343 -2.143 . . . . 1.0 106.868 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.505 ' H ' ' HG2' ' A' ' 65' ' ' GLN . 35.9 mt-30 -49.71 -45.98 49.69 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.315 1.055 . . . . 1.0 112.514 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.546 ' HA ' HG12 ' A' ' 70' ' ' ILE . 89.1 mt -72.35 -40.13 67.58 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.957 -1.474 . . . . 1.0 110.033 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.7 mt -65.39 -15.3 62.45 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.822 -1.551 . . . . 1.0 107.019 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 21.0 m-30 -78.66 -39.19 37.54 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 106.92 -1.511 . . . . 1.0 106.92 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.3 mm -49.97 -40.47 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 114.607 -1.179 . . . . 1.0 111.235 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -50.25 -41.3 50.05 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.485 0.66 . . . . 1.0 109.705 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -66.6 -31.2 71.75 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 123.24 1.495 . . . . 1.0 111.81 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -73.62 -42.29 61.67 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 112.781 -2.009 . . . . 1.0 106.624 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.417 HD13 HG22 ' A' ' 70' ' ' ILE 0.259 1.1 mp . . . . . 0 C--N 1.296 -1.736 0 CA-C-N 113.82 -1.536 . . . . 1.0 107.245 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 119.462 -0.304 . . . . 1.0 110.597 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt -83.16 -28.93 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 C-N-CA 116.07 -2.252 . . . . 1.0 108.327 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.53 -31.39 42.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 114.028 -1.442 . . . . 1.0 109.298 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -50.03 -62.16 1.73 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.619 -1.173 . . . . 1.0 113.032 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -75.8 -27.85 18.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 113.173 -1.83 . . . . 1.0 113.589 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 63' ' ' ILE . 29.6 tp -70.31 -34.97 73.35 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.443 -1.318 . . . . 1.0 107.443 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -82.75 -53.38 5.94 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 116.551 -2.06 . . . . 1.0 108.062 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -52.16 -37.04 53.34 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.82 -1.082 . . . . 1.0 112.796 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.559 ' HA ' HG12 ' A' ' 70' ' ' ILE . 83.5 mt -82.28 -38.63 24.11 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.487 -1.285 . . . . 1.0 110.943 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 9.9 tt -62.86 -23.75 67.47 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.445 -2.058 . . . . 1.0 105.445 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -66.3 -35.26 79.92 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 117.635 -1.626 . . . . 1.0 109.363 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' A' ' 67' ' ' LEU . 12.6 mm -54.29 -38.19 39.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 113.453 -1.703 . . . . 1.0 113.103 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -60.15 -27.36 67.03 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 120.913 1.688 . . . . 1.0 109.188 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -73.86 -22.72 59.64 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.609 1.195 . . . . 1.0 110.422 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -85.97 -55.84 3.76 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 105.424 -2.065 . . . . 1.0 105.424 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--N 1.294 -1.839 0 CA-C-N 113.503 -1.68 . . . . 1.0 111.368 179.813 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 111.648 0.24 . . . . 1.0 111.648 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.424 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.7 pt -82.31 -29.83 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 117.061 -1.856 . . . . 1.0 106.83 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.433 HG23 ' NE2' ' A' ' 65' ' ' GLN . 1.6 mt -61.71 -30.73 48.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.038 -1.437 . . . . 1.0 108.373 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -64.27 -55.83 18.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.43 -1.308 . . . . 1.0 114.228 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -69.7 -28.32 36.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 118.624 -1.23 . . . . 1.0 112.411 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 63' ' ' ILE . 29.0 tp -71.89 -33.28 68.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.433 ' NE2' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -79.41 -43.98 22.32 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 116.872 -1.931 . . . . 1.0 107.278 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.487 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 1.5 pt20 -54.42 -37.06 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.291 -0.963 . . . . 1.0 111.62 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.457 ' HG ' ' HG2' ' A' ' 66' ' ' GLN . 81.8 mt -82.77 -38.89 22.57 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.077 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.6 tp -66.21 -15.49 63.22 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 19.3 m-30 -69.76 -28.32 65.67 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 116.571 -2.052 . . . . 1.0 108.602 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.3 mt -53.44 -42.25 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 114.575 -1.193 . . . . 1.0 110.662 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.41 -32.37 49.32 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.606 0.717 . . . . 1.0 110.051 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -83.13 -18.19 40.38 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.576 -1.193 . . . . 1.0 111.151 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 53.5 mtm180 -96.35 -16.98 20.98 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.875 -1.157 . . . . 1.0 107.875 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 mt . . . . . 0 C--N 1.3 -1.545 0 CA-C-N 113.524 -1.671 . . . . 1.0 107.928 179.183 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.837 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 57.47 -17.99 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.643 0 N-CA-C 117.442 2.386 . . . . 1.0 117.442 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.93 115.65 7.74 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 108.473 -1.851 . . . . 1.0 108.473 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -28.0 -46.36 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.035 1.865 . . . . 1.0 116.035 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.8 p -70.84 -58.32 3.73 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.307 1.051 . . . . 1.0 111.453 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -63.06 -56.76 14.17 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.172 -1.376 . . . . 1.0 111.69 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.55 95.97 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 124.892 1.37 . . . . 1.0 109.854 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.76 -42.63 98.51 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 118.105 -1.998 . . . . 1.0 110.727 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.563 ' HA ' HG12 ' A' ' 60' ' ' ILE . 92.4 t -77.43 -32.0 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.584 -0.846 . . . . 1.0 111.832 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -71.93 -21.64 61.58 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.776 -0.824 . . . . 1.0 108.776 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.92 -38.87 22.23 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.756 -1.565 . . . . 1.0 110.785 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.563 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.6 pt -79.87 -32.94 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 106.676 -1.601 . . . . 1.0 106.676 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.455 HG23 ' NE2' ' A' ' 65' ' ' GLN . 1.3 mt -57.16 -28.1 29.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.185 -1.37 . . . . 1.0 109.227 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -70.54 -51.68 26.98 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.574 -1.65 . . . . 1.0 114.746 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -72.79 -30.03 31.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 C-N-CA 118.314 -1.355 . . . . 1.0 111.489 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 63' ' ' ILE . 31.0 tp -69.32 -34.11 74.17 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.001 -0.741 . . . . 1.0 109.001 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -74.87 -53.86 8.32 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.587 -2.005 . . . . 1.0 105.587 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -50.3 -39.77 46.52 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.431 -1.259 . . . . 1.0 111.61 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.544 ' HA ' HD13 ' A' ' 70' ' ' ILE . 69.5 mt -83.54 -20.88 33.07 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.563 -1.199 . . . . 1.0 110.431 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.3 tp -84.58 -7.37 59.28 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 102.883 -3.006 . . . . 1.0 102.883 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 65' ' ' GLN . 17.6 m-30 -87.05 -37.23 17.64 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.434 -0.906 . . . . 1.0 110.169 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.544 HD13 ' HA ' ' A' ' 67' ' ' LEU . 1.1 pt -50.41 -37.78 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 118.831 -1.148 . . . . 1.0 113.365 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -55.14 -26.81 41.05 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 118.869 -1.132 . . . . 1.0 109.866 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -84.65 -17.75 37.56 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.988 0.899 . . . . 1.0 111.486 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -98.48 -15.58 19.54 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.462 -1.244 . . . . 1.0 108.635 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.4 mt -95.77 -54.4 7.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 112.578 -2.101 . . . . 1.0 109.223 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 77' ' ' ARG . . . -64.49 -65.51 2.95 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.354 -1.403 . . . . 1.0 110.642 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 39.3 m -59.84 9.81 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 114.35 1.241 . . . . 1.0 114.35 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.431 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -128.06 -42.62 1.54 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -82.03 -32.76 30.31 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.184 -0.916 . . . . 1.0 113.307 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.8 t -127.46 33.67 4.81 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.664 1.357 . . . . 1.0 114.664 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.72 39.3 0.13 Allowed 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 119.85 -0.74 . . . . 1.0 111.6 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.2 mm -81.29 59.05 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.033 -1.042 . . . . 1.0 110.008 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.74 38.21 0.87 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.157 -1.977 . . . . 1.0 108.157 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.634 0 O-C-N 119.215 -2.344 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.825 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 62.44 -25.11 0.05 Allowed 'General case' 0 N--CA 1.512 2.636 0 N-CA-C 116.634 2.087 . . . . 1.0 116.634 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.69 139.05 34.37 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 109.562 -1.415 . . . . 1.0 109.562 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -27.53 -54.48 0.09 Allowed 'General case' 0 N--CA 1.511 2.624 0 N-CA-C 115.023 1.49 . . . . 1.0 115.023 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 p -70.73 -41.81 71.38 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.535 -0.757 . . . . 1.0 111.299 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -64.83 -56.78 11.39 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.512 -0.875 . . . . 1.0 109.699 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.18 87.59 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.119 -1.032 . . . . 1.0 108.472 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.8 -39.54 77.51 Favored Glycine 0 N--CA 1.494 2.526 0 CA-C-N 114.165 -1.379 . . . . 1.0 112.348 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.601 ' HA ' HG12 ' A' ' 60' ' ' ILE . 99.4 t -86.75 -39.39 13.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 120.135 -0.626 . . . . 1.0 110.909 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.36 -28.4 69.73 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.17 -30.39 54.87 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 114.227 -1.351 . . . . 1.0 110.746 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.601 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.2 pt -86.3 -35.49 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 116.144 -2.222 . . . . 1.0 107.434 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.503 HG23 ' NE2' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -61.31 -25.24 35.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.832 1.301 . . . . 1.0 108.513 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -62.45 -56.61 16.56 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.122 -1.399 . . . . 1.0 113.806 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.577 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.6 pp -69.6 -30.68 46.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 C-N-CA 118.684 -1.207 . . . . 1.0 111.363 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.9 tp -67.86 -35.17 78.08 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.213 -1.032 . . . . 1.0 108.213 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.503 ' NE2' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -76.83 -47.87 20.13 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 105.676 -1.972 . . . . 1.0 105.676 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 42.2 mt-30 -51.61 -41.05 60.96 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.967 0.889 . . . . 1.0 111.494 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt -76.3 -36.42 58.37 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.511 -1.276 . . . . 1.0 109.866 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.45 -27.18 67.32 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.308 -2.108 . . . . 1.0 105.308 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.479 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 14.6 m-30 -73.53 -48.52 32.5 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 105.728 -1.953 . . . . 1.0 105.728 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 mp -44.43 -43.37 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 124.026 0.829 . . . . 1.0 111.643 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -49.23 -48.46 45.58 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.058 0.932 . . . . 1.0 110.279 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -62.15 -20.15 63.8 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.345 -1.298 . . . . 1.0 112.684 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 24.3 mtt180 -86.72 -43.35 12.64 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 105.742 -1.948 . . . . 1.0 105.742 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.8 mt -58.24 -35.24 52.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 112.934 -1.939 . . . . 1.0 106.537 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.08 -58.15 4.11 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 107.11 -2.396 . . . . 1.0 107.11 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 50.4 t -47.01 -65.17 0.61 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 115.371 -0.414 . . . . 1.0 111.851 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -49.96 -29.25 8.09 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.372 -0.831 . . . . 1.0 111.635 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -104.38 -2.25 25.71 Favored 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 112.955 0.724 . . . . 1.0 112.955 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.8 t -118.4 13.51 13.58 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 123.49 0.494 . . . . 1.0 112.067 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.6 tpt85 -118.79 77.83 1.22 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 120.474 -0.49 . . . . 1.0 111.925 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.2 mt -118.21 33.28 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 CA-C-O 122.866 1.317 . . . . 1.0 108.95 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.49 -54.72 1.21 Allowed Glycine 0 N--CA 1.5 2.929 0 CA-C-N 113.955 -1.475 . . . . 1.0 111.895 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.697 0 O-C-N 118.049 -3.03 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.679 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -80.81 72.87 7.81 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.739 0.78 . . . . 1.0 110.584 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.63 170.56 37.39 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 108.5 -1.84 . . . . 1.0 108.5 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -90.28 -124.4 0.07 Allowed 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.291 -1.744 . . . . 1.0 106.291 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.3 m -31.56 -42.39 0.05 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.848 2.166 . . . . 1.0 116.848 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.414 ' CG ' ' N ' ' A' ' 55' ' ' ALA . 9.3 t-105 -65.72 -67.35 0.45 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.178 -1.409 . . . . 1.0 110.39 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 54' ' ' TRP . . . -51.94 -47.33 64.79 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.736 -1.574 . . . . 1.0 108.261 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -49.38 -42.06 33.17 Favored Glycine 0 N--CA 1.491 2.362 0 CA-C-N 112.934 -1.939 . . . . 1.0 109.819 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.587 ' HA ' HG12 ' A' ' 60' ' ' ILE . 60.3 t -79.95 -38.49 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 C-N-CA 119.034 -1.067 . . . . 1.0 112.305 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -31.18 70.8 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.792 -1.558 . . . . 1.0 106.792 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.9 -33.18 63.9 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 113.363 -1.744 . . . . 1.0 111.878 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.587 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.7 pt -87.54 -26.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 116.222 -2.191 . . . . 1.0 108.426 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -81.92 -32.66 11.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.94 -1.104 . . . . 1.0 110.092 179.471 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -56.62 -53.88 52.53 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.697 -0.801 . . . . 1.0 112.407 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.631 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -71.91 -27.86 28.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 C-N-CA 119.224 -0.99 . . . . 1.0 112.634 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.631 ' N ' HD12 ' A' ' 63' ' ' ILE . 51.2 tp -70.82 -29.66 65.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.764 -1.198 . . . . 1.0 107.764 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -54.72 5.0 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 105.847 -1.909 . . . . 1.0 105.847 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.411 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 87.2 mt-30 -51.07 -37.95 48.71 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.177 -0.92 . . . . 1.0 112.198 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 70' ' ' ILE . 71.1 mt -81.63 -33.37 31.46 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.805 -1.158 . . . . 1.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.48 -18.95 62.98 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 104.856 -2.275 . . . . 1.0 104.856 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.431 ' HB2' ' NH1' ' A' ' 73' ' ' ARG . 18.5 m-30 -72.9 -36.96 67.41 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 117.608 -1.637 . . . . 1.0 108.835 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.568 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.1 mm -48.68 -41.25 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.699 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -36.78 42.8 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -76.78 -20.12 56.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.278 -0.874 . . . . 1.0 111.967 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.431 ' NH1' ' HB2' ' A' ' 69' ' ' PHE . 39.2 mtt180 -91.95 -20.38 21.44 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.418 -1.327 . . . . 1.0 107.418 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.9 mt -86.46 -58.92 3.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 112.266 -2.243 . . . . 1.0 108.008 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -45.94 -74.22 0.24 Allowed Glycine 0 N--CA 1.501 2.994 0 N-CA-C 117.199 1.64 . . . . 1.0 117.199 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 26.7 p -66.56 4.84 0.69 Allowed 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 116.18 1.919 . . . . 1.0 116.18 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -118.52 -40.97 2.85 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 122.784 1.278 . . . . 1.0 109.604 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -78.94 -24.1 44.2 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 112.545 -2.116 . . . . 1.0 108.25 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.6 t -122.29 -134.27 0.29 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 116.376 -0.374 . . . . 1.0 110.092 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 55.08 41.71 31.49 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 123.346 1.546 . . . . 1.0 107.778 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.6 mt -70.52 75.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 113.326 -1.761 . . . . 1.0 108.503 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.56 -32.42 61.21 Favored Glycine 0 N--CA 1.497 2.745 0 CA-C-N 115.283 -0.871 . . . . 1.0 112.22 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.563 0 O-C-N 118.167 -2.96 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.658 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 52' ' ' ASP . 83.4 m-85 66.91 -56.08 0.43 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 114.505 1.298 . . . . 1.0 114.505 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.25 11.73 1.41 Allowed Glycine 0 N--CA 1.505 3.247 0 C-N-CA 121.362 -0.447 . . . . 1.0 112.868 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -29.29 -60.25 0.14 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 113.609 0.966 . . . . 1.0 113.609 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.8 m -57.01 -38.27 72.88 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.624 0.972 . . . . 1.0 113.624 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 14.2 m95 -85.72 -52.1 6.0 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.541 -1.263 . . . . 1.0 112.257 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.38 -45.4 94.51 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.053 -1.43 . . . . 1.0 111.151 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.89 -43.36 99.31 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.676 -1.369 . . . . 1.0 109.676 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.625 ' HA ' HG12 ' A' ' 60' ' ' ILE . 96.3 t -75.87 -33.71 26.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 118.739 -1.184 . . . . 1.0 112.843 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.05 -30.63 67.94 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 105.047 -2.205 . . . . 1.0 105.047 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.37 -34.85 70.82 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.429 -1.26 . . . . 1.0 112.328 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.625 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.1 pt -81.99 -35.85 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 116.828 -1.949 . . . . 1.0 105.816 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.452 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -53.07 -45.74 53.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 105.895 -1.891 . . . . 1.0 105.895 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.456 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 36.5 mmt180 -49.61 -41.44 42.23 Favored 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 118.805 -1.158 . . . . 1.0 113.656 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.556 ' N ' HD13 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -82.54 -27.88 8.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 CA-C-N 114.344 -1.298 . . . . 1.0 109.893 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -72.86 -32.11 65.21 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.264 -1.374 . . . . 1.0 108.786 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 62' ' ' ARG . 35.8 mt-30 -73.31 -48.82 31.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.04 -1.837 . . . . 1.0 106.04 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -56.3 -52.77 63.32 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.12 -1.4 . . . . 1.0 111.287 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 61.3 mt -67.98 -27.36 66.51 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.695 -1.139 . . . . 1.0 111.185 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -71.4 -15.29 62.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 105.796 -1.927 . . . . 1.0 105.796 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -90.78 -49.24 6.56 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 123.569 1.652 . . . . 1.0 106.967 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.9 mt -57.03 -42.9 80.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 111.766 -2.47 . . . . 1.0 110.922 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -18.98 14.84 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.461 -0.895 . . . . 1.0 110.249 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -86.25 -25.33 25.61 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.579 1.181 . . . . 1.0 110.326 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -86.15 -28.87 23.7 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 113.014 -1.903 . . . . 1.0 108.156 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.9 mt -81.28 -57.35 4.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 100.439 -3.912 . . . . 1.0 100.439 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -43.41 -70.31 0.55 Allowed Glycine 0 N--CA 1.494 2.514 0 CA-C-N 113.279 -1.782 . . . . 1.0 114.221 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.7 m -50.41 -48.32 56.2 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 122.155 0.979 . . . . 1.0 112.502 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.446 ' N ' ' HD2' ' A' ' 77' ' ' ARG . 3.0 mpt_? -65.62 -28.73 69.33 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.296 -1.32 . . . . 1.0 112.509 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -55.39 -23.07 22.56 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.638 0.732 . . . . 1.0 111.075 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.0 t -134.27 28.2 3.75 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.065 -1.425 . . . . 1.0 107.94 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.8 ptt85 32.83 44.28 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 122.469 1.128 . . . . 1.0 113.301 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.62 83.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-N 113.922 -1.49 . . . . 1.0 107.216 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.9 26.35 24.63 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 106.249 -2.741 . . . . 1.0 106.249 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.577 0 O-C-N 119.221 -2.34 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.847 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.9 t80 53.18 23.41 3.08 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 122.132 0.968 . . . . 1.0 110.86 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.48 52.54 2.3 Favored Glycine 0 N--CA 1.499 2.836 0 CA-C-O 119.248 -0.751 . . . . 1.0 112.58 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -41.21 -60.88 1.13 Allowed 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 117.714 0.757 . . . . 1.0 112.166 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.2 m -57.49 -30.15 64.86 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.483 -0.781 . . . . 1.0 112.214 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -63.51 -52.93 59.12 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.914 -1.143 . . . . 1.0 107.914 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.6 -43.51 72.23 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 112.466 -2.152 . . . . 1.0 109.163 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.15 -38.77 95.64 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 118.486 -1.816 . . . . 1.0 111.482 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.587 ' HA ' HG12 ' A' ' 60' ' ' ILE . 96.1 t -80.01 -31.23 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 116.445 2.017 . . . . 1.0 116.445 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.96 -27.48 66.63 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.88 -42.51 57.74 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 112.54 -2.118 . . . . 1.0 110.53 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.587 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.4 pt -78.65 -30.03 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 C-N-CA 116.631 -2.028 . . . . 1.0 106.235 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.768 HD12 HE22 ' A' ' 65' ' ' GLN . 1.9 mm -63.76 -31.19 52.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 117.883 -1.527 . . . . 1.0 108.771 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.1 mmt-85 -61.9 -57.64 10.97 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.604 1.335 . . . . 1.0 114.604 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.5 pp -64.88 -31.63 54.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 C-N-CA 118.356 -1.338 . . . . 1.0 111.603 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 63' ' ' ILE . 35.8 tp -70.22 -35.21 73.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.768 HE22 HD12 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -76.86 -49.23 16.22 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 115.873 -2.331 . . . . 1.0 106.225 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.449 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 67.3 mt-30 -48.14 -43.72 31.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 113.712 -1.585 . . . . 1.0 111.94 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -81.88 -30.62 31.87 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.994 -1.457 . . . . 1.0 109.583 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.2 tp -70.28 -20.78 63.01 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 104.562 -2.385 . . . . 1.0 104.562 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 19.0 m-30 -63.25 -29.55 70.86 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.312 -1.355 . . . . 1.0 109.647 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.8 mm -56.97 -38.79 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 113.777 -1.556 . . . . 1.0 111.841 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -22.94 55.58 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.377 -0.929 . . . . 1.0 108.74 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -88.4 -17.5 30.36 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.432 0.634 . . . . 1.0 110.735 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -96.31 -13.8 23.06 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mt -100.93 -59.44 3.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 112.472 -2.149 . . . . 1.0 109.281 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.55 -68.42 1.67 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 115.717 -0.674 . . . . 1.0 112.334 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -53.14 -34.18 55.7 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.213 -0.995 . . . . 1.0 111.409 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.6 ttm-85 -76.71 -29.31 56.19 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.318 -0.953 . . . . 1.0 112.469 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.406 ' O ' ' CB ' ' A' ' 79' ' ' SER . 38.4 t-80 -38.14 -45.93 0.99 Allowed 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 112.878 0.696 . . . . 1.0 112.878 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 78' ' ' HIS . 33.0 t 134.26 123.76 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 105.669 -1.975 . . . . 1.0 105.669 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -177.57 69.01 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 106.646 -1.613 . . . . 1.0 106.646 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 22.0 pt -123.65 147.9 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.22 -63.11 1.02 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 110.341 -1.104 . . . . 1.0 110.341 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.687 0 O-C-N 118.086 -3.008 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.732 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 43.69 31.74 0.49 Allowed 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 114.816 1.414 . . . . 1.0 114.816 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.47 14.7 43.14 Favored Glycine 0 N--CA 1.505 3.284 0 C-N-CA 120.679 -0.772 . . . . 1.0 112.956 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -39.82 -47.92 2.19 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 113.022 0.749 . . . . 1.0 113.022 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 m -61.14 -35.93 78.4 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.484 -0.487 . . . . 1.0 112.196 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -83.42 -54.78 4.72 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 118.346 -1.342 . . . . 1.0 109.769 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.42 -51.08 70.99 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.158 0.98 . . . . 1.0 110.035 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.89 -39.04 76.88 Favored Glycine 0 N--CA 1.49 2.253 0 CA-C-N 113.657 -1.611 . . . . 1.0 112.004 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 60' ' ' ILE . 89.3 t -85.06 -36.28 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 118.848 -1.141 . . . . 1.0 111.758 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 5.5 mm-40 -64.64 -31.6 72.9 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 105.409 -2.071 . . . . 1.0 105.409 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.97 -37.06 72.76 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 113.705 -1.589 . . . . 1.0 111.731 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.574 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.3 pt -82.74 -31.28 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 116.767 -1.973 . . . . 1.0 107.53 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -73.45 -32.27 36.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.364 -1.334 . . . . 1.0 110.231 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 19.5 mmt180 -53.57 -59.53 4.48 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.053 0.93 . . . . 1.0 113.266 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -76.97 -27.43 16.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 113.981 -1.463 . . . . 1.0 113.974 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 63' ' ' ILE . 31.1 tp -71.48 -27.87 63.54 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.418 ' O ' ' CD1' ' A' ' 69' ' ' PHE . 2.6 mp0 -90.25 -53.78 4.31 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 117.885 -1.526 . . . . 1.0 107.219 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -57.2 -36.07 70.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.578 -1.192 . . . . 1.0 111.998 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.616 ' HA ' HG12 ' A' ' 70' ' ' ILE . 87.5 mt -83.43 -30.92 26.92 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 117.707 -1.597 . . . . 1.0 112.234 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 tp -67.56 -21.77 65.43 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 104.406 -2.442 . . . . 1.0 104.406 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 65' ' ' GLN . 17.4 m-30 -70.2 -46.65 64.13 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 117.947 -1.501 . . . . 1.0 107.436 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.616 HG12 ' HA ' ' A' ' 67' ' ' LEU . 9.8 mm -49.46 -42.16 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 113.733 -1.576 . . . . 1.0 111.621 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -50.75 -40.3 54.31 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.663 0.744 . . . . 1.0 110.088 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -66.87 -27.91 67.9 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 123.21 1.481 . . . . 1.0 112.422 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HE ' ' HA ' ' A' ' 70' ' ' ILE . 18.0 mtm105 -79.13 -44.76 21.36 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 112.383 -2.189 . . . . 1.0 106.281 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.4 mt -57.3 -53.25 46.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 113.012 -1.904 . . . . 1.0 107.391 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.55 -56.32 23.85 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 120.575 -0.821 . . . . 1.0 111.725 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 53.3 t -59.92 -35.69 75.43 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.001 1.112 . . . . 1.0 114.001 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -84.08 -29.09 27.09 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 112.983 0.734 . . . . 1.0 112.983 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.4 ' O ' HG13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -35.66 -44.66 0.33 Allowed 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 114.893 1.442 . . . . 1.0 114.893 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.2 m 51.8 42.57 30.06 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 114.971 1.471 . . . . 1.0 114.971 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 53.89 64.23 1.91 Allowed 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 118.204 2.668 . . . . 1.0 118.204 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 78' ' ' HIS . 49.3 mt -86.31 135.47 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 106.884 -1.525 . . . . 1.0 106.884 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.56 -176.36 44.67 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 105.574 -3.01 . . . . 1.0 105.574 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.792 0 O-C-N 119.123 -2.398 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.804 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -107.61 -27.51 10.3 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 112.805 0.668 . . . . 1.0 112.805 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.05 115.08 3.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.024 -1.231 . . . . 1.0 110.024 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -135.54 -120.58 0.16 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.061 -1.829 . . . . 1.0 106.061 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -47.15 -41.84 18.49 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 113.969 1.1 . . . . 1.0 113.969 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.459 ' CD2' ' N ' ' A' ' 55' ' ' ALA . 39.9 p-90 -71.06 -43.28 68.12 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.169 -1.012 . . . . 1.0 111.7 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.459 ' N ' ' CD2' ' A' ' 54' ' ' TRP . . . -65.36 -40.87 94.1 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.58 -1.637 . . . . 1.0 106.58 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.23 -47.32 91.66 Favored Glycine 0 N--CA 1.489 2.218 0 CA-C-N 113.587 -1.642 . . . . 1.0 110.757 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.593 ' HA ' HG12 ' A' ' 60' ' ' ILE . 3.6 p -72.18 -34.12 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 117.307 -1.757 . . . . 1.0 110.089 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -68.86 -27.0 65.42 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.349 -0.982 . . . . 1.0 108.349 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.59 -44.17 19.4 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 112.92 -1.945 . . . . 1.0 109.816 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.593 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.9 pt -73.77 -29.33 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 C-N-CA 116.288 -2.165 . . . . 1.0 106.075 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 4.0 mt -65.42 -24.09 34.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 117.703 -1.599 . . . . 1.0 108.919 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -70.23 -29.61 66.47 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.63 2.085 . . . . 1.0 116.63 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.4 pp -101.99 -21.78 5.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 C-N-CA 117.47 -1.692 . . . . 1.0 108.642 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 63' ' ' ILE . 55.8 tp -77.05 -49.78 14.58 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 123.909 0.756 . . . . 1.0 112.545 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -70.29 -36.27 74.24 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.052 -1.459 . . . . 1.0 107.961 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 9.7 mp0 -66.54 -51.83 52.34 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 113.083 -1.871 . . . . 1.0 108.999 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.474 ' HA ' HD12 ' A' ' 70' ' ' ILE . 3.5 pp -67.98 -29.13 68.09 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 117.668 -1.613 . . . . 1.0 110.419 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -70.29 -19.91 63.06 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.189 -2.152 . . . . 1.0 105.189 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.521 ' CE1' ' HD2' ' A' ' 73' ' ' ARG . 2.2 t80 -81.66 -50.41 9.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.452 -1.684 . . . . 1.0 106.452 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 67' ' ' LEU . 39.3 mt -54.3 -41.83 54.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 112.476 -2.147 . . . . 1.0 109.142 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -44.72 34.56 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.068 0.937 . . . . 1.0 110.358 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -63.66 -23.43 67.37 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.258 -1.337 . . . . 1.0 113.058 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.521 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 14.9 mtp180 -85.52 -45.65 11.59 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 112.993 -1.912 . . . . 1.0 106.324 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.0 mt -55.67 -48.29 77.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 112.659 -2.064 . . . . 1.0 107.672 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.59 -63.19 5.54 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 120.577 -0.821 . . . . 1.0 112.072 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 73' ' ' ARG . 26.5 p -55.64 -41.2 73.21 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.987 -0.685 . . . . 1.0 111.438 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -71.08 -26.83 63.23 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.188 -1.405 . . . . 1.0 109.284 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.487 ' O ' ' HB2' ' A' ' 79' ' ' SER . 29.1 t-80 -73.67 -62.96 1.31 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.444 -1.302 . . . . 1.0 108.177 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' ' 78' ' ' HIS . 11.0 t 168.91 92.32 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 113.58 0.955 . . . . 1.0 113.58 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.558 ' HA ' ' NE ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -116.94 27.86 8.88 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.539 1.161 . . . . 1.0 111.392 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 81' ' ' ILE . 5.0 mp -87.99 77.45 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 106.203 -1.777 . . . . 1.0 106.203 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.35 -64.19 2.11 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 107.404 -2.279 . . . . 1.0 107.404 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.632 0 O-C-N 118.026 -3.043 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.826 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.2 t80 73.55 -43.61 0.56 Allowed 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 113.027 0.751 . . . . 1.0 113.027 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -177.83 86.56 0.07 OUTLIER Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.552 -1.019 . . . . 1.0 110.552 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -125.79 -114.84 0.28 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.752 -0.779 . . . . 1.0 109.172 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 m -33.49 -35.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 115.731 1.752 . . . . 1.0 115.731 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -65.28 -54.03 35.19 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.933 -1.136 . . . . 1.0 107.933 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.2 -49.13 68.33 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 113.085 -1.87 . . . . 1.0 108.757 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -50.91 -44.64 49.96 Favored Glycine 0 N--CA 1.5 2.96 0 CA-C-N 115.18 -0.918 . . . . 1.0 111.698 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.611 ' HA ' HG12 ' A' ' 60' ' ' ILE . 91.0 t -80.91 -32.75 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 119.42 -0.912 . . . . 1.0 111.138 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -71.59 -21.65 61.83 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.935 -1.506 . . . . 1.0 106.935 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.34 -36.75 29.3 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.954 -1.021 . . . . 1.0 110.148 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.611 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.9 pt -80.6 -33.26 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 C-N-CA 116.984 -1.886 . . . . 1.0 105.917 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.433 HG23 ' NE2' ' A' ' 65' ' ' GLN . 1.3 mt -52.06 -29.72 12.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 114.471 -1.241 . . . . 1.0 108.719 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -66.48 -52.49 45.59 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.483 1.66 . . . . 1.0 115.483 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.7 pp -78.07 -28.24 15.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.233 -1.387 . . . . 1.0 111.983 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 63' ' ' ILE . 46.5 tp -68.05 -37.02 80.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.528 -1.286 . . . . 1.0 107.528 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.433 ' NE2' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -76.09 -51.47 12.17 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 117.527 -1.669 . . . . 1.0 106.661 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -49.93 -45.0 50.73 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.598 1.189 . . . . 1.0 111.99 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.0 mt -77.14 -31.87 55.94 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.63 -1.168 . . . . 1.0 111.8 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -67.51 -24.06 65.53 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 102.572 -3.122 . . . . 1.0 102.572 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -75.3 -51.88 12.17 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.003 -1.851 . . . . 1.0 106.003 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.58 -46.34 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 124.253 0.971 . . . . 1.0 111.485 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -46.19 -47.49 17.74 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.815 0.817 . . . . 1.0 112.064 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -64.77 -21.22 66.72 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.901 -1.5 . . . . 1.0 113.272 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -88.61 -44.62 10.49 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 104.975 -2.232 . . . . 1.0 104.975 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.513 ' O ' ' ND1' ' A' ' 78' ' ' HIS . 16.8 mt -60.83 -35.68 66.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 105.109 -2.182 . . . . 1.0 105.109 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.74 -73.81 0.83 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.763 -1.735 . . . . 1.0 108.763 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 78.1 m -49.22 -36.12 19.14 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 115.992 1.849 . . . . 1.0 115.992 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -87.46 -15.58 37.26 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.457 0.91 . . . . 1.0 113.457 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -50.21 -52.13 38.41 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 113.496 0.924 . . . . 1.0 113.496 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.9 t 170.01 155.07 0.05 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.814 -1.55 . . . . 1.0 106.814 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.04 30.55 3.03 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 111.642 -2.526 . . . . 1.0 105.861 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.4 pt 42.36 -123.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 114.732 1.382 . . . . 1.0 114.732 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.75 -161.29 35.07 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 105.551 -3.02 . . . . 1.0 105.551 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.784 0 O-C-N 119.214 -2.345 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.875 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 58.82 20.24 7.77 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-O 121.781 0.8 . . . . 1.0 109.724 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.04 140.72 13.31 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 106.353 -2.699 . . . . 1.0 106.353 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -132.97 -102.07 0.26 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.249 -1.389 . . . . 1.0 107.249 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.9 p -60.49 -48.71 80.57 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 119.603 1.092 . . . . 1.0 112.879 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.93 -63.56 1.03 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 114.081 -1.418 . . . . 1.0 109.17 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.49 95.24 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.027 -1.442 . . . . 1.0 109.007 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.29 -37.71 48.18 Favored Glycine 0 N--CA 1.491 2.365 0 CA-C-N 114.403 -1.271 . . . . 1.0 110.559 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.563 ' HA ' HG12 ' A' ' 60' ' ' ILE . 78.1 t -91.94 -39.68 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.312 -0.955 . . . . 1.0 111.838 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -59.5 -29.54 67.93 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 118.084 -1.446 . . . . 1.0 107.801 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.3 -30.32 48.32 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.128 -1.396 . . . . 1.0 111.859 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.563 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.8 pt -90.11 -25.84 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 C-N-CA 116.038 -2.265 . . . . 1.0 109.563 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.739 HG12 HE22 ' A' ' 65' ' ' GLN . 0.1 OUTLIER -85.44 -30.16 6.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.387 -1.279 . . . . 1.0 109.24 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -55.76 -61.4 2.39 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.453 -1.299 . . . . 1.0 112.589 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -59.45 -30.52 44.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 114.836 -1.074 . . . . 1.0 113.454 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 63' ' ' ILE . 59.2 tp -72.67 -33.1 66.3 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.33 -0.989 . . . . 1.0 108.33 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.739 HE22 HG12 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -78.17 -47.01 19.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 104.972 -2.232 . . . . 1.0 104.972 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 25.2 mt-30 -49.96 -50.23 47.45 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.734 1.254 . . . . 1.0 112.076 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.93 -29.56 60.99 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.177 -1.374 . . . . 1.0 111.727 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.2 tp -71.13 -22.43 62.07 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 103.469 -2.789 . . . . 1.0 103.469 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 66' ' ' GLN . 20.7 m-30 -69.2 -49.67 54.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.099 -1.815 . . . . 1.0 106.099 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.3 -44.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-N 114.228 -1.351 . . . . 1.0 111.38 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -50.27 -46.43 55.09 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.116 0.96 . . . . 1.0 111.963 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -61.42 -31.65 71.59 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 123.566 1.65 . . . . 1.0 112.589 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.5 mtt85 -76.43 -46.05 28.78 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 111.361 -2.654 . . . . 1.0 106.112 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mt -55.73 -52.59 46.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 113.745 -1.571 . . . . 1.0 109.724 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.69 -58.06 16.54 Favored Glycine 0 N--CA 1.5 2.924 0 C-N-CA 120.346 -0.931 . . . . 1.0 112.558 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 48.6 t -55.47 -51.11 68.05 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 118.929 -1.108 . . . . 1.0 110.005 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -60.95 -27.77 68.48 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.909 -1.496 . . . . 1.0 110.912 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.422 ' O ' ' CB ' ' A' ' 79' ' ' SER . 51.6 t-80 -69.95 -25.9 63.87 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 123.84 0.712 . . . . 1.0 109.549 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 78' ' ' HIS . 5.4 t 83.0 74.37 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.481 1.134 . . . . 1.0 108.122 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -110.31 76.75 1.0 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.641 -0.708 . . . . 1.0 110.949 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.9 pt -139.17 167.54 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.319 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.28 80.8 0.08 OUTLIER Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.281 -1.127 . . . . 1.0 110.281 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.651 0 O-C-N 118.203 -2.939 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.747 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -73.64 49.71 0.31 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.339 0.496 . . . . 1.0 112.339 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.51 78.33 0.86 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 106.036 -2.826 . . . . 1.0 106.036 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -88.83 -73.56 0.5 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.873 1.434 . . . . 1.0 114.873 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.8 m -50.64 -60.43 3.04 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 117.685 2.476 . . . . 1.0 117.685 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -65.1 -60.56 2.89 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.153 -1.019 . . . . 1.0 113.386 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.56 89.04 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.635 -0.826 . . . . 1.0 109.475 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.91 -41.13 99.62 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 118.509 -1.805 . . . . 1.0 110.937 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.602 ' HA ' HG12 ' A' ' 60' ' ' ILE . 72.0 t -80.28 -33.72 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 119.385 -0.926 . . . . 1.0 111.296 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -71.62 -22.46 61.7 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.395 -1.335 . . . . 1.0 107.395 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.28 -37.75 23.07 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.818 -1.083 . . . . 1.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.602 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.5 pt -78.79 -32.89 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 105.62 -1.993 . . . . 1.0 105.62 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.563 HG12 HE22 ' A' ' 65' ' ' GLN . 1.5 mt -56.89 -25.02 21.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.607 -1.179 . . . . 1.0 109.701 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -66.62 -52.43 45.23 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 114.187 1.18 . . . . 1.0 114.187 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -81.35 -27.35 10.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 118.715 -1.194 . . . . 1.0 110.658 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 63' ' ' ILE . 43.1 tp -70.69 -30.03 66.49 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.563 HE22 HG12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -84.15 -51.8 6.77 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 116.701 -2.0 . . . . 1.0 106.368 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.517 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 67.0 mt-30 -54.56 -45.19 73.43 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.1 -1.44 . . . . 1.0 113.406 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.2 mt -69.96 -32.66 71.01 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.593 -0.891 . . . . 1.0 108.593 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.9 tp -66.99 -16.91 64.66 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 103.613 -2.736 . . . . 1.0 103.613 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 12.3 m-30 -88.44 -44.96 10.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 105.343 -2.095 . . . . 1.0 105.343 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 66' ' ' GLN . 5.5 mm -58.93 -36.84 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 119.147 -1.021 . . . . 1.0 112.829 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -21.34 33.85 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.201 -1.4 . . . . 1.0 108.562 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -86.49 -17.45 34.15 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.111 0.957 . . . . 1.0 110.163 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -95.26 -16.41 22.48 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.228 -1.351 . . . . 1.0 107.358 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt -94.39 -64.84 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 112.378 -2.192 . . . . 1.0 106.431 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -53.18 -71.68 0.65 Allowed Glycine 0 N--CA 1.495 2.569 0 C-N-CA 120.755 -0.736 . . . . 1.0 114.402 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 37.0 t -54.7 -13.06 0.89 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.312 -0.944 . . . . 1.0 113.187 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -103.33 -29.5 11.2 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.607 -0.437 . . . . 1.0 110.912 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -30.07 70.16 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.858 -1.164 . . . . 1.0 107.858 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 t 78.51 105.22 0.07 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 126.136 2.148 . . . . 1.0 111.664 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -55.65 -13.75 1.81 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 114.419 1.266 . . . . 1.0 114.419 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.6 mm -81.96 56.98 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 122.127 0.965 . . . . 1.0 108.761 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.43 60.06 2.4 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.136 -1.186 . . . . 1.0 110.136 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.658 0 O-C-N 118.714 -2.639 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.743 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 64.15 -69.89 0.08 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 124.577 1.173 . . . . 1.0 113.356 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.1 84.53 0.71 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.637 -1.385 . . . . 1.0 109.637 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -27.04 -58.04 0.09 Allowed 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 115.85 1.796 . . . . 1.0 115.85 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.2 t -61.0 -41.95 97.5 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 119.862 -0.735 . . . . 1.0 110.889 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -61.1 -49.32 77.77 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.31 -40.47 77.93 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.695 -1.593 . . . . 1.0 107.705 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.94 -43.45 98.88 Favored Glycine 0 N--CA 1.497 2.756 0 C-N-CA 118.881 -1.628 . . . . 1.0 110.168 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.57 ' HA ' HG12 ' A' ' 60' ' ' ILE . 92.5 t -70.51 -34.41 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 119.705 -0.798 . . . . 1.0 111.053 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.61 -13.6 62.46 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.172 -1.048 . . . . 1.0 108.172 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.82 -29.62 15.88 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.518 -1.219 . . . . 1.0 109.86 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.7 pt -86.83 -34.22 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 116.75 -1.98 . . . . 1.0 106.357 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.596 HG13 HE22 ' A' ' 65' ' ' GLN . 1.2 mp -62.9 -24.52 36.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.253 -1.379 . . . . 1.0 110.963 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -69.35 -45.79 68.57 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 117.516 -1.674 . . . . 1.0 115.031 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -80.77 -29.67 11.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.101 -1.04 . . . . 1.0 111.876 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 63' ' ' ILE . 42.6 tp -71.23 -27.14 63.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.596 HE22 HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -84.24 -53.76 5.27 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.204 -1.776 . . . . 1.0 106.204 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -53.06 -36.51 60.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.47 -1.292 . . . . 1.0 112.738 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.54 ' HA ' HG12 ' A' ' 70' ' ' ILE . 80.0 mt -80.75 -32.8 35.45 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.158 -1.017 . . . . 1.0 111.806 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -67.91 -21.79 65.11 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 104.252 -2.499 . . . . 1.0 104.252 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.462 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 17.6 m-30 -73.39 -48.22 35.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 117.506 -1.678 . . . . 1.0 107.91 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.54 HG12 ' HA ' ' A' ' 67' ' ' LEU . 7.1 mm -50.55 -41.04 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 114.517 -1.22 . . . . 1.0 111.497 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -48.59 -37.27 17.59 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.172 -0.611 . . . . 1.0 110.525 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.61 -21.33 48.66 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.645 -1.161 . . . . 1.0 111.425 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 22.5 mtp85 -86.56 -22.7 26.15 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 123.448 1.594 . . . . 1.0 107.275 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.9 mt -84.59 -70.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 111.606 -2.543 . . . . 1.0 106.839 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -33.89 -77.52 0.04 OUTLIER Glycine 0 N--CA 1.502 3.045 0 N-CA-C 116.149 1.22 . . . . 1.0 116.149 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 66.4 m -55.64 -30.21 60.58 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.098 1.518 . . . . 1.0 115.098 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -81.34 -25.89 36.02 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.123 -1.065 . . . . 1.0 108.123 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -85.47 -68.55 0.72 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 114.605 -1.18 . . . . 1.0 113.59 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.7 m -162.59 117.62 1.82 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.991 -1.114 . . . . 1.0 107.991 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -159.81 -66.45 0.07 Allowed 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 118.757 -1.177 . . . . 1.0 112.879 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.0 mt -143.56 165.34 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 107.645 -1.242 . . . . 1.0 107.645 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.94 157.27 29.48 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 105.142 -3.183 . . . . 1.0 105.142 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.786 0 O-C-N 118.864 -2.551 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.876 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 41.2 39.25 0.89 Allowed 'General case' 0 N--CA 1.51 2.537 0 CA-C-O 122.401 1.096 . . . . 1.0 112.033 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.58 73.99 0.01 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 116.295 1.278 . . . . 1.0 116.295 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -47.32 -34.15 6.5 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 112.324 0.49 . . . . 1.0 112.324 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.2 m -58.68 -33.74 70.47 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.722 -1.191 . . . . 1.0 109.459 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -90.39 -55.11 3.72 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.49 -0.777 . . . . 1.0 108.945 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.55 -46.93 83.31 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 124.322 1.014 . . . . 1.0 113.501 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.74 -41.53 97.58 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.778 -1.329 . . . . 1.0 109.778 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.598 ' HA ' HG12 ' A' ' 60' ' ' ILE . 97.8 t -73.44 -33.44 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 118.301 -1.36 . . . . 1.0 110.154 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -72.47 -21.06 61.28 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.61 -40.56 16.1 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 113.95 -1.477 . . . . 1.0 109.873 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.598 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.0 pt -75.96 -31.43 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 116.793 -1.963 . . . . 1.0 105.809 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 1.8 mt -60.15 -23.43 27.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 118.215 -1.394 . . . . 1.0 109.019 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -76.0 -52.04 11.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 116.596 -2.042 . . . . 1.0 111.222 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.565 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.3 pp -70.83 -29.17 36.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 118.756 -1.178 . . . . 1.0 111.503 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 63' ' ' ILE . 30.9 tp -67.68 -31.36 71.28 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.547 -1.279 . . . . 1.0 107.547 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.87 -54.14 5.59 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 117.923 -1.511 . . . . 1.0 107.541 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.413 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 88.6 mt-30 -51.72 -38.06 53.61 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.325 -1.307 . . . . 1.0 112.658 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.571 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 64.3 mt -81.62 -37.04 28.2 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.863 -1.062 . . . . 1.0 108.559 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.3 tp -67.09 -14.29 62.76 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.439 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 18.2 m-30 -73.6 -36.61 65.53 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 117.305 -1.758 . . . . 1.0 107.121 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 67' ' ' LEU . 57.2 mt -45.35 -46.15 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 112.853 -1.976 . . . . 1.0 110.749 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -47.3 -43.85 22.9 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.988 0.899 . . . . 1.0 111.172 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.97 -28.65 69.06 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.808 -1.542 . . . . 1.0 112.21 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.534 HH21 ' N ' ' A' ' 70' ' ' ILE . 12.1 mtm180 -79.99 -38.52 31.99 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 113.293 -1.776 . . . . 1.0 107.76 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.554 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 3.6 mt -65.31 -46.81 89.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 113.28 -1.782 . . . . 1.0 109.276 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.32 -56.91 22.53 Favored Glycine 0 N--CA 1.501 3.01 0 N-CA-C 108.281 -1.928 . . . . 1.0 108.281 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 74.2 m -53.18 -44.34 67.81 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.459 -0.871 . . . . 1.0 112.397 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.554 ' HG2' ' HA ' ' A' ' 74' ' ' ILE . 9.6 ptm180 -70.99 -13.06 61.87 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 118.924 -1.11 . . . . 1.0 112.972 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -81.28 -47.37 13.44 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.887 -1.125 . . . . 1.0 113.16 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.543 ' HG ' ' N ' ' A' ' 83' ' ' NH2 . 24.4 t 164.76 -46.15 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.801 0 CA-C-O 121.346 0.593 . . . . 1.0 110.95 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 48.48 58.27 5.39 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 113.971 -1.468 . . . . 1.0 110.398 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.1 mt 72.03 15.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-N 114.017 -1.447 . . . . 1.0 110.276 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.13 -11.64 62.81 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.351 -1.1 . . . . 1.0 110.351 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . 0.543 ' N ' ' HG ' ' A' ' 79' ' ' SER . . . . . . . . 0 C--N 1.299 -1.598 0 O-C-N 118.681 -2.658 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.686 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -80.76 52.49 1.72 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.686 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.24 79.76 0.03 OUTLIER Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.01 -1.566 . . . . 1.0 113.004 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -125.55 -119.4 0.27 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 105.022 -2.214 . . . . 1.0 105.022 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t -50.77 -32.94 21.33 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 119.305 0.957 . . . . 1.0 111.626 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -67.63 -36.59 81.1 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.706 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.18 -36.68 82.28 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.268 -1.012 . . . . 1.0 108.268 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.76 -42.69 16.4 Favored Glycine 0 N--CA 1.498 2.788 0 C-N-CA 118.089 -2.005 . . . . 1.0 112.482 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.556 ' HA ' HG12 ' A' ' 60' ' ' ILE . 85.4 t -78.21 -35.5 19.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 115.993 1.849 . . . . 1.0 115.993 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -64.38 -31.79 73.14 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.145 -1.798 . . . . 1.0 106.145 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.87 -38.55 76.43 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 111.903 -2.408 . . . . 1.0 111.625 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.556 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.9 pt -83.98 -31.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 116.754 -1.978 . . . . 1.0 107.562 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -73.92 -28.68 24.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 117.13 -1.828 . . . . 1.0 109.884 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -59.29 -56.74 18.27 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 117.93 -1.508 . . . . 1.0 112.913 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -73.44 -28.21 24.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 63' ' ' ILE . 28.2 tp -70.02 -32.39 70.52 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.46 -53.81 5.43 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 117.911 -1.516 . . . . 1.0 107.652 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.464 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 23.9 mt-30 -51.28 -37.67 48.64 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.739 -1.118 . . . . 1.0 112.039 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.535 ' HA ' HD13 ' A' ' 70' ' ' ILE . 76.6 mt -84.75 -34.91 22.76 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 117.798 -1.561 . . . . 1.0 110.124 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp -65.67 -22.44 66.64 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 104.398 -2.445 . . . . 1.0 104.398 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 18.5 m-30 -60.21 -32.82 71.47 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 117.337 -1.745 . . . . 1.0 108.109 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 67' ' ' LEU . 1.6 mp -46.98 -42.12 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 C-N-CA 118.359 -1.337 . . . . 1.0 111.083 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.5 -39.2 60.98 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.568 0.699 . . . . 1.0 110.924 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -75.14 -26.15 58.93 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.438 -1.255 . . . . 1.0 111.266 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 43.3 mtm180 -82.98 -24.65 32.83 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.734 -1.58 . . . . 1.0 106.734 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mt -80.72 -58.55 3.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 113.94 -1.482 . . . . 1.0 111.09 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -47.09 -35.25 8.44 Favored Glycine 0 N--CA 1.506 3.314 0 CA-C-O 121.414 0.452 . . . . 1.0 112.338 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.7 m -77.99 -66.8 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.559 -1.32 . . . . 1.0 110.26 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -51.91 -48.08 64.32 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.269 1.211 . . . . 1.0 114.269 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -49.41 -63.3 1.15 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 125.218 1.574 . . . . 1.0 112.208 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 64.9 p -171.67 40.77 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.982 -1.087 . . . . 1.0 110.583 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? 31.5 68.62 0.12 Allowed 'General case' 0 N--CA 1.509 2.515 0 O-C-N 124.95 1.406 . . . . 1.0 110.452 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.425 HD12 ' C ' ' A' ' 81' ' ' ILE . 2.1 pp -95.85 -164.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 114.712 1.375 . . . . 1.0 114.712 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.37 -81.24 0.68 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.859 -1.696 . . . . 1.0 108.859 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.657 0 O-C-N 119.078 -2.425 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.758 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -78.61 -35.46 45.62 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 112.891 0.7 . . . . 1.0 112.891 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.13 -19.55 0.02 OUTLIER Glycine 0 N--CA 1.511 3.658 0 N-CA-C 117.725 1.85 . . . . 1.0 117.725 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -36.21 -45.38 0.45 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.434 1.642 . . . . 1.0 115.434 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.3 m -62.81 -26.43 68.73 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 113.523 0.935 . . . . 1.0 113.523 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 -76.91 -68.67 0.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 106.739 -1.578 . . . . 1.0 106.739 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.2 -55.26 10.88 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 112.128 -2.306 . . . . 1.0 111.096 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.18 -30.45 31.7 Favored Glycine 0 N--CA 1.496 2.642 0 CA-C-N 113.869 -1.514 . . . . 1.0 112.632 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.621 ' HA ' HG12 ' A' ' 60' ' ' ILE . 97.9 t -96.1 -28.29 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 118.815 -1.154 . . . . 1.0 112.44 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -71.69 -29.89 65.08 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 105.127 -2.175 . . . . 1.0 105.127 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.98 79.09 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 113.397 -1.729 . . . . 1.0 111.721 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.621 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.9 pt -82.09 -38.47 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 105.47 -2.048 . . . . 1.0 105.47 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.44 ' N ' HG13 ' A' ' 60' ' ' ILE . 2.6 mt -52.7 -45.84 49.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 106.383 -1.71 . . . . 1.0 106.383 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.471 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 15.0 ttm180 -46.09 -36.42 5.78 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.41 -1.268 . . . . 1.0 110.465 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.522 ' N ' HD13 ' A' ' 63' ' ' ILE . 2.0 mm -91.41 -26.14 5.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.113 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -69.76 -30.95 68.65 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.875 -1.53 . . . . 1.0 108.304 -179.452 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.508 ' HG2' ' N ' ' A' ' 66' ' ' GLN . 4.4 pt20 -85.25 -47.85 9.67 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.109 -1.812 . . . . 1.0 106.109 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.508 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 48.1 mt-30 -54.1 -36.36 63.12 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 117.83 -1.548 . . . . 1.0 109.385 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.588 ' HA ' HG12 ' A' ' 70' ' ' ILE . 97.8 mt -81.43 -36.98 28.8 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.66 -1.216 . . . . 1.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.9 tp -66.35 -17.51 64.81 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 105.278 -2.119 . . . . 1.0 105.278 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 65' ' ' GLN . 19.4 m-30 -76.22 -32.68 59.07 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 117.869 -1.532 . . . . 1.0 109.065 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' A' ' 67' ' ' LEU . 19.4 mm -52.86 -41.48 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.51 -1.223 . . . . 1.0 114.174 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -56.79 -24.18 48.64 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 117.972 -1.491 . . . . 1.0 109.007 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -83.65 -20.76 33.03 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.337 -0.945 . . . . 1.0 110.44 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -89.45 -18.61 26.42 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.443 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.4 mp -95.2 -61.93 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 112.881 -1.963 . . . . 1.0 111.153 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.84 -67.48 2.18 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 120.0 -1.095 . . . . 1.0 112.218 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 78.8 m -56.61 -13.87 2.75 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.37 0.878 . . . . 1.0 113.37 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.6 ttm-85 -102.97 -15.95 15.97 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.233 -0.987 . . . . 1.0 110.415 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -53.21 -73.02 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.446 1.276 . . . . 1.0 114.446 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.2 t 153.35 -165.47 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.273 1 N-CA-C 99.366 -4.309 . . . . 1.0 99.366 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.85 58.09 2.27 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.366 -0.833 . . . . 1.0 110.053 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.7 mm 44.27 49.57 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 CA-C-O 122.315 1.055 . . . . 1.0 111.79 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.8 -97.36 0.43 Allowed Glycine 0 N--CA 1.498 2.804 0 C-N-CA 120.093 -1.051 . . . . 1.0 110.704 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.636 0 O-C-N 118.396 -2.826 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.682 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -78.06 53.45 1.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.064 0.935 . . . . 1.0 111.497 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.36 72.07 0.39 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 107.246 -2.342 . . . . 1.0 107.246 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -102.05 -123.4 0.18 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.7 t -42.16 -35.81 1.03 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.832 1.79 . . . . 1.0 115.832 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.449 ' HA ' HG12 ' A' ' 57' ' ' VAL . 27.1 p-90 -75.79 -38.96 57.74 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 117.436 -1.706 . . . . 1.0 108.19 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.35 -39.25 92.12 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.492 -1.283 . . . . 1.0 108.618 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.6 -44.71 39.21 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.731 -1.223 . . . . 1.0 111.616 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.532 ' HA ' HG12 ' A' ' 60' ' ' ILE . 2.1 p -70.71 -32.47 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 118.356 -1.338 . . . . 1.0 109.783 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.35 -21.49 61.3 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.982 -1.087 . . . . 1.0 108.842 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.15 -40.22 18.46 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.736 -1.575 . . . . 1.0 109.732 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.532 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.3 pt -76.6 -33.01 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 104.74 -2.318 . . . . 1.0 104.74 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 65' ' ' GLN . 1.6 mt -58.48 -37.74 66.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 118.373 -1.331 . . . . 1.0 107.563 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -56.04 -24.0 36.82 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.077 -1.449 . . . . 1.0 113.49 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.2 mm -95.15 -7.61 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 119.634 -0.827 . . . . 1.0 109.23 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.522 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.28 -45.39 5.62 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.933 -0.707 . . . . 1.0 109.552 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -68.79 -27.64 66.06 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 117.709 -1.596 . . . . 1.0 107.687 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -65.4 -61.43 2.11 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.256 -1.338 . . . . 1.0 108.501 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.2 mt -61.94 -32.12 72.51 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.474 -1.239 . . . . 1.0 111.391 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.1 tp -70.38 -14.38 62.54 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.513 ' CD2' HD13 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -91.04 -45.87 8.46 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 105.234 -2.135 . . . . 1.0 105.234 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.513 HD13 ' CD2' ' A' ' 69' ' ' PHE . 9.9 mm -57.8 -37.21 58.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 118.239 -1.384 . . . . 1.0 111.411 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -20.39 15.97 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 118.478 -1.289 . . . . 1.0 109.585 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -85.18 -24.27 27.99 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.982 0.896 . . . . 1.0 109.694 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.457 ' HD3' ' CE1' ' A' ' 69' ' ' PHE . 17.3 mtm105 -90.23 -17.44 27.49 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.597 -1.26 . . . . 1.0 107.597 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.3 mt -91.28 -59.25 3.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 111.838 -2.437 . . . . 1.0 110.426 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.72 -57.4 11.18 Favored Glycine 0 N--CA 1.506 3.329 0 N-CA-C 116.267 1.267 . . . . 1.0 116.267 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 63.7 m -56.97 -33.68 67.3 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.826 -0.687 . . . . 1.0 110.016 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.535 ' HA ' ' NE ' ' A' ' 77' ' ' ARG . 1.1 tpm_? -83.67 -37.88 22.21 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.129 -1.028 . . . . 1.0 109.07 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.54 ' ND1' ' OG ' ' A' ' 79' ' ' SER . 29.4 t-80 -57.67 -43.53 85.07 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 123.651 0.594 . . . . 1.0 109.907 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.54 ' OG ' ' ND1' ' A' ' 78' ' ' HIS . 6.3 p 161.43 -1.02 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 117.079 2.252 . . . . 1.0 117.079 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -50.92 -35.77 34.98 Favored 'General case' 0 N--CA 1.507 2.412 0 C-N-CA 118.169 -1.412 . . . . 1.0 111.648 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 37.0 pt -114.65 41.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.275 -1.75 . . . . 1.0 106.275 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.63 -61.71 4.45 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.477 -2.249 . . . . 1.0 107.477 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.684 0 O-C-N 119.394 -2.239 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.828 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -128.19 72.1 1.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.99 27.56 0.04 OUTLIER Glycine 0 N--CA 1.506 3.353 0 C-N-CA 120.005 -1.093 . . . . 1.0 113.399 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -42.26 -57.55 2.51 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 112.881 0.697 . . . . 1.0 112.881 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -55.44 -31.13 61.67 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.114 0.783 . . . . 1.0 113.114 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -65.58 -58.73 5.06 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.927 -1.508 . . . . 1.0 106.927 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.72 -48.74 58.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 111.866 -2.424 . . . . 1.0 108.787 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.85 -36.99 67.93 Favored Glycine 0 N--CA 1.494 2.538 0 CA-C-N 114.081 -1.418 . . . . 1.0 111.176 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.529 ' HA ' HG12 ' A' ' 60' ' ' ILE . 59.9 t -79.97 -33.02 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 114.699 1.37 . . . . 1.0 114.699 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -65.55 -29.38 69.99 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 116.656 -2.018 . . . . 1.0 107.231 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.05 -36.45 79.9 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 112.069 -2.332 . . . . 1.0 110.553 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.5 pt -84.46 -36.95 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 116.165 -2.214 . . . . 1.0 107.474 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -65.98 -29.65 47.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 117.6 -1.64 . . . . 1.0 110.211 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -63.81 -54.19 38.97 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.207 -1.397 . . . . 1.0 114.239 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.578 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -73.59 -29.13 26.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 118.771 -1.172 . . . . 1.0 112.829 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 63' ' ' ILE . 39.9 tp -69.32 -30.23 68.24 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.417 ' NE2' ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -82.26 -52.41 6.97 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.166 -1.79 . . . . 1.0 106.166 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.475 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 39.3 mt-30 -50.22 -38.33 39.85 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.389 -0.823 . . . . 1.0 113.076 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 68.5 mt -84.15 -33.21 24.29 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.985 -1.007 . . . . 1.0 110.392 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.49 -15.0 61.8 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.035 -2.209 . . . . 1.0 105.035 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 17.4 m-30 -66.86 -37.21 84.01 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 116.823 -1.951 . . . . 1.0 107.716 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 67' ' ' LEU . 32.9 mt -48.31 -47.68 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 114.211 -1.359 . . . . 1.0 111.858 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -34.44 39.79 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.061 0.457 . . . . 1.0 111.087 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.75 -13.42 56.35 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.141 -0.936 . . . . 1.0 111.671 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 49.1 mtm180 -101.02 -20.42 15.4 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.453 -1.249 . . . . 1.0 109.13 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 mt -95.69 -45.98 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 113.401 -1.727 . . . . 1.0 109.018 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -43.19 -62.97 2.21 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 121.329 -0.463 . . . . 1.0 112.686 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 24.7 p -56.44 -25.88 51.92 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 112.975 0.732 . . . . 1.0 112.975 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.1 mtp-105 -90.77 -13.71 33.44 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.56 -0.745 . . . . 1.0 111.528 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.444 ' ND1' ' C ' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -72.29 -17.34 61.88 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.926 -1.11 . . . . 1.0 111.191 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 t 174.63 119.63 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 123.287 0.367 . . . . 1.0 110.836 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -161.62 95.94 1.02 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.853 -0.739 . . . . 1.0 109.04 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 81' ' ' ILE . 2.6 mp -97.14 152.85 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 104.371 -2.455 . . . . 1.0 104.371 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 176.92 173.09 42.17 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 104.939 -3.264 . . . . 1.0 104.939 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.837 0 O-C-N 118.93 -2.512 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.722 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 35.8 t80 71.73 -54.05 0.68 Allowed 'General case' 0 N--CA 1.508 2.449 0 O-C-N 124.265 0.978 . . . . 1.0 111.904 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.65 123.91 7.14 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 106.234 -2.746 . . . . 1.0 106.234 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -108.66 -100.29 0.38 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 117.363 0.582 . . . . 1.0 110.198 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.6 t -45.95 -32.33 2.66 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 113.686 0.995 . . . . 1.0 113.686 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -58.64 -50.81 72.47 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.542 -0.863 . . . . 1.0 110.873 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.16 -42.78 68.67 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.89 -32.47 62.28 Favored Glycine 0 N--CA 1.494 2.554 0 CA-C-N 113.425 -1.716 . . . . 1.0 112.861 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.552 ' HA ' HG12 ' A' ' 60' ' ' ILE . 87.9 t -98.53 -42.63 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 113.087 0.773 . . . . 1.0 113.087 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.4 ' HA ' HG22 ' A' ' 61' ' ' ILE . 7.4 mm-40 -59.79 -28.08 67.11 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.453 -1.299 . . . . 1.0 108.34 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.31 -25.95 51.74 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.93 -1.486 . . . . 1.0 111.612 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.552 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.8 pt -94.57 -35.05 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 117.263 -1.775 . . . . 1.0 110.21 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -71.51 -23.21 22.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 113.743 -1.571 . . . . 1.0 108.272 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -73.61 -52.36 13.67 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 115.38 -2.528 . . . . 1.0 112.15 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.586 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.3 pp -70.66 -29.31 37.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 113.776 1.028 . . . . 1.0 113.776 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 63' ' ' ILE . 26.4 tp -68.87 -37.63 79.19 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.937 -1.505 . . . . 1.0 106.937 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -74.74 -48.15 27.3 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 117.24 -1.784 . . . . 1.0 106.617 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -52.04 -44.17 64.11 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.76 -1.109 . . . . 1.0 112.038 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HA ' HG12 ' A' ' 70' ' ' ILE . 3.6 pp -75.52 -37.65 59.95 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.67 -1.15 . . . . 1.0 109.279 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 67' ' ' LEU . 39.5 mt -67.11 -16.21 64.19 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.928 -1.879 . . . . 1.0 105.928 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.463 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 20.9 m-30 -73.55 -35.72 65.53 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.507 -1.677 . . . . 1.0 106.686 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.0 mm -53.25 -43.71 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.373 -1.285 . . . . 1.0 112.296 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.41 -28.61 44.95 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 120.066 1.303 . . . . 1.0 110.924 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -75.32 -29.68 60.08 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.756 1.265 . . . . 1.0 111.381 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -82.44 -38.64 23.71 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 113.46 -1.7 . . . . 1.0 108.149 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.58 -50.24 72.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 113.141 -1.845 . . . . 1.0 106.794 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -50.83 -51.69 33.06 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.468 -1.349 . . . . 1.0 109.744 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 53.2 t -46.83 -59.29 3.16 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.815 0.817 . . . . 1.0 111.181 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -53.95 -37.74 64.22 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.691 -1.14 . . . . 1.0 112.658 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -84.74 -11.23 56.24 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 118.79 -1.164 . . . . 1.0 109.595 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.9 t -89.56 -25.2 21.48 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 114.333 1.234 . . . . 1.0 114.333 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.0 ttm105 -115.88 57.67 0.75 Allowed 'General case' 0 N--CA 1.507 2.414 0 CA-C-N 119.356 0.98 . . . . 1.0 110.574 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.6 pt -140.72 173.46 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 120.077 -0.649 . . . . 1.0 111.62 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.25 -165.77 32.5 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 104.289 -3.525 . . . . 1.0 104.289 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.733 0 O-C-N 118.865 -2.55 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.875 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 49.72 34.02 6.88 Favored 'General case' 0 N--CA 1.507 2.418 0 CA-C-O 122.255 1.026 . . . . 1.0 109.281 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -127.75 133.12 7.71 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 105.461 -3.056 . . . . 1.0 105.461 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -114.55 -73.46 0.65 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.528 -1.286 . . . . 1.0 107.528 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.6 p -56.82 -42.6 79.89 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.709 -1.132 . . . . 1.0 110.793 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -62.95 -61.11 2.62 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 123.068 1.413 . . . . 1.0 109.971 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.09 -42.44 38.87 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 111.976 -2.375 . . . . 1.0 108.816 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.15 -38.55 72.78 Favored Glycine 0 N--CA 1.488 2.144 0 CA-C-N 113.958 -1.474 . . . . 1.0 112.251 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.629 ' HA ' HG12 ' A' ' 60' ' ' ILE . 1.8 p -73.5 -35.29 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 117.339 -1.744 . . . . 1.0 113.11 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -68.08 -28.79 67.66 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 117.287 -1.765 . . . . 1.0 107.538 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.72 -37.34 73.5 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 112.744 -2.026 . . . . 1.0 112.023 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.629 HG12 ' HA ' ' A' ' 57' ' ' VAL . 4.8 pt -81.31 -35.03 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 106.533 -1.654 . . . . 1.0 106.533 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.427 ' HA ' HD23 ' A' ' 64' ' ' LEU . 1.7 mt -52.14 -43.47 38.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 112.842 -1.981 . . . . 1.0 105.82 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.578 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 81.6 mtm180 -51.86 -31.75 29.19 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 118.586 -1.246 . . . . 1.0 112.418 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.597 ' N ' HD13 ' A' ' 63' ' ' ILE . 1.4 mm -88.66 -17.62 8.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 114.455 -1.248 . . . . 1.0 110.791 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.469 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -83.44 -35.29 25.09 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.392 -1.323 . . . . 1.0 109.434 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.578 ' OE1' ' HA ' ' A' ' 62' ' ' ARG . 7.8 pt20 -76.01 -46.49 29.18 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 116.343 -2.143 . . . . 1.0 106.868 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.505 ' H ' ' HG2' ' A' ' 65' ' ' GLN . 35.9 mt-30 -49.71 -45.98 49.69 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.315 1.055 . . . . 1.0 112.514 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.546 ' HA ' HG12 ' A' ' 70' ' ' ILE . 89.1 mt -72.35 -40.13 67.58 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.957 -1.474 . . . . 1.0 110.033 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.7 mt -65.39 -15.3 62.45 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.822 -1.551 . . . . 1.0 107.019 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 21.0 m-30 -78.66 -39.19 37.54 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 106.92 -1.511 . . . . 1.0 106.92 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.3 mm -49.97 -40.47 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 114.607 -1.179 . . . . 1.0 111.235 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -50.25 -41.3 50.05 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.485 0.66 . . . . 1.0 109.705 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -66.6 -31.2 71.75 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 123.24 1.495 . . . . 1.0 111.81 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -73.62 -42.29 61.67 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 112.781 -2.009 . . . . 1.0 106.624 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.417 HD13 HG22 ' A' ' 70' ' ' ILE 0.259 1.1 mp -60.85 -55.97 21.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 113.82 -1.536 . . . . 1.0 107.245 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.26 -51.81 48.44 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 109.608 -1.397 . . . . 1.0 109.608 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 52.1 t -50.43 -53.95 25.64 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 114.801 -0.699 . . . . 1.0 110.33 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -30.7 61.05 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.641 -0.709 . . . . 1.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -76.1 -9.54 58.71 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 118.872 -1.131 . . . . 1.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.1 t 54.6 14.25 0.81 Allowed 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 115.44 1.644 . . . . 1.0 115.44 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.4 mtp-105 -64.99 -22.45 67.0 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 119.663 -0.815 . . . . 1.0 112.097 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.9 tt -62.16 74.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 123.01 1.386 . . . . 1.0 111.415 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 162.99 -24.19 0.2 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.021 -1.631 . . . . 1.0 109.021 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.508 0 O-C-N 118.731 -2.629 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.764 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -77.44 57.55 1.55 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 122.272 1.034 . . . . 1.0 109.525 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.18 -114.7 5.7 Favored Glycine 0 N--CA 1.493 2.488 0 CA-C-N 115.272 -0.876 . . . . 1.0 112.355 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.4 t0 69.35 -62.78 0.4 Allowed 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 124.827 1.251 . . . . 1.0 110.32 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.0 p -69.69 -59.99 2.6 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-N 114.714 -1.13 . . . . 1.0 111.477 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.475 ' CG ' ' N ' ' A' ' 55' ' ' ALA . 6.7 t-105 -44.01 -71.91 0.07 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.215 -1.812 . . . . 1.0 110.045 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.475 ' N ' ' CG ' ' A' ' 54' ' ' TRP . . . -52.54 -40.11 62.14 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 112.315 -2.221 . . . . 1.0 107.939 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.62 -36.35 70.96 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 114.316 -1.311 . . . . 1.0 110.002 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.56 ' HA ' HG12 ' A' ' 60' ' ' ILE . 95.5 t -78.61 -39.39 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.788 -0.765 . . . . 1.0 110.544 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -29.38 70.25 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 118.325 -1.35 . . . . 1.0 107.684 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.5 -37.09 63.23 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.208 -2.269 . . . . 1.0 110.597 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.56 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.2 pt -83.16 -28.93 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 C-N-CA 116.07 -2.252 . . . . 1.0 108.327 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -71.53 -31.39 42.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 114.028 -1.442 . . . . 1.0 109.298 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -50.03 -62.16 1.73 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.619 -1.173 . . . . 1.0 113.032 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -75.8 -27.85 18.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 113.173 -1.83 . . . . 1.0 113.589 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 63' ' ' ILE . 29.6 tp -70.31 -34.97 73.35 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.443 -1.318 . . . . 1.0 107.443 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -82.75 -53.38 5.94 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 116.551 -2.06 . . . . 1.0 108.062 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -52.16 -37.04 53.34 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.82 -1.082 . . . . 1.0 112.796 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.559 ' HA ' HG12 ' A' ' 70' ' ' ILE . 83.5 mt -82.28 -38.63 24.11 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.487 -1.285 . . . . 1.0 110.943 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 9.9 tt -62.86 -23.75 67.47 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.445 -2.058 . . . . 1.0 105.445 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -66.3 -35.26 79.92 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 117.635 -1.626 . . . . 1.0 109.363 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' A' ' 67' ' ' LEU . 12.6 mm -54.29 -38.19 39.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 113.453 -1.703 . . . . 1.0 113.103 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -60.15 -27.36 67.03 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 120.913 1.688 . . . . 1.0 109.188 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -73.86 -22.72 59.64 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.609 1.195 . . . . 1.0 110.422 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -85.97 -55.84 3.76 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 105.424 -2.065 . . . . 1.0 105.424 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.84 -35.64 34.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 113.503 -1.68 . . . . 1.0 111.368 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.63 -65.66 2.1 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 106.752 -2.539 . . . . 1.0 106.752 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 44.2 t -49.0 -60.3 2.89 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.97 1.47 . . . . 1.0 114.97 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.411 ' HA ' ' HE ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -62.01 -10.35 9.63 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 113.347 0.869 . . . . 1.0 113.347 -179.42 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -63.73 -57.78 8.9 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.651 -1.22 . . . . 1.0 109.75 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.7 t 176.82 63.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.898 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 42.7 25.4 0.05 OUTLIER 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 115.331 1.604 . . . . 1.0 115.331 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.4 mt 56.99 32.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.881 0.848 . . . . 1.0 108.899 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.27 65.69 0.54 Allowed Glycine 0 N--CA 1.498 2.78 0 CA-C-N 115.52 -0.764 . . . . 1.0 112.076 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.65 0 O-C-N 118.5 -2.765 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.839 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 67.8 -44.52 0.48 Allowed 'General case' 0 N--CA 1.51 2.572 0 N-CA-C 116.366 1.987 . . . . 1.0 116.366 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.36 48.74 2.88 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 110.301 -1.12 . . . . 1.0 110.301 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -118.26 -120.51 0.3 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.261 -1.385 . . . . 1.0 107.261 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.4 m -45.87 -33.19 3.04 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 113.953 1.094 . . . . 1.0 113.953 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -52.64 61.94 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 107.763 -1.199 . . . . 1.0 107.763 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.78 -47.01 88.24 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.339 -1.755 . . . . 1.0 108.73 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.62 -41.95 93.92 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 119.103 -1.522 . . . . 1.0 111.917 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 60' ' ' ILE . 94.2 t -79.82 -29.06 12.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 114.433 1.272 . . . . 1.0 114.433 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -65.96 -33.34 75.6 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.575 -2.009 . . . . 1.0 105.575 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.05 93.59 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 111.883 -2.417 . . . . 1.0 111.648 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.7 pt -82.31 -29.83 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 117.061 -1.856 . . . . 1.0 106.83 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.433 HG23 ' NE2' ' A' ' 65' ' ' GLN . 1.6 mt -61.71 -30.73 48.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.038 -1.437 . . . . 1.0 108.373 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -64.27 -55.83 18.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.43 -1.308 . . . . 1.0 114.228 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -69.7 -28.32 36.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 118.624 -1.23 . . . . 1.0 112.411 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 63' ' ' ILE . 29.0 tp -71.89 -33.28 68.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.433 ' NE2' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -79.41 -43.98 22.32 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 116.872 -1.931 . . . . 1.0 107.278 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.487 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 1.5 pt20 -54.42 -37.06 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.291 -0.963 . . . . 1.0 111.62 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.457 ' HG ' ' HG2' ' A' ' 66' ' ' GLN . 81.8 mt -82.77 -38.89 22.57 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.077 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.6 tp -66.21 -15.49 63.22 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 19.3 m-30 -69.76 -28.32 65.67 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 116.571 -2.052 . . . . 1.0 108.602 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.3 mt -53.44 -42.25 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 114.575 -1.193 . . . . 1.0 110.662 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.41 -32.37 49.32 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.606 0.717 . . . . 1.0 110.051 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -83.13 -18.19 40.38 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.576 -1.193 . . . . 1.0 111.151 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 53.5 mtm180 -96.35 -16.98 20.98 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.875 -1.157 . . . . 1.0 107.875 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 mt -93.26 -56.18 5.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 113.524 -1.671 . . . . 1.0 107.928 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.88 -63.67 4.99 Favored Glycine 0 N--CA 1.499 2.836 0 C-N-CA 119.888 -1.148 . . . . 1.0 112.304 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 80.8 m -50.99 -44.97 60.95 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.464 -0.494 . . . . 1.0 110.096 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -63.14 -35.42 80.22 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.564 -0.744 . . . . 1.0 109.426 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.443 ' ND1' ' C ' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -82.81 -15.42 51.71 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 118.431 -1.308 . . . . 1.0 107.48 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.3 p -159.09 101.05 1.58 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 122.106 0.955 . . . . 1.0 113.217 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.576 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -64.28 7.68 0.13 Allowed 'General case' 0 N--CA 1.507 2.399 0 CA-C-N 115.015 -0.993 . . . . 1.0 113.355 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 25.5 mt 47.55 49.45 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-O 122.739 1.257 . . . . 1.0 110.793 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.07 61.33 1.38 Allowed Glycine 0 N--CA 1.497 2.705 0 CA-C-N 114.388 -1.278 . . . . 1.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.676 0 O-C-N 118.374 -2.839 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 121.772 0.796 . . . . 1.0 110.785 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 pt -79.87 -32.94 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 106.676 -1.601 . . . . 1.0 106.676 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.3 mt -57.16 -28.1 29.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.185 -1.37 . . . . 1.0 109.227 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.447 ' C ' HE21 ' A' ' 66' ' ' GLN . 58.2 mtp180 -70.54 -51.68 26.98 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.574 -1.65 . . . . 1.0 114.746 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -72.79 -30.03 31.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 C-N-CA 118.314 -1.355 . . . . 1.0 111.489 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 63' ' ' ILE . 31.0 tp -69.32 -34.11 74.17 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.001 -0.741 . . . . 1.0 109.001 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.581 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -74.87 -53.86 8.32 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.587 -2.005 . . . . 1.0 105.587 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.447 HE21 ' C ' ' A' ' 62' ' ' ARG . 39.3 mt-30 -50.3 -39.77 46.52 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.431 -1.259 . . . . 1.0 111.61 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.544 ' HA ' HD13 ' A' ' 70' ' ' ILE . 69.5 mt -83.54 -20.88 33.07 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.563 -1.199 . . . . 1.0 110.431 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.408 ' O ' ' CD2' ' A' ' 71' ' ' HIS . 15.3 tp -84.58 -7.37 59.28 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 102.883 -3.006 . . . . 1.0 102.883 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 65' ' ' GLN . 17.6 m-30 -87.05 -37.23 17.64 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.434 -0.906 . . . . 1.0 110.169 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.544 HD13 ' HA ' ' A' ' 67' ' ' LEU . 1.1 pt -50.41 -37.78 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 118.831 -1.148 . . . . 1.0 113.365 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -55.14 -26.81 41.05 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 118.869 -1.132 . . . . 1.0 109.866 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.417 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 31.1 t80 -84.65 -17.75 37.56 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.988 0.899 . . . . 1.0 111.486 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -98.48 -15.58 19.54 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.462 -1.244 . . . . 1.0 108.635 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.297 -1.691 0 CA-C-N 112.578 -2.101 . . . . 1.0 109.223 179.714 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 119.083 -0.484 . . . . 1.0 110.746 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.426 ' O ' HD12 ' A' ' 63' ' ' ILE . 2.2 pt -86.3 -35.49 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 116.144 -2.222 . . . . 1.0 107.434 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.31 -25.24 35.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.832 1.301 . . . . 1.0 108.513 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.419 ' C ' HE21 ' A' ' 66' ' ' GLN . 11.6 ttt85 -62.45 -56.61 16.56 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.122 -1.399 . . . . 1.0 113.806 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.577 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.6 pp -69.6 -30.68 46.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 C-N-CA 118.684 -1.207 . . . . 1.0 111.363 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.9 tp -67.86 -35.17 78.08 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.213 -1.032 . . . . 1.0 108.213 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.514 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.83 -47.87 20.13 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 105.676 -1.972 . . . . 1.0 105.676 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 49.4 mt-30 -51.61 -41.05 60.96 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.967 0.889 . . . . 1.0 111.494 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt -76.3 -36.42 58.37 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.511 -1.276 . . . . 1.0 109.866 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.45 -27.18 67.32 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.308 -2.108 . . . . 1.0 105.308 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.479 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 14.6 m-30 -73.53 -48.52 32.5 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 105.728 -1.953 . . . . 1.0 105.728 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 mp -44.43 -43.37 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 124.026 0.829 . . . . 1.0 111.643 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.459 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 5.0 t60 -49.23 -48.46 45.58 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.058 0.932 . . . . 1.0 110.279 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -62.15 -20.15 63.8 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.345 -1.298 . . . . 1.0 112.684 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 24.3 mtt180 -86.72 -43.35 12.64 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 105.742 -1.948 . . . . 1.0 105.742 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.8 mt . . . . . 0 C--N 1.303 -1.418 0 CA-C-N 112.934 -1.939 . . . . 1.0 106.537 179.663 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 119.235 -0.412 . . . . 1.0 111.878 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -87.54 -26.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 116.222 -2.191 . . . . 1.0 108.426 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.92 -32.66 11.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.94 -1.104 . . . . 1.0 110.092 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.457 ' HG2' ' NE2' ' A' ' 66' ' ' GLN . 7.4 ttp180 -56.62 -53.88 52.53 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.697 -0.801 . . . . 1.0 112.407 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.631 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -71.91 -27.86 28.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 C-N-CA 119.224 -0.99 . . . . 1.0 112.634 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.631 ' N ' HD12 ' A' ' 63' ' ' ILE . 51.2 tp -70.82 -29.66 65.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.764 -1.198 . . . . 1.0 107.764 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -54.72 5.0 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 105.847 -1.909 . . . . 1.0 105.847 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.457 ' NE2' ' HG2' ' A' ' 62' ' ' ARG . 30.4 mt-30 -51.07 -37.95 48.71 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.177 -0.92 . . . . 1.0 112.198 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 70' ' ' ILE . 71.1 mt -81.63 -33.37 31.46 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.805 -1.158 . . . . 1.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.48 -18.95 62.98 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 104.856 -2.275 . . . . 1.0 104.856 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.431 ' HB2' ' NH1' ' A' ' 73' ' ' ARG . 18.5 m-30 -72.9 -36.96 67.41 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 117.608 -1.637 . . . . 1.0 108.835 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.568 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.1 mm -48.68 -41.25 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.699 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.469 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -51.17 -36.78 42.8 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -76.78 -20.12 56.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.278 -0.874 . . . . 1.0 111.967 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.431 ' NH1' ' HB2' ' A' ' 69' ' ' PHE . 39.2 mtt180 -91.95 -20.38 21.44 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.418 -1.327 . . . . 1.0 107.418 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.9 mt . . . . . 0 C--N 1.3 -1.548 0 CA-C-N 112.266 -2.243 . . . . 1.0 108.008 179.43 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 112.328 0.492 . . . . 1.0 112.328 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 pt -81.99 -35.85 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 116.828 -1.949 . . . . 1.0 105.816 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.07 -45.74 53.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 105.895 -1.891 . . . . 1.0 105.895 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.606 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 36.5 mmt180 -49.61 -41.44 42.23 Favored 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 118.805 -1.158 . . . . 1.0 113.656 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.556 ' N ' HD13 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -82.54 -27.88 8.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 CA-C-N 114.344 -1.298 . . . . 1.0 109.893 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -72.86 -32.11 65.21 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.264 -1.374 . . . . 1.0 108.786 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.606 ' NE2' ' HA ' ' A' ' 62' ' ' ARG . 6.3 mt-30 -73.31 -48.82 31.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.04 -1.837 . . . . 1.0 106.04 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -56.3 -52.77 63.32 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.12 -1.4 . . . . 1.0 111.287 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 61.3 mt -67.98 -27.36 66.51 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.695 -1.139 . . . . 1.0 111.185 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -71.4 -15.29 62.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 105.796 -1.927 . . . . 1.0 105.796 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -90.78 -49.24 6.56 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 123.569 1.652 . . . . 1.0 106.967 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.9 mt -57.03 -42.9 80.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 111.766 -2.47 . . . . 1.0 110.922 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -18.98 14.84 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.461 -0.895 . . . . 1.0 110.249 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -86.25 -25.33 25.61 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.579 1.181 . . . . 1.0 110.326 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -86.15 -28.87 23.7 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 113.014 -1.903 . . . . 1.0 108.156 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.9 mt . . . . . 0 C--N 1.297 -1.69 0 N-CA-C 100.439 -3.912 . . . . 1.0 100.439 178.916 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.953 0.406 . . . . 1.0 110.53 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.452 ' O ' HD12 ' A' ' 63' ' ' ILE . 2.4 pt -78.65 -30.03 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 C-N-CA 116.631 -2.028 . . . . 1.0 106.235 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 mm -63.76 -31.19 52.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 117.883 -1.527 . . . . 1.0 108.771 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.1 mmt-85 -61.9 -57.64 10.97 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.604 1.335 . . . . 1.0 114.604 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.5 pp -64.88 -31.63 54.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 C-N-CA 118.356 -1.338 . . . . 1.0 111.603 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 63' ' ' ILE . 35.8 tp -70.22 -35.21 73.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.677 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.86 -49.23 16.22 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 115.873 -2.331 . . . . 1.0 106.225 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.449 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 20.6 mt-30 -48.14 -43.72 31.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 113.712 -1.585 . . . . 1.0 111.94 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -81.88 -30.62 31.87 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.994 -1.457 . . . . 1.0 109.583 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.2 tp -70.28 -20.78 63.01 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 104.562 -2.385 . . . . 1.0 104.562 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 19.0 m-30 -63.25 -29.55 70.86 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.312 -1.355 . . . . 1.0 109.647 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.8 mm -56.97 -38.79 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 113.777 -1.556 . . . . 1.0 111.841 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -58.38 -22.94 55.58 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.377 -0.929 . . . . 1.0 108.74 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.417 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 2.6 t80 -88.4 -17.5 30.36 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.432 0.634 . . . . 1.0 110.735 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -96.31 -13.8 23.06 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--N 1.303 -1.451 0 CA-C-N 112.472 -2.149 . . . . 1.0 109.281 179.293 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 111.731 0.271 . . . . 1.0 111.731 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pt -82.74 -31.28 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 116.767 -1.973 . . . . 1.0 107.53 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.45 -32.27 36.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.364 -1.334 . . . . 1.0 110.231 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -53.57 -59.53 4.48 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.053 0.93 . . . . 1.0 113.266 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -76.97 -27.43 16.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 113.981 -1.463 . . . . 1.0 113.974 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 63' ' ' ILE . 31.1 tp -71.48 -27.87 63.54 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.418 ' O ' ' CD1' ' A' ' 69' ' ' PHE . 2.6 mp0 -90.25 -53.78 4.31 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 117.885 -1.526 . . . . 1.0 107.219 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -57.2 -36.07 70.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.578 -1.192 . . . . 1.0 111.998 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.616 ' HA ' HG12 ' A' ' 70' ' ' ILE . 87.5 mt -83.43 -30.92 26.92 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 117.707 -1.597 . . . . 1.0 112.234 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 tp -67.56 -21.77 65.43 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 104.406 -2.442 . . . . 1.0 104.406 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 65' ' ' GLN . 17.4 m-30 -70.2 -46.65 64.13 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 117.947 -1.501 . . . . 1.0 107.436 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.616 HG12 ' HA ' ' A' ' 67' ' ' LEU . 9.8 mm -49.46 -42.16 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 113.733 -1.576 . . . . 1.0 111.621 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.499 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -50.75 -40.3 54.31 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.663 0.744 . . . . 1.0 110.088 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -66.87 -27.91 67.9 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 123.21 1.481 . . . . 1.0 112.422 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HE ' ' HA ' ' A' ' 70' ' ' ILE . 18.0 mtm105 -79.13 -44.76 21.36 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 112.383 -2.189 . . . . 1.0 106.281 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.294 -1.839 0 CA-C-N 113.012 -1.904 . . . . 1.0 107.391 179.776 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.9 pt -73.77 -29.33 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 C-N-CA 116.288 -2.165 . . . . 1.0 106.075 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.524 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 4.0 mt -65.42 -24.09 34.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 117.703 -1.599 . . . . 1.0 108.919 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.434 ' C ' HE21 ' A' ' 66' ' ' GLN . 2.6 tpt180 -70.23 -29.61 66.47 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.63 2.085 . . . . 1.0 116.63 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.4 pp -101.99 -21.78 5.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 C-N-CA 117.47 -1.692 . . . . 1.0 108.642 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 63' ' ' ILE . 55.8 tp -77.05 -49.78 14.58 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 123.909 0.756 . . . . 1.0 112.545 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.524 ' NE2' ' HA ' ' A' ' 61' ' ' ILE . 2.9 mp0 -70.29 -36.27 74.24 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.052 -1.459 . . . . 1.0 107.961 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.434 HE21 ' C ' ' A' ' 62' ' ' ARG . 2.7 mp0 -66.54 -51.83 52.34 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 113.083 -1.871 . . . . 1.0 108.999 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.474 ' HA ' HD12 ' A' ' 70' ' ' ILE . 3.5 pp -67.98 -29.13 68.09 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 117.668 -1.613 . . . . 1.0 110.419 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -70.29 -19.91 63.06 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.189 -2.152 . . . . 1.0 105.189 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.521 ' CE1' ' HD2' ' A' ' 73' ' ' ARG . 2.2 t80 -81.66 -50.41 9.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.452 -1.684 . . . . 1.0 106.452 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 67' ' ' LEU . 39.3 mt -54.3 -41.83 54.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 112.476 -2.147 . . . . 1.0 109.142 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.8 OUTLIER -48.34 -44.72 34.56 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.068 0.937 . . . . 1.0 110.358 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.424 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 53.9 t80 -63.66 -23.43 67.37 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.258 -1.337 . . . . 1.0 113.058 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.521 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 14.9 mtp180 -85.52 -45.65 11.59 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 112.993 -1.912 . . . . 1.0 106.324 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.0 mt . . . . . 0 C--N 1.296 -1.728 0 CA-C-N 112.659 -2.064 . . . . 1.0 107.672 179.686 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.818 0.342 . . . . 1.0 110.148 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.405 ' O ' HD12 ' A' ' 63' ' ' ILE . 2.9 pt -80.6 -33.26 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 C-N-CA 116.984 -1.886 . . . . 1.0 105.917 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.3 mt -52.06 -29.72 12.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 114.471 -1.241 . . . . 1.0 108.719 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -66.48 -52.49 45.59 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.483 1.66 . . . . 1.0 115.483 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.7 pp -78.07 -28.24 15.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.233 -1.387 . . . . 1.0 111.983 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 63' ' ' ILE . 46.5 tp -68.05 -37.02 80.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.528 -1.286 . . . . 1.0 107.528 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.563 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.09 -51.47 12.17 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 117.527 -1.669 . . . . 1.0 106.661 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -49.93 -45.0 50.73 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.598 1.189 . . . . 1.0 111.99 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.0 mt -77.14 -31.87 55.94 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.63 -1.168 . . . . 1.0 111.8 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -67.51 -24.06 65.53 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 102.572 -3.122 . . . . 1.0 102.572 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -75.3 -51.88 12.17 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.003 -1.851 . . . . 1.0 106.003 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.58 -46.34 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 124.253 0.971 . . . . 1.0 111.485 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.485 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 2.7 t60 -46.19 -47.49 17.74 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.815 0.817 . . . . 1.0 112.064 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 58.1 t80 -64.77 -21.22 66.72 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.901 -1.5 . . . . 1.0 113.272 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -88.61 -44.62 10.49 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 104.975 -2.232 . . . . 1.0 104.975 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.8 mt . . . . . 0 C--N 1.296 -1.748 0 N-CA-C 105.109 -2.182 . . . . 1.0 105.109 179.611 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 119.391 -0.338 . . . . 1.0 111.859 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt -90.11 -25.84 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 C-N-CA 116.038 -2.265 . . . . 1.0 109.563 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.44 -30.16 6.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.387 -1.279 . . . . 1.0 109.24 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -55.76 -61.4 2.39 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.453 -1.299 . . . . 1.0 112.589 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -59.45 -30.52 44.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 114.836 -1.074 . . . . 1.0 113.454 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 63' ' ' ILE . 59.2 tp -72.67 -33.1 66.3 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.33 -0.989 . . . . 1.0 108.33 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.427 HE21 ' CA ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -78.17 -47.01 19.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 104.972 -2.232 . . . . 1.0 104.972 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 25.2 mt-30 -49.96 -50.23 47.45 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.734 1.254 . . . . 1.0 112.076 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.93 -29.56 60.99 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.177 -1.374 . . . . 1.0 111.727 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.2 tp -71.13 -22.43 62.07 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 103.469 -2.789 . . . . 1.0 103.469 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 66' ' ' GLN . 20.7 m-30 -69.2 -49.67 54.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.099 -1.815 . . . . 1.0 106.099 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.3 -44.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-N 114.228 -1.351 . . . . 1.0 111.38 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.459 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 1.4 t60 -50.27 -46.43 55.09 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.116 0.96 . . . . 1.0 111.963 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.439 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 85.2 t80 -61.42 -31.65 71.59 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 123.566 1.65 . . . . 1.0 112.589 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.5 mtt85 -76.43 -46.05 28.78 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 111.361 -2.654 . . . . 1.0 106.112 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 C--N 1.298 -1.651 0 CA-C-N 113.745 -1.571 . . . . 1.0 109.724 179.63 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 120.867 0.365 . . . . 1.0 110.29 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 pt -78.79 -32.89 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 105.62 -1.993 . . . . 1.0 105.62 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 65' ' ' GLN . 1.5 mt -56.89 -25.02 21.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.607 -1.179 . . . . 1.0 109.701 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.401 ' HG2' ' NE2' ' A' ' 66' ' ' GLN . 46.9 ttm-85 -66.62 -52.43 45.23 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 114.187 1.18 . . . . 1.0 114.187 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -81.35 -27.35 10.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 118.715 -1.194 . . . . 1.0 110.658 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 63' ' ' ILE . 43.1 tp -70.69 -30.03 66.49 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.641 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -84.15 -51.8 6.77 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 116.701 -2.0 . . . . 1.0 106.368 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.517 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 34.3 mt-30 -54.56 -45.19 73.43 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.1 -1.44 . . . . 1.0 113.406 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.2 mt -69.96 -32.66 71.01 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.593 -0.891 . . . . 1.0 108.593 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.466 ' O ' ' CD2' ' A' ' 71' ' ' HIS . 20.9 tp -66.99 -16.91 64.66 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 103.613 -2.736 . . . . 1.0 103.613 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 12.3 m-30 -88.44 -44.96 10.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 105.343 -2.095 . . . . 1.0 105.343 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 66' ' ' GLN . 5.5 mm -58.93 -36.84 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 119.147 -1.021 . . . . 1.0 112.829 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -57.28 -21.34 33.85 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.201 -1.4 . . . . 1.0 108.562 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -86.49 -17.45 34.15 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.111 0.957 . . . . 1.0 110.163 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -95.26 -16.41 22.48 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.228 -1.351 . . . . 1.0 107.358 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt . . . . . 0 C--N 1.298 -1.653 0 CA-C-N 112.378 -2.192 . . . . 1.0 106.431 179.116 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -86.83 -34.22 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 116.75 -1.98 . . . . 1.0 106.357 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.9 -24.52 36.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.253 -1.379 . . . . 1.0 110.963 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -69.35 -45.79 68.57 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 117.516 -1.674 . . . . 1.0 115.031 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -80.77 -29.67 11.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.101 -1.04 . . . . 1.0 111.876 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 63' ' ' ILE . 42.6 tp -71.23 -27.14 63.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.46 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -84.24 -53.76 5.27 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.204 -1.776 . . . . 1.0 106.204 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -53.06 -36.51 60.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.47 -1.292 . . . . 1.0 112.738 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.54 ' HA ' HG12 ' A' ' 70' ' ' ILE . 80.0 mt -80.75 -32.8 35.45 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.158 -1.017 . . . . 1.0 111.806 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -67.91 -21.79 65.11 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 104.252 -2.499 . . . . 1.0 104.252 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.462 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 17.6 m-30 -73.39 -48.22 35.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 117.506 -1.678 . . . . 1.0 107.91 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.54 HG12 ' HA ' ' A' ' 67' ' ' LEU . 7.1 mm -50.55 -41.04 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 114.517 -1.22 . . . . 1.0 111.497 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -48.59 -37.27 17.59 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.172 -0.611 . . . . 1.0 110.525 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.61 -21.33 48.66 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.645 -1.161 . . . . 1.0 111.425 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 22.5 mtp85 -86.56 -22.7 26.15 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 123.448 1.594 . . . . 1.0 107.275 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.9 mt . . . . . 0 C--N 1.3 -1.582 0 CA-C-N 111.606 -2.543 . . . . 1.0 106.839 179.639 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 121.237 0.541 . . . . 1.0 109.873 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 pt -75.96 -31.43 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 116.793 -1.963 . . . . 1.0 105.809 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mt -60.15 -23.43 27.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 118.215 -1.394 . . . . 1.0 109.019 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -76.0 -52.04 11.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 116.596 -2.042 . . . . 1.0 111.222 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.565 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.3 pp -70.83 -29.17 36.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 118.756 -1.178 . . . . 1.0 111.503 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 63' ' ' ILE . 30.9 tp -67.68 -31.36 71.28 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.547 -1.279 . . . . 1.0 107.547 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.625 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -81.87 -54.14 5.59 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 117.923 -1.511 . . . . 1.0 107.541 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.413 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 24.9 mt-30 -51.72 -38.06 53.61 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.325 -1.307 . . . . 1.0 112.658 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.571 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 64.3 mt -81.62 -37.04 28.2 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.863 -1.062 . . . . 1.0 108.559 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.3 tp -67.09 -14.29 62.76 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.439 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 18.2 m-30 -73.6 -36.61 65.53 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 117.305 -1.758 . . . . 1.0 107.121 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 67' ' ' LEU . 57.2 mt -45.35 -46.15 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 112.853 -1.976 . . . . 1.0 110.749 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.454 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 1.7 t60 -47.3 -43.85 22.9 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.988 0.899 . . . . 1.0 111.172 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.97 -28.65 69.06 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.808 -1.542 . . . . 1.0 112.21 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.534 HH21 ' N ' ' A' ' 70' ' ' ILE . 12.1 mtm180 -79.99 -38.52 31.99 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 113.293 -1.776 . . . . 1.0 107.76 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 mt . . . . . 0 C--N 1.302 -1.471 0 CA-C-N 113.28 -1.782 . . . . 1.0 109.276 179.889 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 119.527 -0.273 . . . . 1.0 111.625 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -83.98 -31.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 116.754 -1.978 . . . . 1.0 107.562 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.92 -28.68 24.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 117.13 -1.828 . . . . 1.0 109.884 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -59.29 -56.74 18.27 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 117.93 -1.508 . . . . 1.0 112.913 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -73.44 -28.21 24.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 63' ' ' ILE . 28.2 tp -70.02 -32.39 70.52 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.46 -53.81 5.43 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 117.911 -1.516 . . . . 1.0 107.652 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.464 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 23.9 mt-30 -51.28 -37.67 48.64 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.739 -1.118 . . . . 1.0 112.039 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.535 ' HA ' HD13 ' A' ' 70' ' ' ILE . 76.6 mt -84.75 -34.91 22.76 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 117.798 -1.561 . . . . 1.0 110.124 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp -65.67 -22.44 66.64 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 104.398 -2.445 . . . . 1.0 104.398 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 18.5 m-30 -60.21 -32.82 71.47 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 117.337 -1.745 . . . . 1.0 108.109 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 67' ' ' LEU . 1.6 mp -46.98 -42.12 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 C-N-CA 118.359 -1.337 . . . . 1.0 111.083 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.481 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.3 OUTLIER -52.5 -39.2 60.98 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.568 0.699 . . . . 1.0 110.924 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -75.14 -26.15 58.93 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.438 -1.255 . . . . 1.0 111.266 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 43.3 mtm180 -82.98 -24.65 32.83 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.734 -1.58 . . . . 1.0 106.734 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--N 1.303 -1.445 0 CA-C-N 113.94 -1.482 . . . . 1.0 111.09 179.576 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 111.721 0.267 . . . . 1.0 111.721 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 61' ' ' ILE . 3.9 pt -82.09 -38.47 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 105.47 -2.048 . . . . 1.0 105.47 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.44 ' N ' HG13 ' A' ' 60' ' ' ILE . 2.6 mt -52.7 -45.84 49.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 106.383 -1.71 . . . . 1.0 106.383 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.621 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 15.0 ttm180 -46.09 -36.42 5.78 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.41 -1.268 . . . . 1.0 110.465 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.522 ' N ' HD13 ' A' ' 63' ' ' ILE . 2.0 mm -91.41 -26.14 5.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.113 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.483 ' C ' HD12 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -69.76 -30.95 68.65 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.875 -1.53 . . . . 1.0 108.304 -179.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.621 ' NE2' ' HA ' ' A' ' 62' ' ' ARG . 1.9 pt20 -85.25 -47.85 9.67 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.109 -1.812 . . . . 1.0 106.109 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.508 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 29.6 mt-30 -54.1 -36.36 63.12 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 117.83 -1.548 . . . . 1.0 109.385 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.588 ' HA ' HG12 ' A' ' 70' ' ' ILE . 97.8 mt -81.43 -36.98 28.8 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.66 -1.216 . . . . 1.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.9 tp -66.35 -17.51 64.81 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 105.278 -2.119 . . . . 1.0 105.278 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 65' ' ' GLN . 19.4 m-30 -76.22 -32.68 59.07 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 117.869 -1.532 . . . . 1.0 109.065 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' A' ' 67' ' ' LEU . 19.4 mm -52.86 -41.48 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.51 -1.223 . . . . 1.0 114.174 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -24.18 48.64 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 117.972 -1.491 . . . . 1.0 109.007 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -83.65 -20.76 33.03 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.337 -0.945 . . . . 1.0 110.44 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -89.45 -18.61 26.42 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.443 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--N 1.302 -1.48 0 CA-C-N 112.881 -1.963 . . . . 1.0 111.153 179.5 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pt -76.6 -33.01 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 104.74 -2.318 . . . . 1.0 104.74 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 65' ' ' GLN . 1.6 mt -58.48 -37.74 66.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 118.373 -1.331 . . . . 1.0 107.563 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -56.04 -24.0 36.82 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.077 -1.449 . . . . 1.0 113.49 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.2 mm -95.15 -7.61 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 119.634 -0.827 . . . . 1.0 109.23 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.522 ' C ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.28 -45.39 5.62 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.933 -0.707 . . . . 1.0 109.552 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 61' ' ' ILE . 4.0 pp0? -68.79 -27.64 66.06 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 117.709 -1.596 . . . . 1.0 107.687 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -65.4 -61.43 2.11 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.256 -1.338 . . . . 1.0 108.501 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.2 mt -61.94 -32.12 72.51 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.474 -1.239 . . . . 1.0 111.391 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.484 ' O ' ' CD2' ' A' ' 71' ' ' HIS . 36.1 tp -70.38 -14.38 62.54 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.513 ' CD2' HD13 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -91.04 -45.87 8.46 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 105.234 -2.135 . . . . 1.0 105.234 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.513 HD13 ' CD2' ' A' ' 69' ' ' PHE . 9.9 mm -57.8 -37.21 58.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 118.239 -1.384 . . . . 1.0 111.411 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.484 ' CD2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -55.94 -20.39 15.97 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 118.478 -1.289 . . . . 1.0 109.585 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -85.18 -24.27 27.99 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.982 0.896 . . . . 1.0 109.694 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.457 ' HD3' ' CE1' ' A' ' 69' ' ' PHE . 17.3 mtm105 -90.23 -17.44 27.49 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.597 -1.26 . . . . 1.0 107.597 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.3 mt . . . . . 0 C--N 1.299 -1.612 0 CA-C-N 111.838 -2.437 . . . . 1.0 110.426 179.179 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 119.64 -0.219 . . . . 1.0 110.553 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -84.46 -36.95 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 116.165 -2.214 . . . . 1.0 107.474 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.98 -29.65 47.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 117.6 -1.64 . . . . 1.0 110.211 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -63.81 -54.19 38.97 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.207 -1.397 . . . . 1.0 114.239 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.578 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -73.59 -29.13 26.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 118.771 -1.172 . . . . 1.0 112.829 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 63' ' ' ILE . 39.9 tp -69.32 -30.23 68.24 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.417 ' NE2' ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -82.26 -52.41 6.97 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.166 -1.79 . . . . 1.0 106.166 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.475 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 50.8 mt-30 -50.22 -38.33 39.85 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.389 -0.823 . . . . 1.0 113.076 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 68.5 mt -84.15 -33.21 24.29 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.985 -1.007 . . . . 1.0 110.392 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.49 -15.0 61.8 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.035 -2.209 . . . . 1.0 105.035 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 17.4 m-30 -66.86 -37.21 84.01 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 116.823 -1.951 . . . . 1.0 107.716 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 67' ' ' LEU . 32.9 mt -48.31 -47.68 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 114.211 -1.359 . . . . 1.0 111.858 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.488 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -51.78 -34.44 39.79 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.061 0.457 . . . . 1.0 111.087 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.75 -13.42 56.35 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.141 -0.936 . . . . 1.0 111.671 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 49.1 mtm180 -101.02 -20.42 15.4 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.453 -1.249 . . . . 1.0 109.13 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--N 1.303 -1.435 0 CA-C-N 113.401 -1.727 . . . . 1.0 109.018 179.293 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 118.799 -0.619 . . . . 1.0 111.612 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 pt -94.57 -35.05 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 117.263 -1.775 . . . . 1.0 110.21 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.51 -23.21 22.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 113.743 -1.571 . . . . 1.0 108.272 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -73.61 -52.36 13.67 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 115.38 -2.528 . . . . 1.0 112.15 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.586 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.3 pp -70.66 -29.31 37.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 113.776 1.028 . . . . 1.0 113.776 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 63' ' ' ILE . 26.4 tp -68.87 -37.63 79.19 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.937 -1.505 . . . . 1.0 106.937 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -74.74 -48.15 27.3 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 117.24 -1.784 . . . . 1.0 106.617 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -52.04 -44.17 64.11 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.76 -1.109 . . . . 1.0 112.038 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HA ' HG12 ' A' ' 70' ' ' ILE . 3.6 pp -75.52 -37.65 59.95 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.67 -1.15 . . . . 1.0 109.279 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 67' ' ' LEU . 39.5 mt -67.11 -16.21 64.19 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.928 -1.879 . . . . 1.0 105.928 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.463 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 20.9 m-30 -73.55 -35.72 65.53 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.507 -1.677 . . . . 1.0 106.686 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.0 mm -53.25 -43.71 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.373 -1.285 . . . . 1.0 112.296 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.474 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -54.41 -28.61 44.95 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 120.066 1.303 . . . . 1.0 110.924 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.474 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 39.9 t80 -75.32 -29.68 60.08 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.756 1.265 . . . . 1.0 111.381 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -82.44 -38.64 23.71 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 113.46 -1.7 . . . . 1.0 108.149 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--N 1.3 -1.556 0 CA-C-N 113.141 -1.845 . . . . 1.0 106.794 179.495 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 112.023 0.379 . . . . 1.0 112.023 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 61' ' ' ILE . 4.8 pt -81.31 -35.03 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 106.533 -1.654 . . . . 1.0 106.533 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.427 ' HA ' HD23 ' A' ' 64' ' ' LEU . 1.7 mt -52.14 -43.47 38.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 112.842 -1.981 . . . . 1.0 105.82 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.721 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 81.6 mtm180 -51.86 -31.75 29.19 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 118.586 -1.246 . . . . 1.0 112.418 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.597 ' N ' HD13 ' A' ' 63' ' ' ILE . 1.4 mm -88.66 -17.62 8.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 114.455 -1.248 . . . . 1.0 110.791 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -83.44 -35.29 25.09 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.392 -1.323 . . . . 1.0 109.434 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.721 ' NE2' ' HA ' ' A' ' 62' ' ' ARG . 4.0 pt20 -76.01 -46.49 29.18 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 116.343 -2.143 . . . . 1.0 106.868 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.505 ' H ' ' HG2' ' A' ' 65' ' ' GLN . 35.9 mt-30 -49.71 -45.98 49.69 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.315 1.055 . . . . 1.0 112.514 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.546 ' HA ' HG12 ' A' ' 70' ' ' ILE . 89.1 mt -72.35 -40.13 67.58 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.957 -1.474 . . . . 1.0 110.033 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.7 mt -65.39 -15.3 62.45 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.822 -1.551 . . . . 1.0 107.019 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 21.0 m-30 -78.66 -39.19 37.54 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 106.92 -1.511 . . . . 1.0 106.92 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.3 mm -49.97 -40.47 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 114.607 -1.179 . . . . 1.0 111.235 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.474 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 1.4 t60 -50.25 -41.3 50.05 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.485 0.66 . . . . 1.0 109.705 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -66.6 -31.2 71.75 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 123.24 1.495 . . . . 1.0 111.81 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -73.62 -42.29 61.67 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 112.781 -2.009 . . . . 1.0 106.624 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.417 HD13 HG22 ' A' ' 70' ' ' ILE 0.259 1.1 mp . . . . . 0 C--N 1.296 -1.736 0 CA-C-N 113.82 -1.536 . . . . 1.0 107.245 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 119.462 -0.304 . . . . 1.0 110.597 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt -83.16 -28.93 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 C-N-CA 116.07 -2.252 . . . . 1.0 108.327 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.53 -31.39 42.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 114.028 -1.442 . . . . 1.0 109.298 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -50.03 -62.16 1.73 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.619 -1.173 . . . . 1.0 113.032 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -75.8 -27.85 18.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 113.173 -1.83 . . . . 1.0 113.589 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 63' ' ' ILE . 29.6 tp -70.31 -34.97 73.35 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.443 -1.318 . . . . 1.0 107.443 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -82.75 -53.38 5.94 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 116.551 -2.06 . . . . 1.0 108.062 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -52.16 -37.04 53.34 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.82 -1.082 . . . . 1.0 112.796 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.559 ' HA ' HG12 ' A' ' 70' ' ' ILE . 83.5 mt -82.28 -38.63 24.11 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.487 -1.285 . . . . 1.0 110.943 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 9.9 tt -62.86 -23.75 67.47 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.445 -2.058 . . . . 1.0 105.445 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -66.3 -35.26 79.92 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 117.635 -1.626 . . . . 1.0 109.363 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' A' ' 67' ' ' LEU . 12.6 mm -54.29 -38.19 39.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 113.453 -1.703 . . . . 1.0 113.103 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.431 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -60.15 -27.36 67.03 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 120.913 1.688 . . . . 1.0 109.188 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.431 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 58.4 t80 -73.86 -22.72 59.64 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.609 1.195 . . . . 1.0 110.422 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -85.97 -55.84 3.76 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 105.424 -2.065 . . . . 1.0 105.424 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--N 1.294 -1.839 0 CA-C-N 113.503 -1.68 . . . . 1.0 111.368 179.813 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 111.648 0.24 . . . . 1.0 111.648 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.424 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.7 pt -82.31 -29.83 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 117.061 -1.856 . . . . 1.0 106.83 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mt -61.71 -30.73 48.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.038 -1.437 . . . . 1.0 108.373 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -64.27 -55.83 18.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.43 -1.308 . . . . 1.0 114.228 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -69.7 -28.32 36.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 118.624 -1.23 . . . . 1.0 112.411 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 63' ' ' ILE . 29.0 tp -71.89 -33.28 68.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.542 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -79.41 -43.98 22.32 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 116.872 -1.931 . . . . 1.0 107.278 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.487 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 1.5 pt20 -54.42 -37.06 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.291 -0.963 . . . . 1.0 111.62 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.457 ' HG ' ' HG2' ' A' ' 66' ' ' GLN . 81.8 mt -82.77 -38.89 22.57 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.077 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.6 tp -66.21 -15.49 63.22 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 19.3 m-30 -69.76 -28.32 65.67 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 116.571 -2.052 . . . . 1.0 108.602 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.3 mt -53.44 -42.25 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 114.575 -1.193 . . . . 1.0 110.662 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.445 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -53.41 -32.37 49.32 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.606 0.717 . . . . 1.0 110.051 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -83.13 -18.19 40.38 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.576 -1.193 . . . . 1.0 111.151 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 53.5 mtm180 -96.35 -16.98 20.98 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.875 -1.157 . . . . 1.0 107.875 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 mt . . . . . 0 C--N 1.3 -1.545 0 CA-C-N 113.524 -1.671 . . . . 1.0 107.928 179.183 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.837 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 57.47 -17.99 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.643 0 N-CA-C 117.442 2.386 . . . . 1.0 117.442 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.93 115.65 7.74 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 108.473 -1.851 . . . . 1.0 108.473 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -28.0 -46.36 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 116.035 1.865 . . . . 1.0 116.035 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.8 p -70.84 -58.32 3.73 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.307 1.051 . . . . 1.0 111.453 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -63.06 -56.76 14.17 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.172 -1.376 . . . . 1.0 111.69 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.55 95.97 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 124.892 1.37 . . . . 1.0 109.854 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.76 -42.63 98.51 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 118.105 -1.998 . . . . 1.0 110.727 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.563 ' HA ' HG12 ' A' ' 60' ' ' ILE . 92.4 t -77.43 -32.0 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.584 -0.846 . . . . 1.0 111.832 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -71.93 -21.64 61.58 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.776 -0.824 . . . . 1.0 108.776 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.92 -38.87 22.23 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.756 -1.565 . . . . 1.0 110.785 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.563 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.6 pt -79.87 -32.94 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 106.676 -1.601 . . . . 1.0 106.676 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 1.3 mt -57.16 -28.1 29.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.185 -1.37 . . . . 1.0 109.227 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.447 ' C ' HE21 ' A' ' 66' ' ' GLN . 58.2 mtp180 -70.54 -51.68 26.98 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.574 -1.65 . . . . 1.0 114.746 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -72.79 -30.03 31.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 C-N-CA 118.314 -1.355 . . . . 1.0 111.489 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 63' ' ' ILE . 31.0 tp -69.32 -34.11 74.17 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.001 -0.741 . . . . 1.0 109.001 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.581 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -74.87 -53.86 8.32 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.587 -2.005 . . . . 1.0 105.587 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.447 HE21 ' C ' ' A' ' 62' ' ' ARG . 39.3 mt-30 -50.3 -39.77 46.52 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.431 -1.259 . . . . 1.0 111.61 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.544 ' HA ' HD13 ' A' ' 70' ' ' ILE . 69.5 mt -83.54 -20.88 33.07 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.563 -1.199 . . . . 1.0 110.431 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.408 ' O ' ' CD2' ' A' ' 71' ' ' HIS . 15.3 tp -84.58 -7.37 59.28 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 102.883 -3.006 . . . . 1.0 102.883 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 65' ' ' GLN . 17.6 m-30 -87.05 -37.23 17.64 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.434 -0.906 . . . . 1.0 110.169 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.544 HD13 ' HA ' ' A' ' 67' ' ' LEU . 1.1 pt -50.41 -37.78 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 118.831 -1.148 . . . . 1.0 113.365 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -55.14 -26.81 41.05 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 118.869 -1.132 . . . . 1.0 109.866 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.417 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 31.1 t80 -84.65 -17.75 37.56 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.988 0.899 . . . . 1.0 111.486 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -98.48 -15.58 19.54 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.462 -1.244 . . . . 1.0 108.635 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.4 mt -95.77 -54.4 7.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 112.578 -2.101 . . . . 1.0 109.223 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 77' ' ' ARG . . . -64.49 -65.51 2.95 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.354 -1.403 . . . . 1.0 110.642 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 39.3 m -59.84 9.81 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 114.35 1.241 . . . . 1.0 114.35 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.431 ' H ' ' C ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -128.06 -42.62 1.54 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -82.03 -32.76 30.31 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.184 -0.916 . . . . 1.0 113.307 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.8 t -127.46 33.67 4.81 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.664 1.357 . . . . 1.0 114.664 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.72 39.3 0.13 Allowed 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 119.85 -0.74 . . . . 1.0 111.6 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.2 mm -81.29 59.05 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.033 -1.042 . . . . 1.0 110.008 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.74 38.21 0.87 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.157 -1.977 . . . . 1.0 108.157 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.634 0 O-C-N 119.215 -2.344 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.825 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 62.44 -25.11 0.05 Allowed 'General case' 0 N--CA 1.512 2.636 0 N-CA-C 116.634 2.087 . . . . 1.0 116.634 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.69 139.05 34.37 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 109.562 -1.415 . . . . 1.0 109.562 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -27.53 -54.48 0.09 Allowed 'General case' 0 N--CA 1.511 2.624 0 N-CA-C 115.023 1.49 . . . . 1.0 115.023 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 p -70.73 -41.81 71.38 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.535 -0.757 . . . . 1.0 111.299 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -64.83 -56.78 11.39 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.512 -0.875 . . . . 1.0 109.699 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.18 87.59 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.119 -1.032 . . . . 1.0 108.472 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.8 -39.54 77.51 Favored Glycine 0 N--CA 1.494 2.526 0 CA-C-N 114.165 -1.379 . . . . 1.0 112.348 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.601 ' HA ' HG12 ' A' ' 60' ' ' ILE . 99.4 t -86.75 -39.39 13.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 120.135 -0.626 . . . . 1.0 110.909 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.36 -28.4 69.73 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.17 -30.39 54.87 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 114.227 -1.351 . . . . 1.0 110.746 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.601 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.2 pt -86.3 -35.49 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 116.144 -2.222 . . . . 1.0 107.434 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 1.0 OUTLIER -61.31 -25.24 35.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.832 1.301 . . . . 1.0 108.513 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.419 ' C ' HE21 ' A' ' 66' ' ' GLN . 11.6 ttt85 -62.45 -56.61 16.56 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.122 -1.399 . . . . 1.0 113.806 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.577 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.6 pp -69.6 -30.68 46.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 C-N-CA 118.684 -1.207 . . . . 1.0 111.363 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.9 tp -67.86 -35.17 78.08 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.213 -1.032 . . . . 1.0 108.213 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.514 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.83 -47.87 20.13 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 105.676 -1.972 . . . . 1.0 105.676 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 49.4 mt-30 -51.61 -41.05 60.96 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.967 0.889 . . . . 1.0 111.494 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt -76.3 -36.42 58.37 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.511 -1.276 . . . . 1.0 109.866 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.45 -27.18 67.32 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.308 -2.108 . . . . 1.0 105.308 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.479 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 14.6 m-30 -73.53 -48.52 32.5 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 105.728 -1.953 . . . . 1.0 105.728 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 mp -44.43 -43.37 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 124.026 0.829 . . . . 1.0 111.643 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.459 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 5.0 t60 -49.23 -48.46 45.58 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.058 0.932 . . . . 1.0 110.279 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -62.15 -20.15 63.8 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.345 -1.298 . . . . 1.0 112.684 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 24.3 mtt180 -86.72 -43.35 12.64 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 105.742 -1.948 . . . . 1.0 105.742 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.8 mt -58.24 -35.24 52.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 112.934 -1.939 . . . . 1.0 106.537 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.08 -58.15 4.11 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 107.11 -2.396 . . . . 1.0 107.11 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 50.4 t -47.01 -65.17 0.61 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 115.371 -0.414 . . . . 1.0 111.851 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -49.96 -29.25 8.09 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.372 -0.831 . . . . 1.0 111.635 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -104.38 -2.25 25.71 Favored 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 112.955 0.724 . . . . 1.0 112.955 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.8 t -118.4 13.51 13.58 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 123.49 0.494 . . . . 1.0 112.067 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.6 tpt85 -118.79 77.83 1.22 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 120.474 -0.49 . . . . 1.0 111.925 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.2 mt -118.21 33.28 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 CA-C-O 122.866 1.317 . . . . 1.0 108.95 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.49 -54.72 1.21 Allowed Glycine 0 N--CA 1.5 2.929 0 CA-C-N 113.955 -1.475 . . . . 1.0 111.895 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.697 0 O-C-N 118.049 -3.03 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.679 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -80.81 72.87 7.81 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.739 0.78 . . . . 1.0 110.584 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.63 170.56 37.39 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 108.5 -1.84 . . . . 1.0 108.5 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -90.28 -124.4 0.07 Allowed 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.291 -1.744 . . . . 1.0 106.291 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.3 m -31.56 -42.39 0.05 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.848 2.166 . . . . 1.0 116.848 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.414 ' CG ' ' N ' ' A' ' 55' ' ' ALA . 9.3 t-105 -65.72 -67.35 0.45 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.178 -1.409 . . . . 1.0 110.39 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 54' ' ' TRP . . . -51.94 -47.33 64.79 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.736 -1.574 . . . . 1.0 108.261 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -49.38 -42.06 33.17 Favored Glycine 0 N--CA 1.491 2.362 0 CA-C-N 112.934 -1.939 . . . . 1.0 109.819 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.587 ' HA ' HG12 ' A' ' 60' ' ' ILE . 60.3 t -79.95 -38.49 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 C-N-CA 119.034 -1.067 . . . . 1.0 112.305 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -31.18 70.8 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.792 -1.558 . . . . 1.0 106.792 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.9 -33.18 63.9 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 113.363 -1.744 . . . . 1.0 111.878 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.587 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.7 pt -87.54 -26.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 116.222 -2.191 . . . . 1.0 108.426 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -81.92 -32.66 11.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.94 -1.104 . . . . 1.0 110.092 179.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.457 ' HG2' ' NE2' ' A' ' 66' ' ' GLN . 7.4 ttp180 -56.62 -53.88 52.53 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.697 -0.801 . . . . 1.0 112.407 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.631 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -71.91 -27.86 28.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 C-N-CA 119.224 -0.99 . . . . 1.0 112.634 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.631 ' N ' HD12 ' A' ' 63' ' ' ILE . 51.2 tp -70.82 -29.66 65.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.764 -1.198 . . . . 1.0 107.764 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -54.72 5.0 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 105.847 -1.909 . . . . 1.0 105.847 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.457 ' NE2' ' HG2' ' A' ' 62' ' ' ARG . 30.4 mt-30 -51.07 -37.95 48.71 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.177 -0.92 . . . . 1.0 112.198 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 70' ' ' ILE . 71.1 mt -81.63 -33.37 31.46 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.805 -1.158 . . . . 1.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.48 -18.95 62.98 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 104.856 -2.275 . . . . 1.0 104.856 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.431 ' HB2' ' NH1' ' A' ' 73' ' ' ARG . 18.5 m-30 -72.9 -36.96 67.41 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 117.608 -1.637 . . . . 1.0 108.835 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.568 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.1 mm -48.68 -41.25 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.699 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.469 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -51.17 -36.78 42.8 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -76.78 -20.12 56.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.278 -0.874 . . . . 1.0 111.967 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.431 ' NH1' ' HB2' ' A' ' 69' ' ' PHE . 39.2 mtt180 -91.95 -20.38 21.44 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.418 -1.327 . . . . 1.0 107.418 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.9 mt -86.46 -58.92 3.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 112.266 -2.243 . . . . 1.0 108.008 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -45.94 -74.22 0.24 Allowed Glycine 0 N--CA 1.501 2.994 0 N-CA-C 117.199 1.64 . . . . 1.0 117.199 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 26.7 p -66.56 4.84 0.69 Allowed 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 116.18 1.919 . . . . 1.0 116.18 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -118.52 -40.97 2.85 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 122.784 1.278 . . . . 1.0 109.604 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -78.94 -24.1 44.2 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 112.545 -2.116 . . . . 1.0 108.25 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.6 t -122.29 -134.27 0.29 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 116.376 -0.374 . . . . 1.0 110.092 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 55.08 41.71 31.49 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 123.346 1.546 . . . . 1.0 107.778 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.6 mt -70.52 75.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 113.326 -1.761 . . . . 1.0 108.503 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.56 -32.42 61.21 Favored Glycine 0 N--CA 1.497 2.745 0 CA-C-N 115.283 -0.871 . . . . 1.0 112.22 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.563 0 O-C-N 118.167 -2.96 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.658 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 52' ' ' ASP . 83.4 m-85 66.91 -56.08 0.43 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 114.505 1.298 . . . . 1.0 114.505 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.25 11.73 1.41 Allowed Glycine 0 N--CA 1.505 3.247 0 C-N-CA 121.362 -0.447 . . . . 1.0 112.868 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -29.29 -60.25 0.14 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 113.609 0.966 . . . . 1.0 113.609 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.8 m -57.01 -38.27 72.88 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.624 0.972 . . . . 1.0 113.624 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 14.2 m95 -85.72 -52.1 6.0 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.541 -1.263 . . . . 1.0 112.257 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.38 -45.4 94.51 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.053 -1.43 . . . . 1.0 111.151 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.89 -43.36 99.31 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.676 -1.369 . . . . 1.0 109.676 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.625 ' HA ' HG12 ' A' ' 60' ' ' ILE . 96.3 t -75.87 -33.71 26.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 118.739 -1.184 . . . . 1.0 112.843 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.05 -30.63 67.94 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 105.047 -2.205 . . . . 1.0 105.047 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.37 -34.85 70.82 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.429 -1.26 . . . . 1.0 112.328 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.625 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.1 pt -81.99 -35.85 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 116.828 -1.949 . . . . 1.0 105.816 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.452 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -53.07 -45.74 53.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 105.895 -1.891 . . . . 1.0 105.895 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.606 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 36.5 mmt180 -49.61 -41.44 42.23 Favored 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 118.805 -1.158 . . . . 1.0 113.656 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.556 ' N ' HD13 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -82.54 -27.88 8.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 CA-C-N 114.344 -1.298 . . . . 1.0 109.893 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -72.86 -32.11 65.21 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.264 -1.374 . . . . 1.0 108.786 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.606 ' NE2' ' HA ' ' A' ' 62' ' ' ARG . 6.3 mt-30 -73.31 -48.82 31.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.04 -1.837 . . . . 1.0 106.04 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -56.3 -52.77 63.32 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.12 -1.4 . . . . 1.0 111.287 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 61.3 mt -67.98 -27.36 66.51 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.695 -1.139 . . . . 1.0 111.185 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -71.4 -15.29 62.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 105.796 -1.927 . . . . 1.0 105.796 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -90.78 -49.24 6.56 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 123.569 1.652 . . . . 1.0 106.967 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.9 mt -57.03 -42.9 80.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 111.766 -2.47 . . . . 1.0 110.922 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -18.98 14.84 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.461 -0.895 . . . . 1.0 110.249 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -86.25 -25.33 25.61 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.579 1.181 . . . . 1.0 110.326 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -86.15 -28.87 23.7 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 113.014 -1.903 . . . . 1.0 108.156 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.9 mt -81.28 -57.35 4.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 100.439 -3.912 . . . . 1.0 100.439 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -43.41 -70.31 0.55 Allowed Glycine 0 N--CA 1.494 2.514 0 CA-C-N 113.279 -1.782 . . . . 1.0 114.221 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.7 m -50.41 -48.32 56.2 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 122.155 0.979 . . . . 1.0 112.502 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.446 ' N ' ' HD2' ' A' ' 77' ' ' ARG . 3.0 mpt_? -65.62 -28.73 69.33 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.296 -1.32 . . . . 1.0 112.509 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -55.39 -23.07 22.56 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.638 0.732 . . . . 1.0 111.075 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.0 t -134.27 28.2 3.75 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.065 -1.425 . . . . 1.0 107.94 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.8 ptt85 32.83 44.28 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 122.469 1.128 . . . . 1.0 113.301 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.62 83.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-N 113.922 -1.49 . . . . 1.0 107.216 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.9 26.35 24.63 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 106.249 -2.741 . . . . 1.0 106.249 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.577 0 O-C-N 119.221 -2.34 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.847 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.9 t80 53.18 23.41 3.08 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 122.132 0.968 . . . . 1.0 110.86 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.48 52.54 2.3 Favored Glycine 0 N--CA 1.499 2.836 0 CA-C-O 119.248 -0.751 . . . . 1.0 112.58 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -41.21 -60.88 1.13 Allowed 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 117.714 0.757 . . . . 1.0 112.166 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.2 m -57.49 -30.15 64.86 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.483 -0.781 . . . . 1.0 112.214 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -63.51 -52.93 59.12 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.914 -1.143 . . . . 1.0 107.914 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.6 -43.51 72.23 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 112.466 -2.152 . . . . 1.0 109.163 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.15 -38.77 95.64 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 118.486 -1.816 . . . . 1.0 111.482 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.587 ' HA ' HG12 ' A' ' 60' ' ' ILE . 96.1 t -80.01 -31.23 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 116.445 2.017 . . . . 1.0 116.445 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.96 -27.48 66.63 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.88 -42.51 57.74 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 112.54 -2.118 . . . . 1.0 110.53 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.587 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.4 pt -78.65 -30.03 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 C-N-CA 116.631 -2.028 . . . . 1.0 106.235 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 1.9 mm -63.76 -31.19 52.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 117.883 -1.527 . . . . 1.0 108.771 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.1 mmt-85 -61.9 -57.64 10.97 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.604 1.335 . . . . 1.0 114.604 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.5 pp -64.88 -31.63 54.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 C-N-CA 118.356 -1.338 . . . . 1.0 111.603 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 63' ' ' ILE . 35.8 tp -70.22 -35.21 73.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.677 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.86 -49.23 16.22 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 115.873 -2.331 . . . . 1.0 106.225 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.449 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 20.6 mt-30 -48.14 -43.72 31.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 113.712 -1.585 . . . . 1.0 111.94 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -81.88 -30.62 31.87 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.994 -1.457 . . . . 1.0 109.583 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.2 tp -70.28 -20.78 63.01 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 104.562 -2.385 . . . . 1.0 104.562 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 19.0 m-30 -63.25 -29.55 70.86 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.312 -1.355 . . . . 1.0 109.647 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.8 mm -56.97 -38.79 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 113.777 -1.556 . . . . 1.0 111.841 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -58.38 -22.94 55.58 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.377 -0.929 . . . . 1.0 108.74 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.417 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 2.6 t80 -88.4 -17.5 30.36 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.432 0.634 . . . . 1.0 110.735 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -96.31 -13.8 23.06 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mt -100.93 -59.44 3.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 112.472 -2.149 . . . . 1.0 109.281 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.55 -68.42 1.67 Allowed Glycine 0 N--CA 1.491 2.358 0 CA-C-N 115.717 -0.674 . . . . 1.0 112.334 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -53.14 -34.18 55.7 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.213 -0.995 . . . . 1.0 111.409 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.6 ttm-85 -76.71 -29.31 56.19 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.318 -0.953 . . . . 1.0 112.469 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.406 ' O ' ' CB ' ' A' ' 79' ' ' SER . 38.4 t-80 -38.14 -45.93 0.99 Allowed 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 112.878 0.696 . . . . 1.0 112.878 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 78' ' ' HIS . 33.0 t 134.26 123.76 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 105.669 -1.975 . . . . 1.0 105.669 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -177.57 69.01 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 106.646 -1.613 . . . . 1.0 106.646 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 22.0 pt -123.65 147.9 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.22 -63.11 1.02 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 110.341 -1.104 . . . . 1.0 110.341 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.687 0 O-C-N 118.086 -3.008 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.732 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 43.69 31.74 0.49 Allowed 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 114.816 1.414 . . . . 1.0 114.816 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.47 14.7 43.14 Favored Glycine 0 N--CA 1.505 3.284 0 C-N-CA 120.679 -0.772 . . . . 1.0 112.956 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -39.82 -47.92 2.19 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 113.022 0.749 . . . . 1.0 113.022 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 m -61.14 -35.93 78.4 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.484 -0.487 . . . . 1.0 112.196 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -83.42 -54.78 4.72 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 118.346 -1.342 . . . . 1.0 109.769 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.42 -51.08 70.99 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.158 0.98 . . . . 1.0 110.035 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.89 -39.04 76.88 Favored Glycine 0 N--CA 1.49 2.253 0 CA-C-N 113.657 -1.611 . . . . 1.0 112.004 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 60' ' ' ILE . 89.3 t -85.06 -36.28 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 118.848 -1.141 . . . . 1.0 111.758 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 5.5 mm-40 -64.64 -31.6 72.9 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 105.409 -2.071 . . . . 1.0 105.409 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.97 -37.06 72.76 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 113.705 -1.589 . . . . 1.0 111.731 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.574 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.3 pt -82.74 -31.28 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 116.767 -1.973 . . . . 1.0 107.53 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -73.45 -32.27 36.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.364 -1.334 . . . . 1.0 110.231 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 19.5 mmt180 -53.57 -59.53 4.48 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.053 0.93 . . . . 1.0 113.266 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -76.97 -27.43 16.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 113.981 -1.463 . . . . 1.0 113.974 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 63' ' ' ILE . 31.1 tp -71.48 -27.87 63.54 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.418 ' O ' ' CD1' ' A' ' 69' ' ' PHE . 2.6 mp0 -90.25 -53.78 4.31 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 117.885 -1.526 . . . . 1.0 107.219 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -57.2 -36.07 70.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.578 -1.192 . . . . 1.0 111.998 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.616 ' HA ' HG12 ' A' ' 70' ' ' ILE . 87.5 mt -83.43 -30.92 26.92 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 117.707 -1.597 . . . . 1.0 112.234 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 tp -67.56 -21.77 65.43 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 104.406 -2.442 . . . . 1.0 104.406 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 65' ' ' GLN . 17.4 m-30 -70.2 -46.65 64.13 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 117.947 -1.501 . . . . 1.0 107.436 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.616 HG12 ' HA ' ' A' ' 67' ' ' LEU . 9.8 mm -49.46 -42.16 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 113.733 -1.576 . . . . 1.0 111.621 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.499 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -50.75 -40.3 54.31 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.663 0.744 . . . . 1.0 110.088 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -66.87 -27.91 67.9 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 123.21 1.481 . . . . 1.0 112.422 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HE ' ' HA ' ' A' ' 70' ' ' ILE . 18.0 mtm105 -79.13 -44.76 21.36 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 112.383 -2.189 . . . . 1.0 106.281 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.4 mt -57.3 -53.25 46.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 113.012 -1.904 . . . . 1.0 107.391 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.55 -56.32 23.85 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 120.575 -0.821 . . . . 1.0 111.725 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 53.3 t -59.92 -35.69 75.43 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.001 1.112 . . . . 1.0 114.001 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -84.08 -29.09 27.09 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 112.983 0.734 . . . . 1.0 112.983 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.4 ' O ' HG13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -35.66 -44.66 0.33 Allowed 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 114.893 1.442 . . . . 1.0 114.893 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.2 m 51.8 42.57 30.06 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 114.971 1.471 . . . . 1.0 114.971 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 53.89 64.23 1.91 Allowed 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 118.204 2.668 . . . . 1.0 118.204 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 78' ' ' HIS . 49.3 mt -86.31 135.47 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 106.884 -1.525 . . . . 1.0 106.884 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.56 -176.36 44.67 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 105.574 -3.01 . . . . 1.0 105.574 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.792 0 O-C-N 119.123 -2.398 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.804 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -107.61 -27.51 10.3 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 112.805 0.668 . . . . 1.0 112.805 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.05 115.08 3.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.024 -1.231 . . . . 1.0 110.024 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -135.54 -120.58 0.16 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.061 -1.829 . . . . 1.0 106.061 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -47.15 -41.84 18.49 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 113.969 1.1 . . . . 1.0 113.969 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.459 ' CD2' ' N ' ' A' ' 55' ' ' ALA . 39.9 p-90 -71.06 -43.28 68.12 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.169 -1.012 . . . . 1.0 111.7 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.459 ' N ' ' CD2' ' A' ' 54' ' ' TRP . . . -65.36 -40.87 94.1 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.58 -1.637 . . . . 1.0 106.58 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.23 -47.32 91.66 Favored Glycine 0 N--CA 1.489 2.218 0 CA-C-N 113.587 -1.642 . . . . 1.0 110.757 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.593 ' HA ' HG12 ' A' ' 60' ' ' ILE . 3.6 p -72.18 -34.12 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 117.307 -1.757 . . . . 1.0 110.089 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -68.86 -27.0 65.42 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.349 -0.982 . . . . 1.0 108.349 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.59 -44.17 19.4 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 112.92 -1.945 . . . . 1.0 109.816 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.593 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.9 pt -73.77 -29.33 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 C-N-CA 116.288 -2.165 . . . . 1.0 106.075 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.524 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 4.0 mt -65.42 -24.09 34.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 117.703 -1.599 . . . . 1.0 108.919 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.434 ' C ' HE21 ' A' ' 66' ' ' GLN . 2.6 tpt180 -70.23 -29.61 66.47 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.63 2.085 . . . . 1.0 116.63 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.4 pp -101.99 -21.78 5.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 C-N-CA 117.47 -1.692 . . . . 1.0 108.642 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 63' ' ' ILE . 55.8 tp -77.05 -49.78 14.58 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 123.909 0.756 . . . . 1.0 112.545 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.524 ' NE2' ' HA ' ' A' ' 61' ' ' ILE . 2.9 mp0 -70.29 -36.27 74.24 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.052 -1.459 . . . . 1.0 107.961 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.434 HE21 ' C ' ' A' ' 62' ' ' ARG . 2.7 mp0 -66.54 -51.83 52.34 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 113.083 -1.871 . . . . 1.0 108.999 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.474 ' HA ' HD12 ' A' ' 70' ' ' ILE . 3.5 pp -67.98 -29.13 68.09 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 117.668 -1.613 . . . . 1.0 110.419 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -70.29 -19.91 63.06 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.189 -2.152 . . . . 1.0 105.189 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.521 ' CE1' ' HD2' ' A' ' 73' ' ' ARG . 2.2 t80 -81.66 -50.41 9.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.452 -1.684 . . . . 1.0 106.452 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 67' ' ' LEU . 39.3 mt -54.3 -41.83 54.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 112.476 -2.147 . . . . 1.0 109.142 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.8 OUTLIER -48.34 -44.72 34.56 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.068 0.937 . . . . 1.0 110.358 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.424 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 53.9 t80 -63.66 -23.43 67.37 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.258 -1.337 . . . . 1.0 113.058 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.521 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 14.9 mtp180 -85.52 -45.65 11.59 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 112.993 -1.912 . . . . 1.0 106.324 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.0 mt -55.67 -48.29 77.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 112.659 -2.064 . . . . 1.0 107.672 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.59 -63.19 5.54 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 120.577 -0.821 . . . . 1.0 112.072 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 73' ' ' ARG . 26.5 p -55.64 -41.2 73.21 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.987 -0.685 . . . . 1.0 111.438 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -71.08 -26.83 63.23 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.188 -1.405 . . . . 1.0 109.284 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.487 ' O ' ' HB2' ' A' ' 79' ' ' SER . 29.1 t-80 -73.67 -62.96 1.31 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.444 -1.302 . . . . 1.0 108.177 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' ' 78' ' ' HIS . 11.0 t 168.91 92.32 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 113.58 0.955 . . . . 1.0 113.58 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.558 ' HA ' ' NE ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -116.94 27.86 8.88 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.539 1.161 . . . . 1.0 111.392 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 81' ' ' ILE . 5.0 mp -87.99 77.45 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 106.203 -1.777 . . . . 1.0 106.203 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.35 -64.19 2.11 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 107.404 -2.279 . . . . 1.0 107.404 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.632 0 O-C-N 118.026 -3.043 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.826 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.2 t80 73.55 -43.61 0.56 Allowed 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 113.027 0.751 . . . . 1.0 113.027 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -177.83 86.56 0.07 OUTLIER Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.552 -1.019 . . . . 1.0 110.552 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -125.79 -114.84 0.28 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.752 -0.779 . . . . 1.0 109.172 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 m -33.49 -35.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 115.731 1.752 . . . . 1.0 115.731 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -65.28 -54.03 35.19 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.933 -1.136 . . . . 1.0 107.933 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.2 -49.13 68.33 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 113.085 -1.87 . . . . 1.0 108.757 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -50.91 -44.64 49.96 Favored Glycine 0 N--CA 1.5 2.96 0 CA-C-N 115.18 -0.918 . . . . 1.0 111.698 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.611 ' HA ' HG12 ' A' ' 60' ' ' ILE . 91.0 t -80.91 -32.75 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 119.42 -0.912 . . . . 1.0 111.138 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -71.59 -21.65 61.83 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.935 -1.506 . . . . 1.0 106.935 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.34 -36.75 29.3 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.954 -1.021 . . . . 1.0 110.148 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.611 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.9 pt -80.6 -33.26 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 C-N-CA 116.984 -1.886 . . . . 1.0 105.917 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.3 mt -52.06 -29.72 12.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 114.471 -1.241 . . . . 1.0 108.719 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -66.48 -52.49 45.59 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.483 1.66 . . . . 1.0 115.483 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.7 pp -78.07 -28.24 15.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.233 -1.387 . . . . 1.0 111.983 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 63' ' ' ILE . 46.5 tp -68.05 -37.02 80.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.528 -1.286 . . . . 1.0 107.528 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.563 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.09 -51.47 12.17 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 117.527 -1.669 . . . . 1.0 106.661 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -49.93 -45.0 50.73 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.598 1.189 . . . . 1.0 111.99 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.0 mt -77.14 -31.87 55.94 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.63 -1.168 . . . . 1.0 111.8 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -67.51 -24.06 65.53 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 102.572 -3.122 . . . . 1.0 102.572 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -75.3 -51.88 12.17 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.003 -1.851 . . . . 1.0 106.003 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.58 -46.34 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 124.253 0.971 . . . . 1.0 111.485 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.485 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 2.7 t60 -46.19 -47.49 17.74 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.815 0.817 . . . . 1.0 112.064 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 58.1 t80 -64.77 -21.22 66.72 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.901 -1.5 . . . . 1.0 113.272 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -88.61 -44.62 10.49 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 104.975 -2.232 . . . . 1.0 104.975 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.513 ' O ' ' ND1' ' A' ' 78' ' ' HIS . 16.8 mt -60.83 -35.68 66.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 105.109 -2.182 . . . . 1.0 105.109 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.74 -73.81 0.83 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.763 -1.735 . . . . 1.0 108.763 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 78.1 m -49.22 -36.12 19.14 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 115.992 1.849 . . . . 1.0 115.992 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -87.46 -15.58 37.26 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.457 0.91 . . . . 1.0 113.457 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -50.21 -52.13 38.41 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 113.496 0.924 . . . . 1.0 113.496 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.9 t 170.01 155.07 0.05 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.814 -1.55 . . . . 1.0 106.814 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.04 30.55 3.03 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 111.642 -2.526 . . . . 1.0 105.861 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.4 pt 42.36 -123.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 114.732 1.382 . . . . 1.0 114.732 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.75 -161.29 35.07 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 105.551 -3.02 . . . . 1.0 105.551 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.784 0 O-C-N 119.214 -2.345 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.875 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 58.82 20.24 7.77 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-O 121.781 0.8 . . . . 1.0 109.724 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.04 140.72 13.31 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 106.353 -2.699 . . . . 1.0 106.353 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -132.97 -102.07 0.26 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.249 -1.389 . . . . 1.0 107.249 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.9 p -60.49 -48.71 80.57 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 119.603 1.092 . . . . 1.0 112.879 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.93 -63.56 1.03 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 114.081 -1.418 . . . . 1.0 109.17 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.49 95.24 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.027 -1.442 . . . . 1.0 109.007 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.29 -37.71 48.18 Favored Glycine 0 N--CA 1.491 2.365 0 CA-C-N 114.403 -1.271 . . . . 1.0 110.559 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.563 ' HA ' HG12 ' A' ' 60' ' ' ILE . 78.1 t -91.94 -39.68 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.312 -0.955 . . . . 1.0 111.838 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -59.5 -29.54 67.93 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 118.084 -1.446 . . . . 1.0 107.801 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.3 -30.32 48.32 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.128 -1.396 . . . . 1.0 111.859 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.563 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.8 pt -90.11 -25.84 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 C-N-CA 116.038 -2.265 . . . . 1.0 109.563 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -85.44 -30.16 6.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.387 -1.279 . . . . 1.0 109.24 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -55.76 -61.4 2.39 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.453 -1.299 . . . . 1.0 112.589 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -59.45 -30.52 44.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 114.836 -1.074 . . . . 1.0 113.454 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 63' ' ' ILE . 59.2 tp -72.67 -33.1 66.3 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.33 -0.989 . . . . 1.0 108.33 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.427 HE21 ' CA ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -78.17 -47.01 19.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 104.972 -2.232 . . . . 1.0 104.972 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 25.2 mt-30 -49.96 -50.23 47.45 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.734 1.254 . . . . 1.0 112.076 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.93 -29.56 60.99 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.177 -1.374 . . . . 1.0 111.727 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.2 tp -71.13 -22.43 62.07 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 103.469 -2.789 . . . . 1.0 103.469 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 66' ' ' GLN . 20.7 m-30 -69.2 -49.67 54.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.099 -1.815 . . . . 1.0 106.099 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.3 -44.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-N 114.228 -1.351 . . . . 1.0 111.38 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.459 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 1.4 t60 -50.27 -46.43 55.09 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.116 0.96 . . . . 1.0 111.963 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.439 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 85.2 t80 -61.42 -31.65 71.59 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 123.566 1.65 . . . . 1.0 112.589 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.5 mtt85 -76.43 -46.05 28.78 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 111.361 -2.654 . . . . 1.0 106.112 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mt -55.73 -52.59 46.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 113.745 -1.571 . . . . 1.0 109.724 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.69 -58.06 16.54 Favored Glycine 0 N--CA 1.5 2.924 0 C-N-CA 120.346 -0.931 . . . . 1.0 112.558 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 48.6 t -55.47 -51.11 68.05 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 118.929 -1.108 . . . . 1.0 110.005 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -60.95 -27.77 68.48 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.909 -1.496 . . . . 1.0 110.912 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.422 ' O ' ' CB ' ' A' ' 79' ' ' SER . 51.6 t-80 -69.95 -25.9 63.87 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 123.84 0.712 . . . . 1.0 109.549 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 78' ' ' HIS . 5.4 t 83.0 74.37 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.481 1.134 . . . . 1.0 108.122 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -110.31 76.75 1.0 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.641 -0.708 . . . . 1.0 110.949 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.9 pt -139.17 167.54 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.319 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.28 80.8 0.08 OUTLIER Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.281 -1.127 . . . . 1.0 110.281 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.651 0 O-C-N 118.203 -2.939 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.747 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -73.64 49.71 0.31 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.339 0.496 . . . . 1.0 112.339 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.51 78.33 0.86 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 106.036 -2.826 . . . . 1.0 106.036 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -88.83 -73.56 0.5 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.873 1.434 . . . . 1.0 114.873 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.8 m -50.64 -60.43 3.04 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 117.685 2.476 . . . . 1.0 117.685 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -65.1 -60.56 2.89 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.153 -1.019 . . . . 1.0 113.386 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.56 89.04 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.635 -0.826 . . . . 1.0 109.475 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.91 -41.13 99.62 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 118.509 -1.805 . . . . 1.0 110.937 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.602 ' HA ' HG12 ' A' ' 60' ' ' ILE . 72.0 t -80.28 -33.72 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 119.385 -0.926 . . . . 1.0 111.296 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -71.62 -22.46 61.7 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.395 -1.335 . . . . 1.0 107.395 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.28 -37.75 23.07 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.818 -1.083 . . . . 1.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.602 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.5 pt -78.79 -32.89 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 105.62 -1.993 . . . . 1.0 105.62 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 1.5 mt -56.89 -25.02 21.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.607 -1.179 . . . . 1.0 109.701 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.401 ' HG2' ' NE2' ' A' ' 66' ' ' GLN . 46.9 ttm-85 -66.62 -52.43 45.23 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 114.187 1.18 . . . . 1.0 114.187 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -81.35 -27.35 10.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 118.715 -1.194 . . . . 1.0 110.658 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 63' ' ' ILE . 43.1 tp -70.69 -30.03 66.49 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.641 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -84.15 -51.8 6.77 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 116.701 -2.0 . . . . 1.0 106.368 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.517 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 34.3 mt-30 -54.56 -45.19 73.43 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.1 -1.44 . . . . 1.0 113.406 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.2 mt -69.96 -32.66 71.01 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.593 -0.891 . . . . 1.0 108.593 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.466 ' O ' ' CD2' ' A' ' 71' ' ' HIS . 20.9 tp -66.99 -16.91 64.66 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 103.613 -2.736 . . . . 1.0 103.613 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 12.3 m-30 -88.44 -44.96 10.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 105.343 -2.095 . . . . 1.0 105.343 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 66' ' ' GLN . 5.5 mm -58.93 -36.84 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 119.147 -1.021 . . . . 1.0 112.829 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -57.28 -21.34 33.85 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.201 -1.4 . . . . 1.0 108.562 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -86.49 -17.45 34.15 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.111 0.957 . . . . 1.0 110.163 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -95.26 -16.41 22.48 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.228 -1.351 . . . . 1.0 107.358 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.7 mt -94.39 -64.84 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 112.378 -2.192 . . . . 1.0 106.431 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -53.18 -71.68 0.65 Allowed Glycine 0 N--CA 1.495 2.569 0 C-N-CA 120.755 -0.736 . . . . 1.0 114.402 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 37.0 t -54.7 -13.06 0.89 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.312 -0.944 . . . . 1.0 113.187 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -103.33 -29.5 11.2 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.607 -0.437 . . . . 1.0 110.912 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -30.07 70.16 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.858 -1.164 . . . . 1.0 107.858 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 t 78.51 105.22 0.07 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 126.136 2.148 . . . . 1.0 111.664 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -55.65 -13.75 1.81 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 114.419 1.266 . . . . 1.0 114.419 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.6 mm -81.96 56.98 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 122.127 0.965 . . . . 1.0 108.761 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.43 60.06 2.4 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.136 -1.186 . . . . 1.0 110.136 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.658 0 O-C-N 118.714 -2.639 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.743 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 64.15 -69.89 0.08 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 124.577 1.173 . . . . 1.0 113.356 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.1 84.53 0.71 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.637 -1.385 . . . . 1.0 109.637 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -27.04 -58.04 0.09 Allowed 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 115.85 1.796 . . . . 1.0 115.85 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.2 t -61.0 -41.95 97.5 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 119.862 -0.735 . . . . 1.0 110.889 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -61.1 -49.32 77.77 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.31 -40.47 77.93 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.695 -1.593 . . . . 1.0 107.705 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.94 -43.45 98.88 Favored Glycine 0 N--CA 1.497 2.756 0 C-N-CA 118.881 -1.628 . . . . 1.0 110.168 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.57 ' HA ' HG12 ' A' ' 60' ' ' ILE . 92.5 t -70.51 -34.41 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 119.705 -0.798 . . . . 1.0 111.053 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.61 -13.6 62.46 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.172 -1.048 . . . . 1.0 108.172 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.82 -29.62 15.88 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.518 -1.219 . . . . 1.0 109.86 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.7 pt -86.83 -34.22 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 116.75 -1.98 . . . . 1.0 106.357 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 1.2 mp -62.9 -24.52 36.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.253 -1.379 . . . . 1.0 110.963 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -69.35 -45.79 68.57 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 117.516 -1.674 . . . . 1.0 115.031 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -80.77 -29.67 11.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 C-N-CA 119.101 -1.04 . . . . 1.0 111.876 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 63' ' ' ILE . 42.6 tp -71.23 -27.14 63.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.46 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -84.24 -53.76 5.27 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.204 -1.776 . . . . 1.0 106.204 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -53.06 -36.51 60.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.47 -1.292 . . . . 1.0 112.738 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.54 ' HA ' HG12 ' A' ' 70' ' ' ILE . 80.0 mt -80.75 -32.8 35.45 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.158 -1.017 . . . . 1.0 111.806 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -67.91 -21.79 65.11 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 104.252 -2.499 . . . . 1.0 104.252 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.462 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 17.6 m-30 -73.39 -48.22 35.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 117.506 -1.678 . . . . 1.0 107.91 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.54 HG12 ' HA ' ' A' ' 67' ' ' LEU . 7.1 mm -50.55 -41.04 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 114.517 -1.22 . . . . 1.0 111.497 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -48.59 -37.27 17.59 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.172 -0.611 . . . . 1.0 110.525 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.61 -21.33 48.66 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.645 -1.161 . . . . 1.0 111.425 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 22.5 mtp85 -86.56 -22.7 26.15 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 123.448 1.594 . . . . 1.0 107.275 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.9 mt -84.59 -70.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 111.606 -2.543 . . . . 1.0 106.839 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -33.89 -77.52 0.04 OUTLIER Glycine 0 N--CA 1.502 3.045 0 N-CA-C 116.149 1.22 . . . . 1.0 116.149 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 66.4 m -55.64 -30.21 60.58 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.098 1.518 . . . . 1.0 115.098 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -81.34 -25.89 36.02 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.123 -1.065 . . . . 1.0 108.123 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -85.47 -68.55 0.72 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 114.605 -1.18 . . . . 1.0 113.59 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.7 m -162.59 117.62 1.82 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.991 -1.114 . . . . 1.0 107.991 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -159.81 -66.45 0.07 Allowed 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 118.757 -1.177 . . . . 1.0 112.879 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.0 mt -143.56 165.34 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 107.645 -1.242 . . . . 1.0 107.645 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.94 157.27 29.48 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 105.142 -3.183 . . . . 1.0 105.142 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.786 0 O-C-N 118.864 -2.551 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.876 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 41.2 39.25 0.89 Allowed 'General case' 0 N--CA 1.51 2.537 0 CA-C-O 122.401 1.096 . . . . 1.0 112.033 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.58 73.99 0.01 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 116.295 1.278 . . . . 1.0 116.295 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -47.32 -34.15 6.5 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 112.324 0.49 . . . . 1.0 112.324 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.2 m -58.68 -33.74 70.47 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.722 -1.191 . . . . 1.0 109.459 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -90.39 -55.11 3.72 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.49 -0.777 . . . . 1.0 108.945 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.55 -46.93 83.31 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 124.322 1.014 . . . . 1.0 113.501 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.74 -41.53 97.58 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.778 -1.329 . . . . 1.0 109.778 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.598 ' HA ' HG12 ' A' ' 60' ' ' ILE . 97.8 t -73.44 -33.44 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 118.301 -1.36 . . . . 1.0 110.154 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -72.47 -21.06 61.28 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.61 -40.56 16.1 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 113.95 -1.477 . . . . 1.0 109.873 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.598 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.0 pt -75.96 -31.43 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 116.793 -1.963 . . . . 1.0 105.809 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 1.8 mt -60.15 -23.43 27.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 118.215 -1.394 . . . . 1.0 109.019 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -76.0 -52.04 11.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 116.596 -2.042 . . . . 1.0 111.222 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.565 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.3 pp -70.83 -29.17 36.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 118.756 -1.178 . . . . 1.0 111.503 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 63' ' ' ILE . 30.9 tp -67.68 -31.36 71.28 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.547 -1.279 . . . . 1.0 107.547 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.625 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -81.87 -54.14 5.59 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 117.923 -1.511 . . . . 1.0 107.541 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.413 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 24.9 mt-30 -51.72 -38.06 53.61 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.325 -1.307 . . . . 1.0 112.658 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.571 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 64.3 mt -81.62 -37.04 28.2 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.863 -1.062 . . . . 1.0 108.559 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.3 tp -67.09 -14.29 62.76 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.439 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 18.2 m-30 -73.6 -36.61 65.53 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 117.305 -1.758 . . . . 1.0 107.121 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 67' ' ' LEU . 57.2 mt -45.35 -46.15 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 112.853 -1.976 . . . . 1.0 110.749 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.454 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 1.7 t60 -47.3 -43.85 22.9 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.988 0.899 . . . . 1.0 111.172 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -65.97 -28.65 69.06 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.808 -1.542 . . . . 1.0 112.21 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.534 HH21 ' N ' ' A' ' 70' ' ' ILE . 12.1 mtm180 -79.99 -38.52 31.99 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 113.293 -1.776 . . . . 1.0 107.76 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.554 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 3.6 mt -65.31 -46.81 89.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 113.28 -1.782 . . . . 1.0 109.276 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.32 -56.91 22.53 Favored Glycine 0 N--CA 1.501 3.01 0 N-CA-C 108.281 -1.928 . . . . 1.0 108.281 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 74.2 m -53.18 -44.34 67.81 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.459 -0.871 . . . . 1.0 112.397 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.554 ' HG2' ' HA ' ' A' ' 74' ' ' ILE . 9.6 ptm180 -70.99 -13.06 61.87 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 118.924 -1.11 . . . . 1.0 112.972 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -81.28 -47.37 13.44 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.887 -1.125 . . . . 1.0 113.16 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.543 ' HG ' ' N ' ' A' ' 83' ' ' NH2 . 24.4 t 164.76 -46.15 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.801 0 CA-C-O 121.346 0.593 . . . . 1.0 110.95 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 48.48 58.27 5.39 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 113.971 -1.468 . . . . 1.0 110.398 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.1 mt 72.03 15.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-N 114.017 -1.447 . . . . 1.0 110.276 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.13 -11.64 62.81 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.351 -1.1 . . . . 1.0 110.351 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . 0.543 ' N ' ' HG ' ' A' ' 79' ' ' SER . . . . . . . . 0 C--N 1.299 -1.598 0 O-C-N 118.681 -2.658 . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.686 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -80.76 52.49 1.72 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.686 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.24 79.76 0.03 OUTLIER Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.01 -1.566 . . . . 1.0 113.004 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -125.55 -119.4 0.27 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 105.022 -2.214 . . . . 1.0 105.022 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t -50.77 -32.94 21.33 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 119.305 0.957 . . . . 1.0 111.626 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -67.63 -36.59 81.1 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.706 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.18 -36.68 82.28 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.268 -1.012 . . . . 1.0 108.268 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.76 -42.69 16.4 Favored Glycine 0 N--CA 1.498 2.788 0 C-N-CA 118.089 -2.005 . . . . 1.0 112.482 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.556 ' HA ' HG12 ' A' ' 60' ' ' ILE . 85.4 t -78.21 -35.5 19.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 115.993 1.849 . . . . 1.0 115.993 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -64.38 -31.79 73.14 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.145 -1.798 . . . . 1.0 106.145 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.87 -38.55 76.43 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 111.903 -2.408 . . . . 1.0 111.625 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.556 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.9 pt -83.98 -31.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 116.754 -1.978 . . . . 1.0 107.562 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -73.92 -28.68 24.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 117.13 -1.828 . . . . 1.0 109.884 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -59.29 -56.74 18.27 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 117.93 -1.508 . . . . 1.0 112.913 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.8 pp -73.44 -28.21 24.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 63' ' ' ILE . 28.2 tp -70.02 -32.39 70.52 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.46 -53.81 5.43 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 117.911 -1.516 . . . . 1.0 107.652 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.464 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 23.9 mt-30 -51.28 -37.67 48.64 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.739 -1.118 . . . . 1.0 112.039 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.535 ' HA ' HD13 ' A' ' 70' ' ' ILE . 76.6 mt -84.75 -34.91 22.76 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 117.798 -1.561 . . . . 1.0 110.124 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp -65.67 -22.44 66.64 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 104.398 -2.445 . . . . 1.0 104.398 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 18.5 m-30 -60.21 -32.82 71.47 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 117.337 -1.745 . . . . 1.0 108.109 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 67' ' ' LEU . 1.6 mp -46.98 -42.12 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 C-N-CA 118.359 -1.337 . . . . 1.0 111.083 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.481 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.3 OUTLIER -52.5 -39.2 60.98 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.568 0.699 . . . . 1.0 110.924 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -75.14 -26.15 58.93 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.438 -1.255 . . . . 1.0 111.266 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 43.3 mtm180 -82.98 -24.65 32.83 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.734 -1.58 . . . . 1.0 106.734 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mt -80.72 -58.55 3.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 113.94 -1.482 . . . . 1.0 111.09 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -47.09 -35.25 8.44 Favored Glycine 0 N--CA 1.506 3.314 0 CA-C-O 121.414 0.452 . . . . 1.0 112.338 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.7 m -77.99 -66.8 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.559 -1.32 . . . . 1.0 110.26 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -51.91 -48.08 64.32 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.269 1.211 . . . . 1.0 114.269 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -49.41 -63.3 1.15 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 125.218 1.574 . . . . 1.0 112.208 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 64.9 p -171.67 40.77 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.982 -1.087 . . . . 1.0 110.583 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? 31.5 68.62 0.12 Allowed 'General case' 0 N--CA 1.509 2.515 0 O-C-N 124.95 1.406 . . . . 1.0 110.452 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.425 ' C ' HD12 ' A' ' 81' ' ' ILE . 2.1 pp -95.85 -164.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 114.712 1.375 . . . . 1.0 114.712 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.37 -81.24 0.68 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.859 -1.696 . . . . 1.0 108.859 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.657 0 O-C-N 119.078 -2.425 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.758 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -78.61 -35.46 45.62 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 112.891 0.7 . . . . 1.0 112.891 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.13 -19.55 0.02 OUTLIER Glycine 0 N--CA 1.511 3.658 0 N-CA-C 117.725 1.85 . . . . 1.0 117.725 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -36.21 -45.38 0.45 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.434 1.642 . . . . 1.0 115.434 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.3 m -62.81 -26.43 68.73 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 113.523 0.935 . . . . 1.0 113.523 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 -76.91 -68.67 0.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 106.739 -1.578 . . . . 1.0 106.739 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.2 -55.26 10.88 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 112.128 -2.306 . . . . 1.0 111.096 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.18 -30.45 31.7 Favored Glycine 0 N--CA 1.496 2.642 0 CA-C-N 113.869 -1.514 . . . . 1.0 112.632 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.621 ' HA ' HG12 ' A' ' 60' ' ' ILE . 97.9 t -96.1 -28.29 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 118.815 -1.154 . . . . 1.0 112.44 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -71.69 -29.89 65.08 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 105.127 -2.175 . . . . 1.0 105.127 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.98 79.09 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 113.397 -1.729 . . . . 1.0 111.721 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.621 HG12 ' HA ' ' A' ' 57' ' ' VAL . 3.9 pt -82.09 -38.47 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 105.47 -2.048 . . . . 1.0 105.47 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.44 ' N ' HG13 ' A' ' 60' ' ' ILE . 2.6 mt -52.7 -45.84 49.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 106.383 -1.71 . . . . 1.0 106.383 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.621 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 15.0 ttm180 -46.09 -36.42 5.78 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.41 -1.268 . . . . 1.0 110.465 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.522 ' N ' HD13 ' A' ' 63' ' ' ILE . 2.0 mm -91.41 -26.14 5.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.113 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.483 ' C ' HD12 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -69.76 -30.95 68.65 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.875 -1.53 . . . . 1.0 108.304 -179.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.621 ' NE2' ' HA ' ' A' ' 62' ' ' ARG . 1.9 pt20 -85.25 -47.85 9.67 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.109 -1.812 . . . . 1.0 106.109 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.508 ' N ' ' HG2' ' A' ' 65' ' ' GLN . 29.6 mt-30 -54.1 -36.36 63.12 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 117.83 -1.548 . . . . 1.0 109.385 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.588 ' HA ' HG12 ' A' ' 70' ' ' ILE . 97.8 mt -81.43 -36.98 28.8 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.66 -1.216 . . . . 1.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.9 tp -66.35 -17.51 64.81 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 105.278 -2.119 . . . . 1.0 105.278 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 65' ' ' GLN . 19.4 m-30 -76.22 -32.68 59.07 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 117.869 -1.532 . . . . 1.0 109.065 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' A' ' 67' ' ' LEU . 19.4 mm -52.86 -41.48 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.51 -1.223 . . . . 1.0 114.174 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -24.18 48.64 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 117.972 -1.491 . . . . 1.0 109.007 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -83.65 -20.76 33.03 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.337 -0.945 . . . . 1.0 110.44 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -89.45 -18.61 26.42 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.443 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.4 mp -95.2 -61.93 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 112.881 -1.963 . . . . 1.0 111.153 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.84 -67.48 2.18 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 120.0 -1.095 . . . . 1.0 112.218 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 78.8 m -56.61 -13.87 2.75 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.37 0.878 . . . . 1.0 113.37 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.6 ttm-85 -102.97 -15.95 15.97 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.233 -0.987 . . . . 1.0 110.415 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -53.21 -73.02 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.446 1.276 . . . . 1.0 114.446 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.2 t 153.35 -165.47 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.273 1 N-CA-C 99.366 -4.309 . . . . 1.0 99.366 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.85 58.09 2.27 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.366 -0.833 . . . . 1.0 110.053 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.7 mm 44.27 49.57 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 CA-C-O 122.315 1.055 . . . . 1.0 111.79 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.8 -97.36 0.43 Allowed Glycine 0 N--CA 1.498 2.804 0 C-N-CA 120.093 -1.051 . . . . 1.0 110.704 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.636 0 O-C-N 118.396 -2.826 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.682 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -78.06 53.45 1.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.064 0.935 . . . . 1.0 111.497 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.36 72.07 0.39 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 107.246 -2.342 . . . . 1.0 107.246 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -102.05 -123.4 0.18 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.7 t -42.16 -35.81 1.03 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.832 1.79 . . . . 1.0 115.832 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.449 ' HA ' HG12 ' A' ' 57' ' ' VAL . 27.1 p-90 -75.79 -38.96 57.74 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 117.436 -1.706 . . . . 1.0 108.19 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.35 -39.25 92.12 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.492 -1.283 . . . . 1.0 108.618 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.6 -44.71 39.21 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.731 -1.223 . . . . 1.0 111.616 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.532 ' HA ' HG12 ' A' ' 60' ' ' ILE . 2.1 p -70.71 -32.47 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 118.356 -1.338 . . . . 1.0 109.783 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.35 -21.49 61.3 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.982 -1.087 . . . . 1.0 108.842 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.15 -40.22 18.46 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 113.736 -1.575 . . . . 1.0 109.732 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.532 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.3 pt -76.6 -33.01 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 104.74 -2.318 . . . . 1.0 104.74 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 65' ' ' GLN . 1.6 mt -58.48 -37.74 66.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 118.373 -1.331 . . . . 1.0 107.563 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -56.04 -24.0 36.82 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.077 -1.449 . . . . 1.0 113.49 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.2 mm -95.15 -7.61 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 119.634 -0.827 . . . . 1.0 109.23 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.522 ' C ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.28 -45.39 5.62 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.933 -0.707 . . . . 1.0 109.552 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 61' ' ' ILE . 4.0 pp0? -68.79 -27.64 66.06 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 117.709 -1.596 . . . . 1.0 107.687 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -65.4 -61.43 2.11 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.256 -1.338 . . . . 1.0 108.501 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.2 mt -61.94 -32.12 72.51 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.474 -1.239 . . . . 1.0 111.391 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.484 ' O ' ' CD2' ' A' ' 71' ' ' HIS . 36.1 tp -70.38 -14.38 62.54 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.513 ' CD2' HD13 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -91.04 -45.87 8.46 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 105.234 -2.135 . . . . 1.0 105.234 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.513 HD13 ' CD2' ' A' ' 69' ' ' PHE . 9.9 mm -57.8 -37.21 58.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 118.239 -1.384 . . . . 1.0 111.411 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.484 ' CD2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -55.94 -20.39 15.97 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 118.478 -1.289 . . . . 1.0 109.585 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -85.18 -24.27 27.99 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.982 0.896 . . . . 1.0 109.694 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.457 ' HD3' ' CE1' ' A' ' 69' ' ' PHE . 17.3 mtm105 -90.23 -17.44 27.49 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.597 -1.26 . . . . 1.0 107.597 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.3 mt -91.28 -59.25 3.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 111.838 -2.437 . . . . 1.0 110.426 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.72 -57.4 11.18 Favored Glycine 0 N--CA 1.506 3.329 0 N-CA-C 116.267 1.267 . . . . 1.0 116.267 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 63.7 m -56.97 -33.68 67.3 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.826 -0.687 . . . . 1.0 110.016 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.535 ' HA ' ' NE ' ' A' ' 77' ' ' ARG . 1.1 tpm_? -83.67 -37.88 22.21 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.129 -1.028 . . . . 1.0 109.07 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.54 ' ND1' ' OG ' ' A' ' 79' ' ' SER . 29.4 t-80 -57.67 -43.53 85.07 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 123.651 0.594 . . . . 1.0 109.907 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.54 ' OG ' ' ND1' ' A' ' 78' ' ' HIS . 6.3 p 161.43 -1.02 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 117.079 2.252 . . . . 1.0 117.079 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -50.92 -35.77 34.98 Favored 'General case' 0 N--CA 1.507 2.412 0 C-N-CA 118.169 -1.412 . . . . 1.0 111.648 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 37.0 pt -114.65 41.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.275 -1.75 . . . . 1.0 106.275 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.63 -61.71 4.45 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.477 -2.249 . . . . 1.0 107.477 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.684 0 O-C-N 119.394 -2.239 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.828 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -128.19 72.1 1.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.99 27.56 0.04 OUTLIER Glycine 0 N--CA 1.506 3.353 0 C-N-CA 120.005 -1.093 . . . . 1.0 113.399 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -42.26 -57.55 2.51 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 112.881 0.697 . . . . 1.0 112.881 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -55.44 -31.13 61.67 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.114 0.783 . . . . 1.0 113.114 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -65.58 -58.73 5.06 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.927 -1.508 . . . . 1.0 106.927 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.72 -48.74 58.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 111.866 -2.424 . . . . 1.0 108.787 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.85 -36.99 67.93 Favored Glycine 0 N--CA 1.494 2.538 0 CA-C-N 114.081 -1.418 . . . . 1.0 111.176 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.529 ' HA ' HG12 ' A' ' 60' ' ' ILE . 59.9 t -79.97 -33.02 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 114.699 1.37 . . . . 1.0 114.699 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -65.55 -29.38 69.99 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 116.656 -2.018 . . . . 1.0 107.231 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.05 -36.45 79.9 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 112.069 -2.332 . . . . 1.0 110.553 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.5 pt -84.46 -36.95 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 116.165 -2.214 . . . . 1.0 107.474 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -65.98 -29.65 47.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 117.6 -1.64 . . . . 1.0 110.211 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -63.81 -54.19 38.97 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.207 -1.397 . . . . 1.0 114.239 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.578 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -73.59 -29.13 26.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 118.771 -1.172 . . . . 1.0 112.829 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 63' ' ' ILE . 39.9 tp -69.32 -30.23 68.24 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.417 ' NE2' ' N ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -82.26 -52.41 6.97 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.166 -1.79 . . . . 1.0 106.166 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.475 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 50.8 mt-30 -50.22 -38.33 39.85 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.389 -0.823 . . . . 1.0 113.076 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 68.5 mt -84.15 -33.21 24.29 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.985 -1.007 . . . . 1.0 110.392 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.49 -15.0 61.8 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.035 -2.209 . . . . 1.0 105.035 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 17.4 m-30 -66.86 -37.21 84.01 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 116.823 -1.951 . . . . 1.0 107.716 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 67' ' ' LEU . 32.9 mt -48.31 -47.68 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 114.211 -1.359 . . . . 1.0 111.858 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.488 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -51.78 -34.44 39.79 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.061 0.457 . . . . 1.0 111.087 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.75 -13.42 56.35 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.141 -0.936 . . . . 1.0 111.671 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 49.1 mtm180 -101.02 -20.42 15.4 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.453 -1.249 . . . . 1.0 109.13 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 mt -95.69 -45.98 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 113.401 -1.727 . . . . 1.0 109.018 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -43.19 -62.97 2.21 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 121.329 -0.463 . . . . 1.0 112.686 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 24.7 p -56.44 -25.88 51.92 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 112.975 0.732 . . . . 1.0 112.975 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.1 mtp-105 -90.77 -13.71 33.44 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.56 -0.745 . . . . 1.0 111.528 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.444 ' ND1' ' C ' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -72.29 -17.34 61.88 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.926 -1.11 . . . . 1.0 111.191 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 t 174.63 119.63 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 123.287 0.367 . . . . 1.0 110.836 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -161.62 95.94 1.02 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.853 -0.739 . . . . 1.0 109.04 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 81' ' ' ILE . 2.6 mp -97.14 152.85 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 104.371 -2.455 . . . . 1.0 104.371 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 176.92 173.09 42.17 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 104.939 -3.264 . . . . 1.0 104.939 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.837 0 O-C-N 118.93 -2.512 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.722 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 35.8 t80 71.73 -54.05 0.68 Allowed 'General case' 0 N--CA 1.508 2.449 0 O-C-N 124.265 0.978 . . . . 1.0 111.904 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.65 123.91 7.14 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 106.234 -2.746 . . . . 1.0 106.234 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -108.66 -100.29 0.38 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 117.363 0.582 . . . . 1.0 110.198 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.6 t -45.95 -32.33 2.66 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 113.686 0.995 . . . . 1.0 113.686 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -58.64 -50.81 72.47 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.542 -0.863 . . . . 1.0 110.873 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.16 -42.78 68.67 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.89 -32.47 62.28 Favored Glycine 0 N--CA 1.494 2.554 0 CA-C-N 113.425 -1.716 . . . . 1.0 112.861 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.552 ' HA ' HG12 ' A' ' 60' ' ' ILE . 87.9 t -98.53 -42.63 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 113.087 0.773 . . . . 1.0 113.087 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.4 ' HA ' HG22 ' A' ' 61' ' ' ILE . 7.4 mm-40 -59.79 -28.08 67.11 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.453 -1.299 . . . . 1.0 108.34 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.31 -25.95 51.74 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.93 -1.486 . . . . 1.0 111.612 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.552 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.8 pt -94.57 -35.05 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 117.263 -1.775 . . . . 1.0 110.21 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -71.51 -23.21 22.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 113.743 -1.571 . . . . 1.0 108.272 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -73.61 -52.36 13.67 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 115.38 -2.528 . . . . 1.0 112.15 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.586 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.3 pp -70.66 -29.31 37.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 113.776 1.028 . . . . 1.0 113.776 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 63' ' ' ILE . 26.4 tp -68.87 -37.63 79.19 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.937 -1.505 . . . . 1.0 106.937 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -74.74 -48.15 27.3 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 117.24 -1.784 . . . . 1.0 106.617 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -52.04 -44.17 64.11 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.76 -1.109 . . . . 1.0 112.038 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HA ' HG12 ' A' ' 70' ' ' ILE . 3.6 pp -75.52 -37.65 59.95 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.67 -1.15 . . . . 1.0 109.279 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 67' ' ' LEU . 39.5 mt -67.11 -16.21 64.19 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 105.928 -1.879 . . . . 1.0 105.928 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.463 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 20.9 m-30 -73.55 -35.72 65.53 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.507 -1.677 . . . . 1.0 106.686 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.0 mm -53.25 -43.71 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-N 114.373 -1.285 . . . . 1.0 112.296 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.474 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -54.41 -28.61 44.95 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 120.066 1.303 . . . . 1.0 110.924 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.474 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 39.9 t80 -75.32 -29.68 60.08 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.756 1.265 . . . . 1.0 111.381 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -82.44 -38.64 23.71 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 113.46 -1.7 . . . . 1.0 108.149 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.58 -50.24 72.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 113.141 -1.845 . . . . 1.0 106.794 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -50.83 -51.69 33.06 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.468 -1.349 . . . . 1.0 109.744 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 53.2 t -46.83 -59.29 3.16 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.815 0.817 . . . . 1.0 111.181 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -53.95 -37.74 64.22 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.691 -1.14 . . . . 1.0 112.658 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -84.74 -11.23 56.24 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 118.79 -1.164 . . . . 1.0 109.595 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.9 t -89.56 -25.2 21.48 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 114.333 1.234 . . . . 1.0 114.333 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.0 ttm105 -115.88 57.67 0.75 Allowed 'General case' 0 N--CA 1.507 2.414 0 CA-C-N 119.356 0.98 . . . . 1.0 110.574 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.6 pt -140.72 173.46 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 120.077 -0.649 . . . . 1.0 111.62 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.25 -165.77 32.5 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 104.289 -3.525 . . . . 1.0 104.289 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.733 0 O-C-N 118.865 -2.55 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.875 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 49.72 34.02 6.88 Favored 'General case' 0 N--CA 1.507 2.418 0 CA-C-O 122.255 1.026 . . . . 1.0 109.281 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -127.75 133.12 7.71 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 105.461 -3.056 . . . . 1.0 105.461 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -114.55 -73.46 0.65 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.528 -1.286 . . . . 1.0 107.528 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.6 p -56.82 -42.6 79.89 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.709 -1.132 . . . . 1.0 110.793 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -62.95 -61.11 2.62 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 123.068 1.413 . . . . 1.0 109.971 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.09 -42.44 38.87 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 111.976 -2.375 . . . . 1.0 108.816 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.15 -38.55 72.78 Favored Glycine 0 N--CA 1.488 2.144 0 CA-C-N 113.958 -1.474 . . . . 1.0 112.251 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.629 ' HA ' HG12 ' A' ' 60' ' ' ILE . 1.8 p -73.5 -35.29 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 117.339 -1.744 . . . . 1.0 113.11 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -68.08 -28.79 67.66 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 117.287 -1.765 . . . . 1.0 107.538 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.72 -37.34 73.5 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 112.744 -2.026 . . . . 1.0 112.023 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.629 HG12 ' HA ' ' A' ' 57' ' ' VAL . 4.8 pt -81.31 -35.03 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 106.533 -1.654 . . . . 1.0 106.533 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.427 ' HA ' HD23 ' A' ' 64' ' ' LEU . 1.7 mt -52.14 -43.47 38.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 112.842 -1.981 . . . . 1.0 105.82 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.721 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 81.6 mtm180 -51.86 -31.75 29.19 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 118.586 -1.246 . . . . 1.0 112.418 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.597 ' N ' HD13 ' A' ' 63' ' ' ILE . 1.4 mm -88.66 -17.62 8.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 114.455 -1.248 . . . . 1.0 110.791 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -83.44 -35.29 25.09 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.392 -1.323 . . . . 1.0 109.434 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.721 ' NE2' ' HA ' ' A' ' 62' ' ' ARG . 4.0 pt20 -76.01 -46.49 29.18 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 116.343 -2.143 . . . . 1.0 106.868 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.505 ' H ' ' HG2' ' A' ' 65' ' ' GLN . 35.9 mt-30 -49.71 -45.98 49.69 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.315 1.055 . . . . 1.0 112.514 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.546 ' HA ' HG12 ' A' ' 70' ' ' ILE . 89.1 mt -72.35 -40.13 67.58 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.957 -1.474 . . . . 1.0 110.033 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.7 mt -65.39 -15.3 62.45 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 117.822 -1.551 . . . . 1.0 107.019 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 21.0 m-30 -78.66 -39.19 37.54 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 106.92 -1.511 . . . . 1.0 106.92 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.3 mm -49.97 -40.47 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 114.607 -1.179 . . . . 1.0 111.235 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.474 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 1.4 t60 -50.25 -41.3 50.05 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.485 0.66 . . . . 1.0 109.705 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -66.6 -31.2 71.75 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 123.24 1.495 . . . . 1.0 111.81 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -73.62 -42.29 61.67 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 112.781 -2.009 . . . . 1.0 106.624 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.417 HD13 HG22 ' A' ' 70' ' ' ILE 0.259 1.1 mp -60.85 -55.97 21.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 113.82 -1.536 . . . . 1.0 107.245 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.26 -51.81 48.44 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 109.608 -1.397 . . . . 1.0 109.608 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 52.1 t -50.43 -53.95 25.64 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 114.801 -0.699 . . . . 1.0 110.33 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -30.7 61.05 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.641 -0.709 . . . . 1.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -76.1 -9.54 58.71 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 118.872 -1.131 . . . . 1.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.1 t 54.6 14.25 0.81 Allowed 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 115.44 1.644 . . . . 1.0 115.44 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.4 mtp-105 -64.99 -22.45 67.0 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 119.663 -0.815 . . . . 1.0 112.097 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.9 tt -62.16 74.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 123.01 1.386 . . . . 1.0 111.415 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 162.99 -24.19 0.2 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.021 -1.631 . . . . 1.0 109.021 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.508 0 O-C-N 118.731 -2.629 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.764 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -77.44 57.55 1.55 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 122.272 1.034 . . . . 1.0 109.525 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.18 -114.7 5.7 Favored Glycine 0 N--CA 1.493 2.488 0 CA-C-N 115.272 -0.876 . . . . 1.0 112.355 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.4 t0 69.35 -62.78 0.4 Allowed 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 124.827 1.251 . . . . 1.0 110.32 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.0 p -69.69 -59.99 2.6 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-N 114.714 -1.13 . . . . 1.0 111.477 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.475 ' CG ' ' N ' ' A' ' 55' ' ' ALA . 6.7 t-105 -44.01 -71.91 0.07 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.215 -1.812 . . . . 1.0 110.045 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.475 ' N ' ' CG ' ' A' ' 54' ' ' TRP . . . -52.54 -40.11 62.14 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 112.315 -2.221 . . . . 1.0 107.939 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.62 -36.35 70.96 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 114.316 -1.311 . . . . 1.0 110.002 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.56 ' HA ' HG12 ' A' ' 60' ' ' ILE . 95.5 t -78.61 -39.39 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.788 -0.765 . . . . 1.0 110.544 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -29.38 70.25 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 118.325 -1.35 . . . . 1.0 107.684 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.5 -37.09 63.23 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.208 -2.269 . . . . 1.0 110.597 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.56 HG12 ' HA ' ' A' ' 57' ' ' VAL . 2.2 pt -83.16 -28.93 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 C-N-CA 116.07 -2.252 . . . . 1.0 108.327 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -71.53 -31.39 42.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 114.028 -1.442 . . . . 1.0 109.298 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -50.03 -62.16 1.73 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.619 -1.173 . . . . 1.0 113.032 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 64' ' ' LEU . 2.0 pp -75.8 -27.85 18.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 113.173 -1.83 . . . . 1.0 113.589 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 63' ' ' ILE . 29.6 tp -70.31 -34.97 73.35 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.443 -1.318 . . . . 1.0 107.443 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -82.75 -53.38 5.94 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 116.551 -2.06 . . . . 1.0 108.062 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -52.16 -37.04 53.34 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.82 -1.082 . . . . 1.0 112.796 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.559 ' HA ' HG12 ' A' ' 70' ' ' ILE . 83.5 mt -82.28 -38.63 24.11 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.487 -1.285 . . . . 1.0 110.943 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 9.9 tt -62.86 -23.75 67.47 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 105.445 -2.058 . . . . 1.0 105.445 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -66.3 -35.26 79.92 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 117.635 -1.626 . . . . 1.0 109.363 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' A' ' 67' ' ' LEU . 12.6 mm -54.29 -38.19 39.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 113.453 -1.703 . . . . 1.0 113.103 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.431 ' CD2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -60.15 -27.36 67.03 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 120.913 1.688 . . . . 1.0 109.188 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.431 ' N ' ' CD2' ' A' ' 71' ' ' HIS . 58.4 t80 -73.86 -22.72 59.64 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.609 1.195 . . . . 1.0 110.422 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -85.97 -55.84 3.76 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 105.424 -2.065 . . . . 1.0 105.424 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.84 -35.64 34.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 113.503 -1.68 . . . . 1.0 111.368 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.63 -65.66 2.1 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 106.752 -2.539 . . . . 1.0 106.752 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 44.2 t -49.0 -60.3 2.89 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.97 1.47 . . . . 1.0 114.97 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.411 ' HA ' ' HE ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -62.01 -10.35 9.63 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 113.347 0.869 . . . . 1.0 113.347 -179.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -63.73 -57.78 8.9 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.651 -1.22 . . . . 1.0 109.75 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.7 t 176.82 63.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.898 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 42.7 25.4 0.05 OUTLIER 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 115.331 1.604 . . . . 1.0 115.331 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.4 mt 56.99 32.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-O 121.881 0.848 . . . . 1.0 108.899 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.27 65.69 0.54 Allowed Glycine 0 N--CA 1.498 2.78 0 CA-C-N 115.52 -0.764 . . . . 1.0 112.076 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.65 0 O-C-N 118.5 -2.765 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.839 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 67.8 -44.52 0.48 Allowed 'General case' 0 N--CA 1.51 2.572 0 N-CA-C 116.366 1.987 . . . . 1.0 116.366 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.36 48.74 2.88 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 110.301 -1.12 . . . . 1.0 110.301 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -118.26 -120.51 0.3 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.261 -1.385 . . . . 1.0 107.261 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.4 m -45.87 -33.19 3.04 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 113.953 1.094 . . . . 1.0 113.953 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -52.64 61.94 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 107.763 -1.199 . . . . 1.0 107.763 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.78 -47.01 88.24 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.339 -1.755 . . . . 1.0 108.73 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.62 -41.95 93.92 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 119.103 -1.522 . . . . 1.0 111.917 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 60' ' ' ILE . 94.2 t -79.82 -29.06 12.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 114.433 1.272 . . . . 1.0 114.433 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -65.96 -33.34 75.6 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.575 -2.009 . . . . 1.0 105.575 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.05 93.59 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 111.883 -2.417 . . . . 1.0 111.648 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 57' ' ' VAL . 1.7 pt -82.31 -29.83 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 117.061 -1.856 . . . . 1.0 106.83 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mt -61.71 -30.73 48.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.038 -1.437 . . . . 1.0 108.373 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -64.27 -55.83 18.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.43 -1.308 . . . . 1.0 114.228 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 64' ' ' LEU . 1.9 pp -69.7 -28.32 36.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 118.624 -1.23 . . . . 1.0 112.411 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 63' ' ' ILE . 29.0 tp -71.89 -33.28 68.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.542 ' N ' HE21 ' A' ' 65' ' ' GLN . 0.0 OUTLIER -79.41 -43.98 22.32 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 116.872 -1.931 . . . . 1.0 107.278 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.487 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 1.5 pt20 -54.42 -37.06 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.291 -0.963 . . . . 1.0 111.62 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.457 ' HG ' ' HG2' ' A' ' 66' ' ' GLN . 81.8 mt -82.77 -38.89 22.57 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.077 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.6 tp -66.21 -15.49 63.22 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' A' ' 66' ' ' GLN . 19.3 m-30 -69.76 -28.32 65.67 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 116.571 -2.052 . . . . 1.0 108.602 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.3 mt -53.44 -42.25 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 114.575 -1.193 . . . . 1.0 110.662 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.445 ' CD2' ' C ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -53.41 -32.37 49.32 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.606 0.717 . . . . 1.0 110.051 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -83.13 -18.19 40.38 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.576 -1.193 . . . . 1.0 111.151 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 69' ' ' PHE . 53.5 mtm180 -96.35 -16.98 20.98 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.875 -1.157 . . . . 1.0 107.875 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 mt -93.26 -56.18 5.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 113.524 -1.671 . . . . 1.0 107.928 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.88 -63.67 4.99 Favored Glycine 0 N--CA 1.499 2.836 0 C-N-CA 119.888 -1.148 . . . . 1.0 112.304 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 80.8 m -50.99 -44.97 60.95 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.464 -0.494 . . . . 1.0 110.096 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -63.14 -35.42 80.22 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.564 -0.744 . . . . 1.0 109.426 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.443 ' ND1' ' C ' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -82.81 -15.42 51.71 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 118.431 -1.308 . . . . 1.0 107.48 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.3 p -159.09 101.05 1.58 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 122.106 0.955 . . . . 1.0 113.217 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.576 ' H ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -64.28 7.68 0.13 Allowed 'General case' 0 N--CA 1.507 2.399 0 CA-C-N 115.015 -0.993 . . . . 1.0 113.355 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 25.5 mt 47.55 49.45 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-O 122.739 1.257 . . . . 1.0 110.793 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.07 61.33 1.38 Allowed Glycine 0 N--CA 1.497 2.705 0 CA-C-N 114.388 -1.278 . . . . 1.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.676 0 O-C-N 118.374 -2.839 . . . . 1.0 . . . . . . . . . . 0 0 . 1 stop_ save_